Publications and communications of Yves Henrotin

Articles in scientific journals with peer reviewing

Raman, R., Antony, M., Nivelle, R., Lavergne, A., Zappia, J., Guerrero Limon, G., Caetano da Silva, C., Kumari, P., Sojan, J. M., Degueldre, C., Bahri, M. A., Ostertag, A., Collet, C., Cohen-Solal, M., Plenevaux, A., Henrotin, Y., Renn, J., & Muller, M. (23 January 2024). The Osteoblast Transcriptome in Developing Zebrafish Reveals Key Roles for Extracellular Matrix Proteins Col10a1a and Fbln1 in Skeletal Development and Homeostasis. Biomolecules, 14 (2), 139. doi:10.3390/biom14020139

Raman, R., Bahri, M. A., Degueldre, C., Caetano da Silva, C., Sanchez, C., Ostertag, A., Collet, C., Cohen-Solal, M., Plenevaux, A., Henrotin, Y., & Muller, M. (14 January 2024). A Zebrafish Mutant in the Extracellular Matrix Protein Gene efemp1 as a Model for Spinal Osteoarthritis. Animals, 14 (1), 74. doi:10.3390/ani14010074

Henrotin, Y., Herman, J., Uebelhoer, M., Wauquier, F., Boutin-Wittrant, L., Donneau, A.-F., Monseur, J., Fotso, V. M., Duquenne, M., Wagner, M., Bouvret, E., Costes, B., & Wittrant, Y. (21 September 2023). Oral supplementation with fish cartilage hydrolysate in an adult population suffering from knee pain and function discomfort: results from an innovative approach combining an exploratory clinical study and an ex vivo clinical investigation. BMC Musculoskeletal Disorders, 24 (1), 748. doi:10.1186/s12891-023-06800-4

Zappia, J., Tong, Q., Van der Cruyssen, R., Cornelis, F. M. F., Lambert, C., Pinto Coelho, T., Grisart, J., Kague, E., Lories, R. J., Muller, M., Elewaut, D., Hammond, C. L., Sanchez, C., & Henrotin, Y. (20 September 2023). Osteomodulin downregulation is associated with osteoarthritis development. Bone Research, 11 (1), 49. doi:10.1038/s41413-023-00286-5

Gérain, J., Uebelhoer, M., Costes, B., Herman, J., Pietri, S., Donneau, A.-F., Monseur, J., & Henrotin, Y. (22 June 2023). NASAFYTOL® supplementation in adults hospitalized with COVID-19 infection: results from an exploratory open-label randomized controlled trial. Frontiers in Nutrition, 10. doi:10.3389/fnut.2023.1137407

Lawford, B. J., Master, H., Larsen, J. B., Bartholdy, C., Corrigan, P., Ginnerup-Nielsen, E., Le, C., Teoli, A., Bennell, K. L., Metcalf, B., Hinman, R. S., Button, K., Collins, N. J., Cottrell, E., Henrotin, Y., Skou, S. T., Thoma, L. M., Wellsandt, E., White, D. K., & Holden, M. A. (2023). What should a toolkit to aid the delivery of therapeutic exercise for hip and knee osteoarthritis look like? Qualitative analysis of an international survey of 318 researchers, clinicians, and consumers by the OARSI Rehabilitation Discussion Group. Musculoskeletal Care. doi:10.1002/msc.1732

Henrotin, Y., Szekanecz, Z., & Masuko, K. (2023). Editorial: Reviews in rheumatology. Frontiers in Medicine, 10, 1153419. doi:10.3389/fmed.2023.1153419

Im, G.-I., & Henrotin, Y. (2023). Regenerative medicine for early osteoarthritis. Therapeutic Advances in Musculoskeletal Disease, 15, 1759720X231194813. doi:10.1177/1759720X231194813

Uebelhoer, M., Lambert, C., Grisart, J., Guse, K., Plutizki, S., & Henrotin, Y. (2023). Interleukins, growth factors, and transcription factors are key targets for gene therapy in osteoarthritis: A scoping review. Frontiers in Medicine, 10, 1148623. doi:10.3389/fmed.2023.1148623

Henrotin, Y., Dierckxsens, Y., Delisse, G., Maes, N., & Albert, A. (December 2022). Curcuma longa and Boswellia serrata extract combination for hand osteoarthritis: an open-label pre-post trial. Pharmaceutical Biology, 60 (1), 2295 - 2299. doi:10.1080/13880209.2022.2147550

Conrozier, T., Diraçoglù, D., Monfort, J., Chevalier, X., Bard, H., Baron, D., Jerosch, J., Migliore, A., Richette, P., & Henrotin, Y. (2022). EUROVISCO Good Practice Recommendations for a First Viscosupplementation in Patients with Knee Osteoarthritis. Cartilage, 19476035221138958. doi:10.1177/19476035221138958

Holden, M. A., Metcalf, B., Lawford, B. J., Hinman, R. S., Boyd, M., Button, K., Collins, N. J., Cottrell, E., Henrotin, Y., Larsen, J. B., Master, H., Skou, S. T., Thoma, L. M., Rydz, R., Wellsandt, E., White, D. K., & Bennell, K. (2022). Recommendations for the delivery of therapeutic exercise for people with knee and/or hip osteoarthritis. An international consensus study from the OARSI Rehabilitation Discussion Group. Osteoarthritis and Cartilage. doi:10.1016/j.joca.2022.10.009

Henrotin, Y., Michlmayr, C., Rau, S. M., Quirke, A.-M., Bigoni, M., & Ueberall, M. A. (October 2022). Combination of Enzymes and Rutin to Manage Osteoarthritis Symptoms: Lessons from a Narrative Review of the Literature. Rheumatology and Therapy, 9 (5), 1305 - 1327. doi:10.1007/s40744-022-00472-7

Sanchez, C., Zappia, J., Lambert, C., FOGUENNE, J., Dierckxsens, Y., Dubuc, J.-E., Delcour, J.-P., Gothot, A., & Henrotin, Y. (11 August 2022). Curcuma longa and Boswellia serrata Extracts Modulate Different and Complementary Pathways on Human Chondrocytes In Vitro: Deciphering of a Transcriptomic Study. Frontiers in Pharmacology, 13. doi:10.3389/fphar.2022.931914

Henrotin, Y., Cozannet, R. L., Fança-Berthon, P., Truillet, R., Cohen-Solhal, M., DunnGalvin, G., Grouin, J.-M., & Doolan, A. (07 July 2022). Rubus idaeus extract improves symptoms in knee osteoarthritis patients: results from a phase II double-blind randomized controlled trial. BMC Musculoskeletal Disorders, 23 (1), 650. doi:10.1186/s12891-022-05612-2

Angelini, F., Widera, P., Mobasheri, A., Blair, J., Struglics, A., Uebelhoer, M., Henrotin, Y., Marijnissen, A. C., Kloppenburg, M., Blanco, F. J., Haugen, I. K., Berenbaum, F., Ladel, C., Larkin, J., Bay-Jensen, A. C., & Bacardit, J. (2022). Osteoarthritis endotype discovery via clustering of biochemical marker data. Annals of the Rheumatic Diseases, 81 (5), 666-675. doi:10.1136/annrheumdis-2021-221763

Henrotin, Y. (2022). Osteoarthritis in year 2021: biochemical markers. Osteoarthritis and Cartilage, 30 (2), 237-248. doi:10.1016/j.joca.2021.11.001

Horcajada, M.-N., Beaumont, M., Sauvageot, N., Poquet, L., Saboundjian, M., Costes, B., Verdonk, P., Brands, G., Brasseur, J., Urbin-Choffray, D., Vandenberghe, M., Brabants, K., De Vlam, K., Fache, W., Jandrain, B., Grek, V., MALAISE, M., & Henrotin, Y. (2022). An oleuropein-based dietary supplement may improve joint functional capacity in older people with high knee joint pain: findings from a multicentre-RCT and post hoc analysis. Therapeutic Advances in Musculoskeletal Disease, 14, 1759720X211070205. doi:10.1177/1759720X211070205

Sanchez, C., Lambert, C., Dubuc, J.-E., Bertrand, J., Pap, T., & Henrotin, Y. (20 December 2021). Syndecan-4 is Increased in Osteoarthritic Knee, but not Hip or Shoulder, Articular Hypertrophic Chondrocytes. Cartilage, 13 (Issue 2_suppl), 862S-871. doi:10.1177/1947603519870855

Sanchez, C., Hemmer, K., Krömmelbein, N., Seilheimer, B., Dubuc, J.-E., Antoine, C., & Henrotin, Y. (11 May 2021). Reduction of Matrix Metallopeptidase 13 and Promotion of Chondrogenesis by Zeel T in Primary Human Osteoarthritic Chondrocytes. Frontiers in Pharmacology, 12, 1-12. doi:10.3389/fphar.2021.635034

Conrozier, T., Raman, R., Chevalier, X., Henrotin, Y., Monfort, J., Diraçoglù, D., Bard, H., Baron, D., Jerosch, J., Richette, P., & Migliore, A. (2021). Viscosupplementation for the treatment of osteoarthritis. The contribution of EUROVISCO group. Therapeutic Advances in Musculoskeletal Disease, 13. doi:10.1177/1759720X211018605

Henrotin, Y., Antoine, C., Zwerts, E., Neutelings, T., & Bouvret, E. (2021). Oral supplementation with fish cartilage hydrolysate accelerates joint function recovery in rat model of traumatic knee osteoarthritis. Food Science and Nutrition, 9 (6), 2877-2885. doi:10.1002/fsn3.2244

Henrotin, Y., Tits, C., Paul, J., Gramme, P., Helleputte, T., Migliore, A., Richette, P., Chevalier, X., Monfort, J., Diracoglu, D., Bard, H., Jerosch, J., Baron, D., Raghu, R., & Conrozier, T. (2021). Retreatment with Hyaluronic Acid Viscosupplementation in Knee Osteoarthritis: Agreement between EUROVISCO Guidelines and Current Medical Practice. Cartilage, 19476035211053827. doi:10.1177/19476035211053827

Hick, A.-C., Malaise, M., Loeuille, D., Conrozier, T., Maugars, Y., Pelousse, F., Tits, C., & Henrotin, Y. (2021). Cartilage Biomarkers Coll2-1 and Coll2-1NO2 Are Associated with Knee OA MRI Features and Are Helpful in Identifying Patients at Risk of Disease Worsening. Cartilage. doi:10.1177/19476035211021892

Holden, M. A., Button, K., Collins, N. J., Henrotin, Y., Hinman, R. S., Larsen, J. B., Metcalf, B., Master, H., Skou, S. T., Thoma, L. M., Wellsandt, E., White, D. K., & Bennell, K. (2021). Guidance for Implementing Best Practice Therapeutic Exercise for Patients With Knee and Hip Osteoarthritis: What Does the Current Evidence Base Tell Us? Arthritis Care and Research, 73 (12), 1746-1753. doi:10.1002/acr.24434

L'Hote, C., Cordier, B., Labasse, A., Boileau, C., Costes, B., & Henrotin, Y. (2021). Identification of new biomarkers for sarcopenia and characterization of cathepsin D biomarker. JCSM Rapid Communications, 4, 122-132. doi:10.1002/rco2.26

Lambert, C., Bellemère, G., Boyer, G., Ponelle, F., Bauer, T., Legeny, M.-C., Baudouin, C., & Henrotin, Y. (2021). Composition Analysis and Pharmacological Activity of Avocado/Soybean Unsaponifiable Products Used in the Treatment of Osteoarthritis. Frontiers in Pharmacology, 12, 781389. doi:10.3389/fphar.2021.781389

Lambert, C., Zappia, J., Sanchez, C., Florin, A., Dubuc, J.-E., & Henrotin, Y. (2021). The Damage-Associated Molecular Patterns (DAMPs) as Potential Targets to Treat Osteoarthritis: Perspectives From a Review of the Literature. Frontiers in Medicine, 7, 607186. doi:10.3389/fmed.2020.607186

Mobasheri, A., Fonseca, J. E., Gualillo, O., Henrotin, Y., Largo, R., Herrero-Beaumont, G., & Rocha, F. A. C. (2021). Editorial: Inflammation and Biomarkers in Osteoarthritis. Frontiers in Medicine, 8, 727700. doi:10.3389/fmed.2021.727700

Florin, A., Lambert, C., Sanchez, C., Zappia, J., Durieux, N., Tieppo, A. M., Mobasheri, A., & Henrotin, Y. (2020). The secretome of skeletal muscle cells: A systematic review. Osteoarthritis and Cartilage Open. doi:10.1016/j.ocarto.2019.100019

Batshon, G., Elayyan, J., Qiq, O., Reich, E., Ben-Aderet, L., Kandel, L., Haze, A., Steinmeyer, J., Lefebvre, V., Zhang, H., Elisseeff, J., Henrotin, Y., Mobasheri, A., & Dvir-Ginzberg, M. (2020). Serum NT/CT SIRT1 ratio reflects early osteoarthritis and chondrosenescence. Annals of the Rheumatic Diseases, 79 (10), 1370-1380. doi:10.1136/annrheumdis-2020-217072

Henrotin, Y., Dierckxsens, Y., Delisse, G., SEIDEL, L., & Albert, A. (2020). Curcuminoids and Boswellia serrata extracts combination decreases tendinopathy symptoms: findings from an open-label post-observational study. Current Medical Research and Opinion, 1-20. doi:10.1080/03007995.2020.1860923

Montjean, R., Escaich, S., Paolini, R., Carelli, C., Pirson, S., Neutelings, T., Henrotin, Y., & Vêtu, C. (2020). REG-O3 chimeric peptide combining growth hormone and somatostatin sequences improves joint function and prevents cartilage degradation in rat model of traumatic knee osteoarthritis. PLoS ONE, 15 (4), 0231240. doi:10.1371/journal.pone.0231240

Zappia, J., Joiret, M., Sanchez, C., Lambert, C., Geris, L., Muller, M., & Henrotin, Y. (2020). From translation to protein degradation as mechanisms for regulating biological functions: A review on the SLRP family in skeletal tissues. Biomolecules, 10, 80. doi:10.3390/biom10010080

Henrotin, Y. (February 2019). Les nouveaux biomarqueurs de l'arthrose. Lettre du Rhumatologue, 449, 16-19.

Boisson, M., Borderie, D., Henrotin, Y., Teboul-Coré, S., Lefèvre-Colau, M.-M., Rannou, F., & Nguyen, C. (2019). Serum biomarkers in people with chronic low back pain and Modic 1 changes: a case-control study. Scientific Reports, 9 (1). doi:10.1038/s41598-019-46508-x

de Visser, H. M., Sanchez, C., Mastbergen, S. C., Lafeber, F. P. J. G., Henrotin, Y., & Weinans, H. (2019). Fib3-3 as a Biomarker for Osteoarthritis in a Rat Model with Metabolic Dysregulation. Cartilage, 10 (3), 329-334. doi:10.1177/1947603518754629

Elango, J., Saravanakumar, K., Rahman, S. U., Henrotin, Y., Regenstein, J. M., Wu, W., & Bao, B. (2019). Chitosan-collagen 3d matrix mimics trabecular bone and regulates rankl-mediated paracrine cues of differentiated osteoblast and mesenchymal stem cells for bone marrow macrophage-derived osteoclastogenesis. Biomolecules, 9 (5). doi:10.3390/biom9050173

Henrotin, Y., Bannuru, R., Malaise, M., Ea, H.-K., Confavreux, C., Bentin, J., Urbin-Choffray, D., Conrozier, T., Brasseur, J.-P., Thomas, P., Hick, A.-C., Marinello, A., Giordan, N., & Richette, P. (2019). Hyaluronan derivative HYMOVIS® increases cartilage volume and type ii collagen turnover in osteoarhritic knee: Data from MOKHA study. BMC Musculoskeletal Disorders, 20 (1). doi:10.1186/s12891-019-2667-0

Henrotin, Y., Malaise, M., Wittoek, R., De Vlam, K., Brasseur, J.-P., Luyten, F. P., Jiangang, Q., Van Den Berghe, M., Uhoda, R., Bentin, J., De Vroey, T., Erpicum, L., Donneau, A.-F., & Dierckxsens, Y. (2019). Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: A double-blind multicenter randomized placebo controlled three-arm study. Arthritis Research and Therapy, 21 (1). doi:10.1186/s13075-019-1960-5

Henrotin, Y., Patrier, S., Pralus, A., Roche, M., & Nivoliez, A. (2019). Protective Actions of Oral Administration of Bifidobacterium longum CBi0703 in Spontaneous Osteoarthritis in Dunkin Hartley Guinea Pig Model. Cartilage. doi:10.1177/1947603519841674

Hick, A.-C., Fonck, M., Costes, B., Cobraiville, E., Pirson, S., Garcia, L., Labasse, A., Vander Poelen, S., & Henrotin, Y. (2019). Serum Levels of Coll2-1, a Specific Biomarker of Cartilage Degradation, Are Not Affected by Sampling Conditions, Circadian Rhythm, and Seasonality. Cartilage, 1947603519878489. doi:10.1177/1947603519878489

Lambert, C., Borderie, D., Dubuc, J.-E., Rannou, F., & Henrotin, Y. (2019). Type II collagen peptide Coll2-1 is an actor of synovitis. Osteoarthritis and Cartilage, 27 (11), 1680-1691. doi:10.1016/j.joca.2019.07.009

Mobasheri, A., Lambert, C., & Henrotin, Y. (2019). Coll2-1 and Coll2-1NO2 as exemplars of collagen extracellular matrix turnover–biomarkers to facilitate the treatment of osteoarthritis? Expert Review of Molecular Diagnostics, 19 (9), 803-812. doi:10.1080/14737159.2019.1646641

Mobasheri, A., van Spil, W. E., Budd, E., Uzieliene, I., Bernotiene, E., Bay-Jensen, A.-C., Larkin, J., Levesque, M. C., Gualillo, O., & Henrotin, Y. (2019). Molecular taxonomy of osteoarthritis for patient stratification, disease management and drug development: biochemical markers associated with emerging clinical phenotypes and molecular endotypes. Current Opinion in Rheumatology, 31 (1), 80-89. doi:10.1097/BOR.0000000000000567

Legrand, C., Ahmed, U., Anwar, A., Rajpoot, K., Pasha, S., Lambert, C., Davidson, R. K., Clark, I. M., Thornalley, P. J., Henrotin, Y., & Rabbani, N. (June 2018). Glycation marker glucosepane increases with the progression of osteoarthritis and correlates with morphological and functional changes of cartilage in vivo. Arthritis Research and Therapy, 20 (1), 131. doi:10.1186/s13075-018-1636-6

Conrozier, T., Monfort, J., Chevalier, X., Raman, R., Richette, P., Diraçoglù, D., Bard, H., Baron, D., Jerosch, J., Migliore, A., & Henrotin, Y. (2018). EUROVISCO Recommendations for Optimizing the Clinical Results of Viscosupplementation in Osteoarthritis. Cartilage. doi:10.1177/1947603518783455

Elango, J., Lee, J., Wang, S., Henrotin, Y., De Val, J. E. M. S., Regenstein, J. M., Lim, S. Y., Bao, B., & Wu, W. (2018). Evaluation of differentiated bone cells proliferation by blue shark skin collagen via biochemical for bone tissue engineering. Marine Drugs, 16 (10), 350. doi:10.3390/md16100350

Elango, J., Sanchez, C., de Val, J. E. M. S., Henrotin, Y., Wang, S., Motaung, K. S. C. M., Guo, R., Wang, C., Robinson, J., Regenstein, J. M., Bao, B., & Wu, W. (2018). Cross-talk between primary osteocytes and bone marrow macrophages for osteoclastogenesis upon collagen treatment. Scientific Reports, 8 (1), 5318. doi:10.1038/s41598-018-23532-x

Henrotin, Y. (2018). Avocado/Soybean Unsaponifiables (Piacledine®300) show beneficial effect on the metabolism of osteoarthritic cartilage, synovium and subchondral bone: An overview of the mechanisms. AIMS Medical Science, 5 (1), 33-52.

Henrotin, Y. (2018). Avancées de la recherche sur les marqueurs biologiques de l'arthrose. Bulletin de l'Académie Nationale de Médecine, 202 (1-2), 173-181. doi:10.1016/s0001-4079(19)30349-8

Henrotin, Y., Chevalier, X., Raman, R. N., Richette, P., Montfort, J., Jerosch, J. G., Baron, D., Bard, H., Carrillon, Y., Migliore, A., & Conrozier, T. (2018). EUROVISCO Guidelines for the Design and Conduct of Clinical Trials Assessing the Disease-Modifying Effect of Knee Viscosupplementation. Cartilage. doi:10.1177/1947603518783521

Henrotin, Y., & Mobasheri, A. (2018). Natural Products for Promoting Joint Health and Managing Osteoarthritis. Current Rheumatology Reports, 20 (11), 72. doi:10.1007/s11926-018-0782-9

Raman, R. N., Henrotin, Y., Chevalier, X., Migliore, A., Jerosch, J., Montfort, J., Bard, H., Baron, D., Richette, P., & Conrozier, T. (2018). Decision Algorithms for the Retreatment with Viscosupplementation in Patients Suffering from Knee Osteoarthritis: Recommendations from the EUROpean VIScosupplementation COnsensus Group (EUROVISCO). Cartilage. doi:10.1177/1947603517693043

Sanchez, C., Mazzucchelli, G., Lambert, C., Comblain, F., De Pauw, E., & Henrotin, Y. (2018). Comparison of secretome from osteoblasts derived from sclerotic versus non-sclerotic subchondral bone in OA: A pilot study. PLoS ONE, 13 (3), 0194591. doi:10.1371/journal.pone.0194591

Tavasolian, F., Abdollahi, E., Rezaei, R., Momtazi-borojeni, A. A., Henrotin, Y., & Sahebkar, A. (2018). Altered Expression of MicroRNAs in Rheumatoid Arthritis. Journal of Cellular Biochemistry, 119 (1), 478-487. doi:10.1002/jcb.26205

Sanchez, C., Bay-Jensen, A.-C., Pap, T., Dvir-Ginzberg, M., Quasnichka, H., Barrett-Jolley, R., Mobasheri, A., & Henrotin, Y. (August 2017). Chondrocyte secretome: a source of novel insights and exploratory biomarkers of osteoarthritis. Osteoarthritis and Cartilage, 25, 1199-1209. doi:10.1016/j.joca.2017.02.797

Demoulin, C., Depas, Y., Vanderthommen, M., Henrotin, Y., Wolfs, S., Cagnie, B., & Hidalgo, B. (March 2017). LA THÉRAPIE MANUELLE ORTHOPÉDIQUE : définition, caractéristiques et mise au point sur la situation en Belgique. Revue Médicale de Liège, 72 (3), 126-131.

Bartels, E. M., Henrotin, Y., Bliddal, H., Centonze, P., & Henriksen, M. (2017). Relationship between weight loss in obese knee osteoarthritis patients and serum biomarkers of cartilage breakdown: secondary analyses of a randomised trial. Osteoarthritis and Cartilage, 25 (10), 1641-1646. doi:10.1016/j.joca.2017.06.009

Comblain, F., Barthelemy, N., Lefebvre, M., Schwartz, C., Lesponne, I., Serisier, S., Feugier, A., Balligand, M., & Henrotin, Y. (2017). A randomized, double-blind, prospective, placebo-controlled study of the efficacy of a diet supplemented with curcuminoids extract, hydrolyzed collagen and green tea extract in owner's dogs with osteoarthritis. BMC Veterinary Research, 13, 395. doi:10.1186/s12917-017-1317-8

Comblain, F., Rocasalbas, G., Gautier, S., & Henrotin, Y. (2017). Chitosan : a promising polymer for cartilage repair and viscosupplementation. Bio-medical Materials and Engineering. doi:10.3233/BME-171643

Elayyan, J., Lee, E.-J., Gabay, O., Smith, C. A., Qiq, O., Reich, E., Mobasheri, A., Henrotin, Y., Kimber, S. J., & Dvir-Ginzberg, M. (2017). LEF1-mediated MMP13 gene expression is repressed by SIRT1 in human chondrocytes. FASEB Journal. doi:10.1096/fj.201601253R

Henrotin, Y., Berenbaum, F., Chevalier, X., Marty, M., Richette, P., & Rannou, F. (2017). Reduction of the Serum Levels of a Specific Biomarker of Cartilage Degradation (Coll2-1) by Hyaluronic Acid (KARTILAGE® CROSS) Compared to Placebo in Painful Knee Osteoarthritis Patients: The EPIKART Study, a Pilot Prospective Comparative Randomized Double Blind Trial. BMC Musculoskeletal Disorders, 18 (1). doi:10.1186/s12891-017-1585-2

Lazzarini, N., Runhaar, J., Bay-Jensen, A. C., Thudium, C. S., Bierma-Zeinstra, S. M. A., Henrotin, Y., & Bacardit, J. (2017). A machine learning approach for the identification of new biomarkers for knee osteoarthritis development in overweight and obese women. Osteoarthritis and Cartilage, 25 (12), 2014-2021. doi:10.1016/j.joca.2017.09.001

Legrand, C., Lambert, C., Comblain, F., Sanchez, C., & Henrotin, Y. (2017). Review of soluble biomarkers of osteoarthritis: lessons from animal model. Cartilage, 1-23. doi:10.1177/1947603516656739

Luo, Y., Sinkeviciute, D., He, Y., Karsdal, M., Henrotin, Y., Mobasheri, A., Önnerfjord, P., & Bay-Jensen, A. (2017). The minor collagens in articular cartilage. Protein and Cell, 8 (8), 560-572. doi:10.1007/s13238-017-0377-7

Mobasheri, A., Bay-Jensen, A.-C., Gualillo, O., Larkin, J., Levesque, M. C., & Henrotin, Y. (2017). Soluble biochemical markers of osteoarthritis: Are we close to using them in clinical practice? Best Practice and Research. Clinical Rheumatology, 31, 705-720. doi:10.1016/j.berh.2018.07.002

Comblain, F., Dubuc, J.-E., Lambert, C., Sanchez, C., Lesponne, I., Serisier, S., & Henrotin, Y. (2016). Identification of Targets of a New Nutritional Mixture for Osteoarthritis Management Composed by Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract. PLoS ONE. doi:10.1371/journal.pone.0156902

Henrotin, Y., Sanchez, C., Bay-Jensen, A. C., & Mobasheri, A. (June 2016). Osteoarthritis biomarkers derived from cartilage extracellular matrix: Current status and future perspectives. Annals of Physical and Rehabilitation Medicine, 59 (3), 145-148. doi:10.1016/j.rehab.2016.03.004

Runhaar, J.* , Sanchez, C.* , Taralla, S., Henrotin, Y., & Bierma-Zeinstra, S. M. A. (April 2016). Fibulin-3 fragments are prognostic biomarkers of osteoarthritis incidence in overweight and obese women. Osteoarthritis and Cartilage, 24 (4), 672-678. doi:10.1016/j.joca.2015.10.013
* These authors have contributed equally to this work.

Bay-Jensen, A.-C., Henrotin, Y., Karsdal, M., & Mobasheri, A. (2016). The need for predictive, prognostic, objective and complementary blood-based biomarkers in osteoarthritis (OA). EBioMedicine. doi:10.1016/j.ebiom.2016.05.004

Bay-Jensen, A. C., Reker, D., Kjelgaard-Petersen, C. F., Mobasheri, A., Karsdal, M. A., Ladel, C., Henrotin, Y., & Thudium, C. S. (2016). Osteoarthritis year in review 2015: soluble biomarkers and the BIPED criteria. Osteoarthritis and Cartilage, 24 (1), 9-20. doi:10.1016/j.joca.2015.10.014

Comblain, F., Serisier, S., Barthelemy, N., Balligand, M., & Henrotin, Y. (2016). Review of dietary supplements for the management of osteoarthritis in dogs in studies from 2004 to 2014. Journal of Veterinary Pharmacology and Therapeutics, 39, 1-15. doi:10.1111/jvp.12251

Demoulin, C., Roussel, N., Marty, M., Mathy, C., Genevay, S., Henrotin, Y., Tomasella, M., Mahieu, G., & Vanderthommen, M. (2016). Les croyances délétères des patients lombalgiques : revue narrative de la littérature. Revue Médicale de Liège, 71 (1), 40-46.

Demoulin, C., Vanderthommen, M., GROSDENT, S., & Henrotin, Y. (2016). Techniques de réhabilitation abdominale et spinale pour le patient lombalgique. EMC - Kinésithérapie - Médecine Physique - Réadaptation.

Hochberg, M. C., Martel-Pelletier, J., Monfort, J., Moller, I., Castillo, J. R., Arden, N., Berenbaum, F., Blanco, F. J., Conaghan, P. G., Domenech, G., Henrotin, Y., Pap, T., Richette, P., Sawitzke, A., du Souich, P., Pelletier, J. P., & Group, M. I. (2016). Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Annals of the Rheumatic Diseases, 75 (1), 37-44. doi:10.1136/annrheumdis-2014-206792

Moller, I., Gharbi, M., Martinez Serrano, H., Herrero Barbero, M., Verges Milano, J., & Henrotin, Y. (2016). Effect of chondroitin sulfate on soluble biomarkers of osteoarthritis: a method to analyze and interpret the results from an open-label trial in unilateral knee osteoarthritis patients. BMC Musculoskeletal Disorders, 17 (1), 416. doi:10.1186/s12891-016-1268-4

Sahebkar, A., & Henrotin, Y. (2016). Analgesic Efficacy and Safety of Curcuminoids in Clinical Practice: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Pain Medicine. doi:10.1093/pm/pnv024

Oprenyeszk, F., Sanchez, C., Dubuc, J.-E., Maquet, V., Henrist, C., Compère, P., & Henrotin, Y. (28 May 2015). Chitosan enriched three-dimensional matrix reduces inflammatory and catabolic mediators production by human chondrocytes. PLoS ONE, 10 (5). doi:10.1371/journal.pone.0128362

Réeff, J., Oprenyeszk, F., Franck, T., Goole, J., De Vriese, C., Serteyn, D., Henrotin, Y., & Amighi, K. (28 April 2015). Development and evaluation in vitro and in vivo of injectable hydrolipidic gels with sustained-release properties for the management of articular pathologies such as osteoarthritis. International Journal of Pharmaceutics, 490, 74-84. doi:10.1016/j.ijpharm.2015.04.064

Comblain, F., Sanchez, C., Lesponne, I., Balligand, M., Serisier, S., & Henrotin, Y. (2015). Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract Synergically Inhibit Inflammatory and Catabolic Mediator's Synthesis by Normal Bovine and Osteoarthritic Human Chondrocytes in Monolayer. PLoS ONE. doi:10.1371/journal.pone.0121654

Henrotin, Y., Raman, R., Richette, P., Bard, H., Jerosch, J., Conrozier, T., Chevalier, X., & Migliore, A. (2015). Consensus statement on viscosupplementation with hyaluronic acid for the management of osteoarthritis. Seminars in Arthritis and Rheumatism, 45 (2), 140-9. doi:10.1016/j.semarthrit.2015.04.011

Henrotin, Y., Sanchez, C., Cornet, A., Van de Put, J., Douette, P., & Gharbi, M. (2015). Soluble biomarkers development in osteoarthritis: from discovery to personalized medicine. Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals, 20 (8), 540-6. doi:10.3109/1354750X.2015.1123363

Horcajada, M.-N.* , Sanchez, C.* , Membrez Scalfo, Drion, P., Comblain, F., Taralla, S., Donneau, A.-F., Offord, E. A., & Henrotin, Y. (2015). Oleuropein or rutin consumption decreases the spontaneous development of osteoarthritis in the Hartley guinea pig. Osteoarthritis and Cartilage, 23 (1), 94-102. doi:10.1016/j.joca.2014.08.016
* These authors have contributed equally to this work.

Jordan, J. M., & Henrotin, Y. (2015). Osteoarthritis research society international initiative on recommendations for conducting clinical trials in osteoarthritis: overview. Osteoarthritis and Cartilage, 23 (5), 671-3. doi:10.1016/j.joca.2015.03.016

Kloppenburg, M., Maheu, E., Kraus, V. B., Cicuttini, F., Doherty, M., Dreiser, R. L., Henrotin, Y., Jiang, G. L., Mandl, L., Martel-Pelletier, J., Nelson, A. E., Neogi, T., Pelletier, J. P., Punzi, L., Ramonda, R., Simon, L. S., Wang, S., & Group, O. H. C. T. R. W. (2015). OARSI Clinical Trials Recommendations: Design and conduct of clinical trials for hand osteoarthritis. Osteoarthritis and Cartilage, 23 (5), 772-86. doi:10.1016/j.joca.2015.03.007

Kraus, V. B., Blanco, F. J., Englund, M., Henrotin, Y., Lohmander, L. S., Losina, E., Onnerfjord, P., & Persiani, S. (2015). OARSI Clinical Trials Recommendations: Soluble biomarker assessments in clinical trials in osteoarthritis. Osteoarthritis and Cartilage, 23 (5), 686-97. doi:10.1016/j.joca.2015.03.002

Landsmeer, M. L., Runhaar, J., Henrotin, Y., Middelkoop van, M., Oei, E. H., Vroegindeweij, D., Reijman, M., van Osch, G. J., Koes, B. W., Bindels, P. J., & Bierma-Zeinstra, S. M. A. (2015). Association of urinary biomarker COLL2-1NO2 with incident clinical and radiographic knee OA in overweight and obese women. Osteoarthritis and Cartilage, 23 (8), 1398-404. doi:10.1016/j.joca.2015.04.011

Lane, N. E., Hochberg, M. C., Nevitt, M. C., Simon, L. S., Nelson, A. E., Doherty, M., Henrotin, Y., & Flechsenhar, K. (2015). OARSI Clinical Trials Recommendations: Design and conduct of clinical trials for hip osteoarthritis. Osteoarthritis and Cartilage, 23 (5), 761-71. doi:10.1016/j.joca.2015.03.006

Mathy, C., Cedraschi, C., Broonen, J.-P., Azzi, A., & Henrotin, Y. (2015). Volition and low back pain: When patients talk. Annals of Physical and Rehabilitation Medicine, 58 (6), 326-31. doi:10.1016/j.rehab.2015.10.005

McAlindon, T. E., Bannuru, R. R., Sullivan, M. C., Arden, N. K., Berenbaum, F., Bierma-Zeinstra, S. M. A., Hawker, G. A., Henrotin, Y., Hunter, D. J., Kawaguchi, H., Kwoh, K., Lohmander, S., Rannou, F., Roos, E. M., & Underwood, M. (2015). Corrigendum to '2014 OARSI Guidelines for the Non-Surgical Management of Knee Osteoarthritis' [Osteoarthritis and Cartilage 22(2014) 363-388]. Osteoarthritis and Cartilage, 23 (6), 1026-1034. doi:10.1016/j.joca.2015.02.014

McAlindon, T. E., Driban, J. B., Henrotin, Y., Hunter, D. J., Jiang, G. L., Skou, S. T., Wang, S., & Schnitzer, T. (2015). OARSI Clinical Trials Recommendations: Design, conduct, and reporting of clinical trials for knee osteoarthritis. Osteoarthritis and Cartilage, 23 (5), 747-60. doi:10.1016/j.joca.2015.03.005

Mobasheri, A., & Henrotin, Y. (2015). Biomarkers of (osteo)arthritis. Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals, 20 (8), 513-8. doi:10.3109/1354750X.2016.1140930

Richette, P., Chevalier, X., Ea, H. K., Eymard, F., Henrotin, Y., Ornetti, P., Sellam, J., Cucherat, M., & Marty, M. (2015). Hyaluronan for knee osteoarthritis: an updated meta-analysis of trials with low risk of bias. RMD Open, 1 (1), 000071. doi:10.1136/rmdopen-2015-000071

Sanchez, C., Horcajada, M.-N., Membrez Scalfo, F., Ameye, L., Offord, E., & Henrotin, Y. (2015). Carnosol Inhibits Pro-Inflammatory and Catabolic Mediators of Cartilage Breakdown in Human Osteoarthritic Chondrocytes and Mediates Cross-Talk between Subchondral Bone Osteoblasts and Chondrocytes. PLoS ONE, 10 (8), 0136118. doi:10.1371/journal.pone.0136118

Henrotin, Y., & Mathy, C. (November 2014). Au stade aigu: traiter efficacement pour éviter le passage à la chronicité. Concours Medical, 136, 693-695.

Henrotin, Y., Lambert, C., & Richette, P. (April 2014). Importance of synovitis in osteoarthritis: Evidence for the use of glycosaminoglycans against synovial inflammation. Seminars in Arthritis and Rheumatism, 43 (5), 579-87. doi:10.1016/j.semarthrit.2013.10.005

Pesesse, L., Sanchez, C., Walsh, D., Delcour, J.-P., Baudouin, C., Msika, P., & Henrotin, Y. (April 2014). Bone sialoprotein as a potential key factor implicated in the pathophysiology of osteoarthritis. Osteoarthritis and Cartilage, 22 (4), 547-56. doi:10.1016/j.joca.2014.01.010

McAlindon, T. E., & Henrotin, Y. (March 2014). OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis and Cartilage, 22 (3), 363-388. doi:10.1016/j.joca.2014.01.003

Henrotin, Y., Pesesse, L., & Lambert, C. (February 2014). Targeting the synovial angiogenesis as a novel treatment approach to osteoarthritis. Therapeutic Advances in Musculoskeletal Disease, 6 (1), 20-34. doi:10.1177/1759720X13514669

Henrotin, Y. (2014). L'inhibition des voies de signalisation est-elle une possibilité thérapeutique pour l'arthrose? Revue du Rhumatisme, 81, 275-277. doi:10.1016/j.rhum.2014.02.005

Henrotin, Y. (2014). Does signalling pathways inhibition hold therapeutic promise for osteoarthritis? Joint Bone Spine, 81, 281-283. doi:10.1016/j.jbspin.2014.03.002

Henrotin, Y. (2014). Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial. BMC Complementary and Alternative Medicine. doi:10.1186/1472-6882-14-159

Henrotin, Y., Marty, M., & Mobasheri, A. (2014). What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis? Maturitas, 78, 184-187. doi:10.1016/j.maturitas.2014.04.015

Lambert, C., Dubuc, J.-E., Montell, E., Verges, J., Munaut, C., Noël, A., & Henrotin, Y. (2014). Gene expression pattern of synovial cells from inflammatory and normal areas of osteoarthritis synovial membrane. Arthritis and Rheumatism, sous presse. doi:10.1002/art.38315

Dobson, F., & Henrotin, Y. (October 2013). OARSI recommended performance-based tests to assess clinical function in osteoathritis of hip and knee: author's reply. Osteoarthritis and Cartilage, 21 (10), 1625-1626.

Oprenyeszk, F., Chausson, M., Maquet, V., Dubuc, J.-E., & Henrotin, Y. (August 2013). Protective effect of a new biomaterial against the development of experimental osteoarthritis lesions in rabbit: a pilot study evaluating the intra-articular injection of alginate-chitosan beads dispersed in an hydrogel. Osteoarthritis and Cartilage, 21 (8), 1099-1107. doi:10.1016/j.joca.2013.04.017

Gharbi, M., Sanchez, C., Mazzucchelli, G., De Pauw, E., & Henrotin, Y. (2013). Identification of differential pattern of protein expression in canine osteoarthritis serum after anterior cruciate ligament transection: a proteomic analysis. Veterinary Journal, 197 (3), 848-53. doi:10.1016/j.tvjl.2013.05.037

Henrotin, Y. (2013). L’instabilité cervicogénique. Réflexions Rhumatologiques, 17 (162), 11-13.

Henrotin, Y., Chevalier, X., DEBERG, M., Balblanc, J. C., Richette, P., Mulleman, D., Maillet, B., Rannou, F., Piroth, C., Mathieu, P., & Conrozier, T. (2013). Early decrease of serum biomarkers of type II collagen degradation (Coll2-1) and joint inflammation (Coll2-1 NO(2) ) by hyaluronic acid intra-articular injections in patients with knee osteoarthritis: a research study part of the Biovisco study. Journal of Orthopaedic Research, 31 (6), 901-7. doi:10.1002/jor.22297

Henrotin, Y., Labasse, A., Franck, T., Bosseloir, A., Bury, T., & DEBERG, M. (2013). Collagen catabolism through Coll2-1 and Coll2-1NO and myeloperoxidase activity in marathon runners. SpringerPlus, 2 (1), 92. doi:10.1186/2193-1801-2-92

Henrotin, Y., & Lambert, C. (2013). Chondroitin and glucosamine in the management of osteoarthritis: an update. Current Rheumatology Reports. doi:10.1007/s11926-013-0361-z

Pesesse, L., Sanchez, C., Delcour, J.-P., Bellahcene, A., Baudouin, C., Msika, P., & Henrotin, Y. (2013). Consequences of chondrocyte hypertrophy on osteoarthritic cartilage: potential effect on angiogenesis. Osteoarthritis and Cartilage, 21 (12), 1913-23. doi:10.1016/j.joca.2013.08.018

Henrotin, Y., Pesesse, L., & Sanchez, C. (December 2012). Subchondral bone and osteoarthritis: biological and cellular aspects. Osteoporosis International, 23 (Suppl 8), 847–S851. doi:10.1007/s00198-012-2162-z

Lambert, C., Mathy-Hartert, M., Dubuc, J., Montell, E., Vergés, J., Munaut, C., Noël, A., & Henrotin, Y. (March 2012). Characterization of synovial angiogenesis in osteoarthritis patients and its modulation by chondroitin sulfate. Arthritis Research and Therapy, 14 (2), 58. doi:10.1186/ar3771

Demoulin, C., Marty, M., Genevay, S., Vanderthommen, M., Mahieu, G., & Henrotin, Y. (2012). Effectiveness of preventive back educational interventions for low back pain: a critical review of randomized controlled clinical trials. European Spine Journal, 21, 2520-2530. doi:10.1007/s00586-012-2445-2

Henrotin, Y. (2012). Osteoarthritis year 2011 in review: biochemical markers of osteoarthritis: an overview of research and initiatives. Osteoarthritis and Cartilage, 20 (3), 215-7. doi:10.1016/j.joca.2012.01.008

Henrotin, Y. (2012). Interpretation of metaanalyses: pitfalls should be more widely recognized. Journal of Rheumatology, 39 (6), 1107-9. doi:10.3899/jrheum.111420

Henrotin, Y., Gharbi, M., Mazzucchelli, G., Dubuc, J.-E., De Pauw, E., & DEBERG, M. (2012). Fibulin 3 peptides Fib3-1 and Fib3-2 are potential biomarkers of osteoarthritis. Arthritis and Rheumatism, 64 (7), 2260-7. doi:10.1002/art.34392

Henrotin, Y., Hauzeur, J.-P., Bruel, P., & Appelboom, T. (2012). Intra-articular use of a medical device composed of hyaluronic acid and chondroitin sulfate (Structovial CS): effects on clinical, ultrasonographic and biological parameters. BMC Research Notes, 5 (1), 407. doi:10.1186/1756-0500-5-407

Henrotin, Y., Martel-Pelletier, J., Msika, P., Guillou, G. B., & DEBERG, M. (2012). Usefulness of specific OA biomarkers, Coll2-1 and Coll2-1NO(2), in the anterior cruciate ligament OA canine model. Osteoarthritis and Cartilage, 20 (7), 787-90. doi:10.1016/j.joca.2012.03.016

Henrotin, Y., & Mobasheri, A. (2012). Soluble Biomarkers in Osteoarthritis – Current Status and Future Prospects? European Musculoskeletal Review, 7 (4), 217-220.

Henrotin, Y., Mobasheri, A., & Marty, M. (2012). Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis? Arthritis Research and Therapy, 14 (1), 201. doi:10.1186/ar3657

Henrotin, Y., Pesesse, L., & Sanchez, C. (2012). L’os sous chondral et l’angiogenèse : deux nouvelles cibles thérapeutiques de l’arthrose. Réflexions Rhumatologiques, 16, 19-21.

Mobasheri, A., Henrotin, Y., Biesalski, H.-K., & Shakibaei, M. (2012). Scientific Evidence and Rationale for the Development of Curcumin and Resveratrol as Nutraceutricals for Joint Health. International Journal of Molecular Sciences, 13, 4202-4232. doi:10.3390/ijms13044202

Punzi, L., Ramonda, R., DEBERG, M., Frallonardo, P., Campana, C., Musacchio, E., & Henrotin, Y. (2012). Coll2-1, Coll2-1NO2 and myeloperoxidase serum levels in erosive and non-erosive osteoarthritis of the hands. Osteoarthritis and Cartilage, 20 (6), 557-61. doi:10.1016/j.joca.2012.02.638

Sanchez, C., Pesesse, L., Gabay, O., Delcour, J.-P., Msika, P., Baudouin, C., & Henrotin, Y. (2012). Regulation of subchondral bone osteoblast metabolism by cyclic compression. Arthritis and Rheumatism, 64 (4), 1193-203. doi:10.1002/art.33445

Broonen, J.-P., Marty, M., Legout, V., Cedraschi, C., & Henrotin, Y. (2011). La volition est-elle un chaînon manquant de la prise en charge du patient lombalgique ? Revue du Rhumatisme, 78 (1), 238-41. doi:10.1016/j.rhum.2010.08.019

Broonen, J.-P., Marty, M., Legout, V., Cedraschi, C., & Henrotin, Y. (2011). Is volition the missing link in the management of low back pain? Joint Bone Spine, 78, 364-367. doi:10.1016/j.jbspin.2010.10.009

Conrozier, T., Balblanc, J. C., Richette, P., Mulleman, D., Maillet, B., Henrotin, Y., Rannou, F., Piroth, C., Hilliquin, P., Mathieu, P., Walliser-Lohse, A., Rousselot, I., Plattner, V., Maillefert, J. F., Vignon, E., & Chevalier, X. (2011). Early effect of hyaluronic acid intra-articular injections on serum and urine biomarkers in patients with knee osteoarthritis: An open-label observational prospective study. Journal of Orthopaedic Research. doi:10.1002/jor.21580

Gharbi, M., Deberg, M., & Henrotin, Y. (2011). Application for proteomic techniques in studying osteoarthritis: a review. Frontiers in Physiology, 2 (90), 4-14. doi:10.3389/fphys.2011.00090

Henrotin, Y. (2011). Muscle: a source of progenitor cells for bone fracture healing. BMC Medicine, 9, 136. doi:10.1186/1741-7015-9-136

Henrotin, Y., Lambert, C., Couchourel, D., Ripoll, C., & Chiotelli, E. (2011). Nutraceuticals: do they represent a new era in the management of osteoarthritis? - a narrative review from the lessons taken with five products. Osteoarthritis and Cartilage, 19 (1), 1-21. doi:10.1016/j.joca.2010.10.017

Henrotin, Y., Moyse, D., Bazin, T., Cedraschi, C., Duplan, B., Duquesnoy, B., Laroche, F., Valat, J.-P., & Marty, M. (2011). Study of the information delivery by general practitioners and rheumatologists to patients with acute low back pain. European Spine Journal, 20 (5), 720-30. doi:10.1007/s00586-010-1612-6

Henrotin, Y., Pesesse, L., & Sanchez, C. (2011). La dégénérescence discale est-elle une histoire d’« Os » ? Revue du Rhumatisme, 78, 3-7. doi:10.1016/j.monrhu.2010.09.004

Kraus, V. B., Burnett, B., Coindreau, J., Cottrell, S., Eyre, D., Gendreau, M., Gardiner, J., Garnero, P., Hardin, J., Henrotin, Y., Heinegard, D., Ko, A., Lohmander, L. S., Matthews, G., Menetski, J., Moskowitz, R., Persiani, S., Poole, A. R., Rousseau, J.-C., & Todman, M. (2011). Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis and Cartilage, 19 (5), 515-42. doi:10.1016/j.joca.2010.08.019

Mathy, C., Broonen, J.-P., Henrotin, Y., Marty, M., Legout, V., Genevay, S., Duplan, B., Bazin, T., Laroche, F., Savarieau, B., & Cedraschi, C. (2011). Development and validation of a questionnaire assessing volitional competencies to enhance the performance of physical activities in chronic low back pain patients. BMC Musculoskeletal Disorders, 12, 111. doi:10.1186/1471-2474-12-111

Mobasheri, A., & Henrotin, Y. (2011). Biomarkers of Osteoarthritis: A Review of Recent Research Progress on Soluble Biochemical Markers, Published Patents and Areas for Future Development. Recent Patents on Biomarkers, 1 (1), 25-43.

Perrot, S., Marty, M., Legout, V., Moyse, D., Henrotin, Y., & Rozenberg, S. (2011). Ecological or recalled assessments in chronic musculoskeletal pain? A comparative study of prospective and recalled pain assessments in low back pain and lower limb painful osteoarthritis. Pain Medicine, 12 (3), 427-36. doi:10.1111/j.1526-4637.2011.01052.x

Pesesse, L., Sanchez, C., & Henrotin, Y. (2011). Osteochondral plate angiogenesis: A new treatment target in osteoarthritis. Joint Bone Spine, 78, 144-149. doi:10.1016/j.jbspin.2010.07.001

Pesesse, L., Sanchez, C., & Henrotin, Y. (2011). Néovascularisation de la plaque ostéochondrale : nouvelle cible thérapeutique del'arthrose. Revue du Rhumatisme, 78 (1), 12-17. doi:10.1016/j.rhum.2010.05.004

Rego-Perez, I., Fernandez-Moreno, M., Deberg, M., Pertega, S., Fernandez-Lopez, C., Oreiro, N., Henrotin, Y., & Blanco, F. J. (2011). Mitochondrial DNA haplogroups and serum levels of proteolytic enzymes in patients with osteoarthritis. Annals of the Rheumatic Diseases, 70 (4), 646-52. doi:10.1136/ard.2010.133637

Verwilghen, D., Enzerink, E., Martens, A., Franck, T., Balligand, M., Henrotin, Y., Detilleux, J., & Serteyn, D. (2011). Relationship between arthroscopic joint evaluation and the levels of Coll2-1, Coll2-1NO(2), and myeloperoxidase in the blood and synovial fluid of horses affected with osteochondrosis of the tarsocrural joint. Osteoarthritis and Cartilage, 19 (11), 1323-9. doi:10.1016/j.joca.2011.08.002

Verwilghen, D., Martens, A., Busschers, E., Franck, T., Deberg, M., Henrotin, Y., Vander Heyden, L., & Serteyn, D. (2011). Coll2-1, Coll2-1NO2 and myeloperoxidase concentrations in the synovial fluid of equine tarsocrural joints affected with osteochondrosis. Veterinary Research Communications, 35 (7), 401-8. doi:10.1007/s11259-011-9487-5

Henrotin, Y. (2010). Recommandations européennes pour la prise en charge des patients souffrant de lombalgie aiguë et chronique. Kinesitherapie, La Revue, 108, 14-15. doi:10.1016/S1779-0123(10)74974-3

Henrotin, Y., & Chevalier, X. (2010). Recommandations sur la prise en charge de l'arthrose de la hanche et du genou: pour qui ? Pourquoi ? Pourquoi faire ? Presse Médicale, 39 (11), 1180-1188.

Henrotin, Y., & Chevalier, X. (2010). Recommandations sur la prise en charge de l'arthrose de la hanche et du genou. Pour qui ? Pourquoi ? Pour quoi faire ? Presse Médicale. doi:10.1016/j.lpm.2010.03.029

Henrotin, Y., Clutterbuck, A. L., Allaway, D., Lodwig, E. M., Harris, P., Mathy, M., Shakibaei, M., & Mobasheri, A. (2010). Biological actions of curcumin on articular chondrocytes. Osteoarthritis and Cartilage, 18 (2), 141-9. doi:10.1016/j.joca.2009.10.002

Henrotin, Y., & DEBERG, M. (2010). Les marqueurs biologiques du collagène de type II. De nouveaux outils d'évaluation de l'arthrose. Ortho-Rhumato, 8 (6), 226-230.

Henrotin, Y., & Deberg, M. (2010). De nouveaux outils d’évaluation de l’arthrose. Ortho-Rhumato, 8, 1-5.

Henrotin, Y., Mathy, M., Sanchez, C., & Lambert, C. (2010). Chondroitin sulfate in the treatment of osteoarthritis: from in vitro studies to clinical recommendations. Therapeutic Advances in Musculoskeletal Disease, 2 (6), 335-348. doi:10.1177/1759720X10383076

Henrotin, Y., & Mobasheri, A. (2010). Curcumin in the treatment of osteoarthritis: the proof-of-concept. Journal of Tropical Medicinal Plants, 10 (2), 123-132.

Herman, L., Hubert, P., Herfs, M., Kustermans, G., Henrotin, Y., Bousarghin, L., Boniver, J., & Delvenne, P. (2010). The L1 major capsid protein of HPV16 differentially modulates APC trafficking according to the vaccination or natural infection context. European Journal of Immunology, 40 (11), 3075-84. doi:10.1002/eji.201040571

Huebner, J. L., Williams, J. M., Deberg, M., Henrotin, Y., & Kraus, V. B. (2010). Collagen fibril disruption occurs early in primary guinea pig knee osteoarthritis. Osteoarthritis and Cartilage, 18 (3), 397-405. doi:10.1016/j.joca.2009.09.011

Mobasheri, A., & Henrotin, Y. (2010). Identification, validation and qualification of biomarkers for osteoarthritis in humans and companion animals: mission for the next decade. Veterinary Journal, 185 (2), 95-7. doi:10.1016/j.tvjl.2010.05.026

Rego-Perez, I., Fernandez-Moreno, M., Deberg, M., Pertega, S., Fenandez-Lopez, C., Oreiro, N., Henrotin, Y., & Blanco, F. J. (2010). Mitochondrial DNA haplogroups modulate the serum levels of biomarkers in patients with osteoarthritis. Annals of the Rheumatic Diseases, 69 (5), 910-7. doi:10.1136/ard.2009.117416

Richette, P., Eymard, C., Deberg, M., Vidaud, D., de Kerguenec, C., Valla, D., Vicaut, E., Bardin, T., & Henrotin, Y. (2010). Increase in type II collagen turnover after iron depletion in patients with hereditary haemochromatosis. Rheumatology, 49 (4), 760-6. doi:10.1093/rheumatology/kep429

Mathy, M., Jacquemond-Collet, I., Priem, F., Sanchez, C., Lambert, C., & Henrotin, Y. (December 2009). Curcumin inhibits pro-inflammatory mediators and metalloproteinase-3 production by chondrocytes. Inflammation Research, 58, 899-908. doi:10.1007/s00011-009-0063-1

Herfs, M., Herman, L., Hubert, P., Minner, F., Arafa, M. M. M., Roncarati, P., Henrotin, Y., Boniver, J., & Delvenne, P. (April 2009). High expression of PGE2 enzymatic pathways in cervical (pre)neoplastic lesions and functional consequences for antigen-presenting cells. Cancer Immunology, Immunotherapy, 58 (4), 603-614. doi:10.1007/s00262-008-0584-4

Chevalier, X., & Henrotin, Y. (2009). OARSI recommendations on knee and hip osteoarthritis: use with discernment. Joint Bone Spine, 76 (5), 455-7. doi:10.1016/j.jbspin.2009.04.005

Henrotin, Y. (2009). Need for high-standard translation methodology for the dissemination of guidelines. Osteoarthritis and Cartilage, 17 (12), 1536-8. doi:10.1016/j.joca.2009.06.005

Henrotin, Y., Deberg, M., Mathy, M., & Deby-Dupont, G. (2009). Biochemical biomarkers of oxidative collagen damage. Advances in Clinical Chemistry, 49, 31-55. doi:10.1016/S0065-2423(09)49002-4

Henrotin, Y., & Dubuc, J.-E. (2009). Cartilage repair in osteoarthritic patients: utopia or real opportunity? F1000 Reports Medecine, 1, 88. doi:10.3410/M1-88

Henrotin, Y., Marty, M., Appelboom, T., Avouac, B., Berenbaum, F., Briole, V., Djian, P., Dougados, M., Forestier, R., Genevay, S., Lequesne, M., Maheu, E., Poiraudeau, S., Rannou, F., Richette, P., Spector, T., Dubuc, J.-E., & Chevalier, X. (2009). Traduction française des recommandations de l’Osteoarthritis Research Society International (OARSI) sur la prise en charge de la gonarthrose et de la coxarthrose. Revue du Rhumatisme, 76, 279-288. doi:10.1016/j.rhum.2008.07.020

Henrotin, Y., Pesesse, L., & Sanchez, C. (2009). Subchondral bone in osteoarthritis physiopathology: state-of-the art and perspectives. Bio-medical Materials and Engineering, 19 (4-5), 311-6. doi:10.3233/BME-2009-0596

Marty, M., & Henrotin, Y. (2009). Information for patients with low back pain: from research to clinical practice. Joint Bone Spine, 76 (6), 621-2. doi:10.1016/j.jbspin.2009.09.003

Marty, M., Rozenberg, S., Legout, V., Durand-Zaleski, I., Moyse, D., Henrotin, Y., & Perrot, S. (2009). Influence of time, activities, and memory on the assessment of chronic low back pain intensity. Spine, 34 (15), 1604-9. doi:10.1097/BRS.0b013e3181a15359

Sanchez, C., Gabay, O., Salvat, C., Henrotin, Y., & Berenbaum, F. (2009). Mechanical loading highly increases IL-6 production and decreases OPG expression by osteoblasts. Osteoarthritis and Cartilage, 17 (4), 473-81. doi:10.1016/j.joca.2008.09.007

Verwilghen, D., Busoni, V., Gangl, M., Franck, T., Lejeune, J.-P., Vander Heyden, L., Detilleux, J., Grulke, S., Deberg, M., Henrotin, Y., & Serteyn, D. (2009). Relationship between biochemical markers and radiographic scores in the evaluation of the osteoarticular status of Warmblood stallions. Research in Veterinary Science, 87 (2), 319-28. doi:10.1016/j.rvsc.2009.02.002

Gabay, O., Hall, D., Berenbaum, F., Henrotin, Y., & Sanchez, C. (December 2008). Arthrose et obésité : Modèles expérimentaux. Revue du Rhumatisme, 75 (12), 1215-1219. doi:10.1016/j.rhum.2008.07.015

Henrotin, Y. (2008). Avocado/Soybean Unsaponifiable (Asu) to Treat Osteoarthritis: A Clarification. Osteoarthritis and Cartilage. doi:10.1016/j.joca.2008.01.010

Mathy, M., Hogge, L., Sanchez, C., Deby, G., Crielaard, J.-M., & Henrotin, Y. (10 February 2008). Interleukin-1beta and Interleukin-6 Disturb the Antioxidant Enzyme System in Bovine Chondrocytes: A Possible Explanation for Oxidative Stress Generation. Osteoarthritis and Cartilage, 16, 756-763. doi:10.1016/j.joca.2007.10.009

Deberg, M., Dubuc, J. E., Labasse, A., Sanchez, C., Quettier, E., Bosseloir, A., Crielaard, J.-M., & Henrotin, Y. (February 2008). One-Year Follow-up of Coll2-1, Coll2-1no2 and Myeloperoxydase Serum Levels in Osteoarthritis Patients after Hip or Knee Replacement. Annals of the Rheumatic Diseases, 67 (2), 168-74. doi:10.1136/ard.2007.073452

Sanchez, C., Deberg, M., Bellahcene, A., Castronovo, V., Msika, P., Delcour, J.-P., Crielaard, J.-M., & Henrotin, Y. (February 2008). Phenotypic Characterization of Osteoblasts from the Sclerotic Zones of Osteoarthritic Subchondral Bone. Arthritis and Rheumatism, 58 (2), 442-55. doi:10.1002/art.23159

Gabay, O., Hall, D., Berenbaum, F., Henrotin, Y., & Sanchez, C. (2008). Osteoarthritis and obesity: Experimental models. Joint Bone Spine, 75, 675-679. doi:10.1016/j.jbspin.2008.07.011

Sanchez, C., Gabay, O., Henrotin, Y., & Berenbaum, F. (2008). Osteoblast: A cell under compression. Bio-medical Materials and Engineering, 18 (4-5), 221-4. doi:10.3233/BME-2008-0528

Lamour, V., Detry, C., Sanchez, C., Henrotin, Y., Castronovo, V., & Bellahcene, A. (14 December 2007). Runx2-and histone deacetylase 3-mediated repression is relieved in differentiating human osteoblast cells to allow high bone sialoprotein expression. Journal of Biological Chemistry, 282 (50), 36240-36249. doi:10.1074/jbc.M705833200

Ameye, L. G., Deberg, M., Oliveira, M., Labasse, A., Aeschlimann, J. M., & Henrotin, Y. (October 2007). The chemical biomarkers C2C, Coll2-1, and Coll2-1NO(2) provide complementary information on type II collagen catabolism in healthy and osteoarthritic mice. Arthritis and Rheumatism, 56 (10), 3336-3346. doi:10.1002/art.22875

Lejeune, J.-P., Serteyn, D., Gangl, M., Schneider, N., Deby-Dupont, G., Deberg, M., & Henrotin, Y. (July 2007). Plasma concentrations of a type II collagen-derived peptide and its nitrated form in growing ardenner sound horses and in horses suffering from juvenile digital degenerative osteoarthropathy. Veterinary Research Communications, 31 (5), 591-601. doi:10.1007/s11259-007-3518-2

Gangl, M., Deberg, M., Lejeune, J.-P., Schneider, N., Grulke, S., Peters, F., Vila, T., Deby-Dupont, G., Serteyn, D., & Henrotin, Y. (2007). A type II-collagen derived peptide and its nitrated form as new markers of inflammation and cartilage degradation in equine osteochondral lesions. Research in Veterinary Science, 82, 68-75. doi:10.1016/j.rvsc.2006.03.008

Henrotin, Y., Addison, S., Kraus, V., & Deberg, M. (2007). Type II collagen markers in osteoarthritis: what do they indicate? Current Opinion in Rheumatology, 19 (5), 444-50. doi:10.1097/BOR.0b013e32829fb3b5

Henrotin, Y., Blanco, F., Aigner, T., & Kurz, B. (2007). The Significance of Oxidative Stress in Articular Cartilage Ageing and Degradation. Current Rheumatology Reviews, 3, 261-274. doi:10.2174/157339707782408955

Henrotin, Y., & Kurz, B. (2007). Antioxidant to treat osteoarthritis: dream or reality? Current Drug Targets, 8 (2), 347-57. doi:10.2174/138945007779940151

Henrotin, Y., Deberg, M., Crielaard, J.-M., Piccardi, N., Msika, P., & Sanchez, C. (August 2006). Avocado/soybean unsaponifiables prevent the inhibitory effect of osteoarthritic subchondral osteoblasts on aggrecan and type II collagen synthesis by chondrocytes. Journal of Rheumatology, 33 (8), 1668-1678.

Burton, A. K., Balague, F., Cardon, G., Eriksen, H. R., Henrotin, Y., Lahad, A., Leclerc, A., Muller, G., & van der Beek, A. J. (2006). Chapter 2. European guidelines for prevention in low back pain : November 2004. European Spine Journal, 15 Suppl 2, 136-68. doi:10.1007/s00586-006-1070-3

Henrotin, Y. (2006). Nutraceuticals in the management of osteoarthritis: an overview. Journal of Veterinary Pharmacology and Therapeutics, 29 (Suppl. 1), 201-203.

Henrotin, Y., Rozenberg, S., Balagué, F., Leclerc, A., Roux, E., Cédraschi, C., Marty, M., & Valat, J.-P. (2006). Recommandations européennes (COST B13) en matière de prévention et pour la prise en charge de la lombalgie non spécifique. Revue du Rhumatisme, 73 (Suppl 2), 35-52.

Lejeune, J.-P., Schneider, N., Henrotin, Y., & Serteyn, D. (2006). Degenerative osteoarthropathy in horses: pathogeny and diagnostic. Annales de Médecine Vétérinaire, 150 (3), 173-192.

Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (November 2005). Subchondral bone osteoblasts induce phenotypic changes in human osteoarthritic chondrocytes. Osteoarthritis and Cartilage, 13 (11), 988-997. doi:10.1016/j.joca.2005.07.012

Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (November 2005). Osteoblasts from the sclerotic subchondral bone downregulate aggrecan but upregulate metalloproteinases expression by chondrocytes. This effect is mimicked by interleukin-6, -1 beta and oncostatin M pre-treated non-sclerotic osteoblasts. Osteoarthritis and Cartilage, 13 (11), 979-987. doi:10.1016/j.joca.2005.03.008

Henrotin, Y., Sanchez, C., & Balligand, M. (July 2005). Pharmaceutical and nutraceutical management of canine osteoarthritis: Present and future perspectives. Veterinary Journal, 170 (1), 113-123. doi:10.1016/j.tvjl.2004.08.014

Jupsin, I., Collette, J., Henrotin, Y., Bruyère, O., Sarlet, N., & Reginster, J.-Y. (April 2005). Strontium Ranelate (Fujisawa/Servier). Current Opinion in Investigational Drugs, 6 (4), 435-44.

Deberg, M., Labasse, A., Christgau, S., Cloos, P., Bang Henriksen, D., Chapelle, J.-P., Zegels, B., Reginster, J.-Y., & Henrotin, Y. (March 2005). New serum biochemical markers (Coll 2-1 and Coll 2-1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis. Osteoarthritis and Cartilage, 13 (3), 258-265. doi:10.1016/j.joca.2004.12.002

Deberg, M., Labasse, A., Collette, J., Seidel, L., Reginster, J.-Y., & Henrotin, Y. (2005). One-year increase of Coll 2-1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progression. Osteoarthritis and Cartilage, 13 (12), 1059-65. doi:10.1016/j.joca.2005.06.014

Demoulin, C., Fauconnier, C., Vanderthommen, M., & Henrotin, Y. (2005). Recommandations pour l'elaboration d'un bilan fonctionnel de base du patient lombalgique. Revue Médicale de Liège, 60 (7-8, Jul-Aug), 661-8.

Henrotin, Y., Kurz, B., & Aigner, T. (2005). Oxygen and reactive oxygen species in cartilage degradation: friends or foes? Osteoarthritis and Cartilage, 13 (8), 643-54. doi:10.1016/j.joca.2005.04.002

Martin, G., Andriamanalijaona, R., Mathy, M., Henrotin, Y., & Pujol, J.-P. (2005). Comparative effects of IL-1beta and hydrogen peroxide (H2O2) on catabolic and anabolic gene expression in juvenile bovine chondrocytes. Osteoarthritis and Cartilage, 13 (10), 915-24. doi:10.1016/j.joca.2005.03.009

Mathy, M., Burton, S., Deby, G., Devel, P., Reginster, J.-Y., & Henrotin, Y. (2005). Influence of oxygen tension on nitric oxide and prostaglandin E2 synthesis by bovine chondrocytes. Osteoarthritis and Cartilage, 13 (1), 74-9. doi:10.1016/j.joca.2004.09.009

Muller, G., Burton, A., Balague, F., Cardon, G., Eriksen, H., Henrotin, Y., Lahad, A., Leclerc, A., & Vanderbeek, A. (2005). Evidence for the efficacy of preventive means for low back pain. Physioscience, 1, 100-12.

Reginster, J.-Y., Bruyère, O., Fraikin, G., & Henrotin, Y. (2005). Current Concepts in the Therapeutic Management of Osteoarthritis with Glucosamine. Bulletin. Hospital for Joint Diseases, 63 (1-2), 31-36.

Sanchez, C., Deberg, M., Devel, P., Reginster, J.-Y., Henrotin, Y., & Burton, S. (October 2004). Differential Regulation of Chondrocyte Metabolism by Oncostatin M and Interleukin-6. Osteoarthritis and Cartilage, 12 (10), 801-10. doi:10.1016/j.joca.2004.06.011

Reginster, J.-Y., Sarkar, S., Zegels, B., Henrotin, Y., Bruyère, O., Agnusdei, D., & Collette, J. (February 2004). Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk. BONE, 34 (2), 344-351. doi:10.1016/j.bone.2003.10.004

Christgau, S., Henrotin, Y., Tanko, L. B., Rovati, L. C., Collette, J., Bruyère, O., Deroisy, R., & Reginster, J.-Y. (2004). Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate. Clinical and Experimental Rheumatology, 22 (1, JAN-FEB), 36-42.

Henrotin, Y., Deberg, M., Dubuc, J. E., Quettier, E., Christgau, S., & Reginster, J.-Y. (2004). Type II collagen peptides for measuring cartilage degradation. Biorheology, 41 (3-4), 543-547.

Martin, G., Andriamanalijaona, R., Grassel, S., Dreier, R., Mathy, M., Bogdanowicz, P., Boumediene, K., Henrotin, Y., Bruckner, P., & Pujol, J.-P. (2004). Effect of hypoxia and reoxygenation on gene expression and response to interleukin-1 in cultured articular chondrocytes. Arthritis and Rheumatism, 50 (11), 3549-60. doi:10.1002/art.20596

Mouithys-Mickalad, A., Deby, G., Mathy, M., Habraken, Y., Nys, M., Henrotin, Y., Lamy, M., & Deby, C. (2004). Effects of glucocorticoids on the respiratory burst of Chlamydia-primed THP-1 cells. Biochemical and Biophysical Research Communications, 318 (4), 941-8. doi:10.1016/j.bbrc.2004.04.120

Reginster, J.-Y., & Henrotin, Y. (2004). Les nouveaux médicaments de l'arthrose. Pharma-Sphère, 85, 22-25.

Reginster, J.-Y., Bruyère, O., Lecart, M.-P., & Henrotin, Y. (September 2003). Naturocetic (glucosamine and chondroitin sulfate) compounds as structure-modifying drugs in the treatment of osteoarthritis. Current Opinion in Rheumatology, 15, 651-655. doi:10.1097/00002281-200309000-00022

Henrotin, Y., Sanchez, C., Deberg, M., Piccardi, N., Guillou, G. B., Msika, P., & Reginster, J.-Y. (August 2003). Avocado/soybean unsaponifiables increase aggrecan synthesis and reduce catabolic and proinflammatory mediator production by human osteoarthritic chondrocytes. Journal of Rheumatology, 30 (8), 1825-1834.

Reginster, J.-Y., Bruyère, O., & Henrotin, Y. (August 2003). New perspectives in the management of osteoarthritis. Structure modification: Facts or fantasy? Journal of Rheumatology. Supplement, 67 (Suppl. 67), 14-20.

Richy, F., Bruyère, O., Ethgen, O., Cucherat, M., Henrotin, Y., & Reginster, J.-Y. (14 July 2003). Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis - A comprehensive meta-analysis. Archives of Internal Medicine, 163 (13), 1514-1522. doi:10.1001/archinte.163.13.1514

Bruyère, O., COLLETTE, J., Ethgen, O., Rovati, L. C., Giacovelli, G., Henrotin, Y., Seidel, L., & Reginster, J.-Y. (May 2003). Biochemical markers of bone and cartilage remodeling in prediction of longterm progression of knee osteoarthritis. Journal of Rheumatology, 30 (5), 1043-50.

Bruyère, O., Dardenne, C.-B., Lejeune, E., Zegels, B., Pahaut, A., Richy, F., Seidel, L., Ethgen, O., Henrotin, Y., & Reginster, J.-Y. (May 2003). Subchondral tibial bone mineral density predicts future joint space narrowing at the medial femoro-tibial compartment in patients with knee osteoarthritis. BONE, 32 (5), 541-545. doi:10.1016/S8756-3282(03)00059-0

Bruyère, O., Henrotin, Y., Honore, A., Rovati, L. C., Seidel, L., Dardenne, C.-B., & Reginster, J.-Y. (April 2003). Impact of the joint space width measurement method on the design of knee osteoarthritis studies. Aging Clinical and Experimental Research, 15 (2), 136-41. doi:10.1007/BF03324491

Reginster, J.-Y., Kvasz, A., Bruyère, O., & Henrotin, Y. (February 2003). is there any rationale for prescribing hormone replacement therapy (HTR) to prevent or to treat osteoarthritis? Osteoarthritis and Cartilage, 11 (2), 87-91. doi:10.1053/joca.2002.0872

Sanchez, C., Mathy-Hartert, M., Deberg, M., Ficheux, H., Reginster, J.-Y., & Henrotin, Y. (01 February 2003). Effects of rhein on human articular chondrocytes in alginate beads. Biochemical Pharmacology, 65 (3), 377-388. doi:10.1016/S0006-2952(02)01485-5

Bruyère, O., Honore, A., Ethgen, O., Rovati, L. C., Giacovelli, G., Henrotin, Y., Seidel, L., & Reginster, J.-Y. (January 2003). Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate. Osteoarthritis and Cartilage, 11 (1), 1-5. doi:10.1053/joca.2002.0848

Henrotin, Y., Bruckner, P., & Pujol, J. P. (2003). The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis and Cartilage, 11 (10), 747-55. doi:10.1016/S1063-4584(03)00150-X

Mathy, M., Martin, G., Devel, P., Deby, G., Pujol, J. P., Reginster, J.-Y., & Henrotin, Y. (2003). Reactive oxygen species downregulate the expression of pro-inflammatory genes by human chondrocytes. Inflammation Research, 52 (3), 111-8. doi:10.1007/s000110300023

Mayer, F., Schlumberger, A., van Cingel, R., Henrotin, Y., Laube, W., & Schmidtbleicher, D. (2003). Training and testing in open versus closed kinetic chain. Isokinetics and Exercise Science, 11, 181-7. doi:10.3233/ies-2003-0154

Sanchez, C., Mateus, M., Defresne, M.-P., Crielaard, J.-M., Reginster, J.-Y., & Henrotin, Y. (April 2002). Metabolism of human articular chondrocytes cultured in alginate beads. Longterm effects of interleukin 1 beta and nonsteroidal antiinflammatory drugs. Journal of Rheumatology, 29 (4), 772-782.

Ayache, N., Boumediene, K., Mathy, M., Reginster, J.-Y., Henrotin, Y., & Pujol, J.-P. (2002). Expression of TGF-betas and their receptors is differentially modulated by reactive oxygen species and nitric oxide in human articular chondrocytes. Osteoarthritis and Cartilage, 10 (5), 344-52. doi:10.1053/joca.2001.0499

Bruyère, O., Honore, A., Rovati, L. C., Giacovelli, G., Henrotin, Y., Seidel, L., & Reginster, J.-Y. (2002). Radiologic features poorly predict clinical outcomes in knee osteoarthritis. Scandinavian Journal of Rheumatology, 31 (1), 13-6. doi:10.1080/030097402317255309

Henrotin, Y., Sanchez, C., & Reginster, J.-Y. (January 2002). The inhibition of metalloproteinases to treat osteoarthritis: reality and new perspectives. Expert Opinion on Therapeutic Patents, 12 (1), 29-43. doi:10.1517/13543776.12.1.29

Mathy, M., Deby, G., Reginster, J.-Y., Ayache, N., Pujol, J.-P., & Henrotin, Y. (2002). Regulation by reactive oxygen species of interleukin-1beta, nitric oxide and prostaglandin E(2) production by human chondrocytes. Osteoarthritis and Cartilage, 10 (7), 547-55. doi:10.1053/joca.2002.0789

Van Tulder, M., Kovacs, F., Müller, G., Airaksinen, O., Balagué, F., Broos, L., Burton, K., Gil del Real, M.-T., Hänninnen, O., & Henrotin, Y. (2002). European guidelines for the management of low back pain. Acta Orthopaedica Scandinavica. Supplement, 73 ((Suppl 305)), 20-25.

Reginster, J.-Y., Paul, I., & Henrotin, Y. (July 2001). Comment positionner l'acéclofénac au sein de l'arsenal thérapeutique des pathologies ostéo-articulaires chroniques ? Revue Médicale de Liège, 56 (7), 484-8.

Henrotin, Y., Deby-Dupont, G., & Reginster, J.-Y. (June 2001). Les mediateurs biochimiques de l'inflammation. Revue Médicale de Liège, 56 (6), 433-42.

Reginster, J.-Y., & Henrotin, Y. (March 2001). Pharma clinics. Comment je traite.... L'arthrose. 2eme partie: Nouvelles perspectives therapeutiques. Revue Médicale de Liège, 56 (3), 135-9.

Reginster, J.-Y., & Henrotin, Y. (February 2001). Pharma clinics. Comment je traite.... L'arthrose. 1ère partie: Rappel physiopathologique et traitement symptomatique. Revue Médicale de Liège, 56 (2), 63-7.

Appelboom, T., Schuermans, J., Verbruggen, G., Henrotin, Y., & REGINSTER, J.-Y. (2001). Symptoms modifying effect of avocado/soybean unsaponifiables (ASU) in knee osteoarthritis. A double blind, prospective, placebo-controlled study. Scandinavian Journal of Rheumatology, 30 (4), 242-7. doi:10.1080/030097401316909602

Crielaard, J.-M., Henrotin, Y., DEFAWEUX, M., TOMASELLA, M., & Vanderthommen, M. (2001). L'Ecole du dos. Bulletin d'Éducation du Patient à sa Maladie, 20, 21-22.

De Leval, X., Delarge, J., Devel, P., Neven, P., Michaux, C., Masereel, B., Pirotte, B., David, J. L., Henrotin, Y., & Dogne, J.-M. (2001). Evaluation of classical NSAIDs and COX-2 selective inhibitors on purified ovine enzymes and human whole blood. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 64, 211-216. doi:10.1054/plef.2001.0262

Henrotin, Y., de Leval, X., Mathy, M., Mouithys-Mickalad, A., Deby, G., Dogné, J.-M., Delarge, J., & Reginster, J.-Y. (2001). In vitro effects of aceclofenac and its metabolites on the production by chondrocytes of inflammatory mediators. Inflammation Research, 50 (8), 391-9. doi:10.1007/PL00000261

Henrotin, Y., Labasse, A., Zheng, S. X., Galais, P., Tsouderos, Y., Crielaard, J.-M., & Reginster, J.-Y. (2001). Strontium ranelate increases cartilage matrix formation. Journal of Bone and Mineral Research, 16 (2), 299-308. doi:10.1359/jbmr.2001.16.2.299

Henrotin, Y., Vanderthommen, M., Fauconnier, C., Grisart, J., Masquelier, E., Peretz, A., Toussaint, F., Lemaitre, D., Angenot, P., Mahieu, G., Rossion, P., Bailly, D., Mahy, J. L., Chif, D., Dechef, P., & Crielaard, J.-M. (2001). Définition, critères de qualité et évaluation d'un programme de type école du dos. Recommandations de la Société belge des écoles du dos. Revue du Rhumatisme, 68, 185-191. doi:10.1016/S1169-8330(00)00095-8

Reginster, J.-Y., Deroisy, R., Rovati, L. C., Lee, R. L., Lejeune, E., Bruyère, O., Giacovelli, G., Henrotin, Y., Dacre, J. E., & Gosset, C. (January 2001). Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. The Lancet, 357, 251-256. doi:10.1016/S0140-6736(00)03610-2

Reginster, J.-Y., Henrotin, Y., Christiansen, C., Gamwell-Henriksen, E., Bruyère, O., Collette, J., & Christgau, S. (2001). Bone resorption in post-menopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I. Calcified Tissue International, 69 (3), 130-137. doi:10.1007/s002230020042

Zheng, S. X., Mouithys-Mickalad, A., Dupont, G., Deby, C., Maroulis, A. P., Labasse, A. H., Lamy, M., Crielaard, J.-M., Reginster, J.-Y., & Henrotin, Y. (November 2000). In Vitro Study of the Antioxidant Properties of Nimesulide and 4-Oh Nimesulide: Effects on Hrp- and Luminol-Dependent Chemiluminescence Produced by Human Chondrocytes. Osteoarthritis and Cartilage, 8 (6), 419-25. doi:10.1053/joca.1999.0317

De Leval, X., Delarge, J., Somers, F., De Tullio, P., Henrotin, Y., Pirotte, B., & Dogne, J.-M. (2000). Recent advances in inducible cyclooxygenase (COX-2) inhibition. Current Medicinal Chemistry, 7 (10), 1041-1062. doi:10.2174/0929867003374417

De Leval, X., Henrotin, Y., Labasse, A., Reginster, J.-Y., Neven, P., Delarge, J., Somers, F., Masereel, B., Pirotte, B., & Dogne, J.-M. (2000). Comparison of the effects of nimesulide and nimesulide-L-lysine on PGE2 production by COX-1 and COX-2 and on chondrocyte metabolism in vitro. Pharmacy and Pharmacology Communications, 6, 83-87. doi:10.1211/146080800128735683

Henrotin, Y., Croisier, J.-L., Reginster, J.-Y., & CRIELAARD, J.-M. (2000). Bases scientifiques du traitement physique de la gonarthrose. Kiné 2000 : Revue Européenne de la Kinésitherapie, 11 (4), 86-94.

Henrotin, Y., Zheng, S. X., Labasse, A. H., Dupont, G., Crielaard, J.-M., & REGINSTER, J.-Y. (2000). Modulation of human chondrocyte metabolism by recombinant human interferon. Osteoarthritis and Cartilage, 8 (6), 474-82. doi:10.1053/joca.1999.0323

Mouithys-Mickalad, A., Zheng, S. X., Dupont, G., Deby, C., Lamy, M., Reginster, J.-Y., & Henrotin, Y. (2000). In vitro study of the antioxidant properties of non steroidal anti-inflammatory drugs by chemiluminescence and electron spin resonance (ESR). Free Radical Research, 33 (5), 607-21. doi:10.1080/10715760000301131

Reginster, J.-Y., Gillot, V., Bruyère, O., & Henrotin, Y. (2000). Evidence of nutriceutical effectiveness in the treatment of osteoarthritis. Current Rheumatology Reports, 2 (6), 472-477. doi:10.1007/s11926-000-0023-9

Reginster, J.-Y., & Henrotin, Y. (2000). Conception actuelle du traitement de l’arthrose. Revue de la Médecine Générale, 177, 382-389.

Henrotin, Y., & Reginster, J.-Y. (May 1999). In-Vitro Differences among Nonsteroidal Antiinflammatory Drugs in Their Activities Related to Osteoarthritis Pathophysiology. Osteoarthritis and Cartilage, 7 (3), 355-7. doi:10.1053/joca.1998.0197

Henrotin, Y., & Reginster, J.-Y. (May 1999). Anabolic Events in Osteoarthritis. Osteoarthritis and Cartilage, 7 (3), 310-2. doi:10.1053/joca.1998.0175

Reginster, J.-Y., Henrotin, Y., & Gosset, C. (March 1999). Promising New Agents in Osteoporosis. Drugs in R&D, 1 (3), 195-201. doi:10.2165/00126839-199901030-00001

de Leval, X., Dogné, J.-M., Neven, P., Labasse, A., Delarge, J., Reginster, J.-Y., & Henrotin, Y. (1999). Effects of Nimesulide and Indometacin on Cox-1 and Cox-2: A Comparative Study. Journal de Pharmacie de Belgique, 54 (3), 89-90.

Henrotin, Y., Labasse, A., Guillou, B., Crielaard, J.-M., & Reginster, J.-Y. (1999). Advocado/soybean unsaponifiable mixture increased high molecular weight proteoglycans synthesis by human articular chondrocytes. Annals of Rheumatoid Arthritis, 230, 963.

Henrotin, Y., Labasse, A. H., Simonis, P. E., Zheng, S. X., Dupont, G., Famaey, J. P., Crielaard, J.-M., & Reginster, J.-Y. (1999). Effects of Nimesulide and Sodium Diclofenac on Interleukin-6, Interleukin-8, Proteoglycans and Prostaglandin E2 Production by Human Articular Chondrocytes in Vitro. Clinical and Experimental Rheumatology, 17 (2), 151-60.

Reginster, J.-Y., Halkin, V., Henrotin, Y., & Gosset, C. (1999). Treatment of Osteoporosis: Role of Bone-Forming Agents. Osteoporosis International, 9 Suppl 2, 91-6. doi:10.1007/PL00004167

Reginster, J.-Y., & Henrotin, Y. (1999). New Therapeutic options. Bone Depeche, 5, 95-101.

Henrotin, Y., Zheng, S. X., Dupont, G., Labasse, A. H., Crielaard, J.-M., & Reginster, J.-Y. (August 1998). Nitric Oxide Downregulates Interleukin 1β (IL-1β) Stimulated IL-6, IL-8, and Prostaglandin E2 Production by Human Chondrocytes. Journal of Rheumatology, 25 (8), 1595-601.

Henrotin, Y., Labasse, A. H., Jaspar, J. M., De Groote, D. D., Zheng, S. X., Guillou, G. B., & Reginster, J.-Y. (1998). Effects of three avocado/soybean unsaponifiable mixtures on metalloproteinases, cytokines and prostaglandin E2 production by human articular chondrocytes. Clinical Rheumatology, 17 (1), 31-9. doi:10.1007/BF01450955

Henrotin, Y., & Reginster, J.-Y. (1998). Le cartilage articulaire peut-il se régénérer ? (2ème partie). Le Généraliste, 415, 11.

Henrotin, Y., & Reginster, J.-Y. (1998). Le cartilage articulaire peut-il se régénérer ? (1ère partie). Le Généraliste, 414, 31.

Henrotin, Y., & Reginster, J.-Y. (1998). Le cartilage articulaire peut-il se régénérer ? Journal du Médecin (Le), 1129, 33.

Bassleer, C., Franchimont, P., Henrotin, Y., Franchimont, N., Geenen, V., & Reginster, J.-Y. (March 1996). Effects of Ipriflavone and Its Metabolites on Human Articular Chondrocytes Cultivated in Clusters. Osteoarthritis and Cartilage, 4, 1-8. doi:10.1016/S1063-4584(96)80002-1

Henrotin, Y., De Groote, D. D., Labasse, A. H., Gaspar, S. E., Zheng, S. X., Geenen, V., & Reginster, J.-Y. (1996). Effects of exogenous IL-1 beta, TNF alpha, IL-6, IL-8 and LIF on cytokine production by human articular chondrocytes. Osteoarthritis and Cartilage, 4 (3), 163-73. doi:10.1016/S1063-4584(96)80012-4

Henrotin, Y., Labasse, A., Jaspar, J., De Groote, D., Zheng, S., & Reginster, J.-Y. (1996). Is IL-6 capable to modify chondrocyte metabolism ? Clinical Rheumatology, 15, 539.

Henrotin, Y., De Groote, D., Labasse, A., Deby, C., Geenen, V., & Reginster, J.-Y. (1995). Cytokines and cartilage degradation. Mediators of Inflammation, 4, 229-230.

Henrotin, Y., Franchimont, P., & Reginster, J.-Y. (1995). Interactions between IL-1bêta, IL-6, IL-8 and LIF produced by human chondrocytes. The Official EULAR Journal for Education and Information, 24, 134.

Henrotin, Y., Deby-Dupont, G., DEBY, C., De Bruyn, M., Lamy, M., & FRANCHIMONT, P. (1993). Production of active oxygen species by isolated human chondrocytes. British Journal of Rheumatology, 32 (7), 562-7. doi:10.1093/rheumatology/32.7.562

Henrotin, Y., Bassleer, C., & Franchimont, P. (July 1992). In Vitro Effects of Etodolac and Acetylsalicylic Acid on Human Chondrocyte Metabolism. Agents and Actions, 36 (3-4), 317-23.

Bassleer, C., Henrotin, Y., & Franchimont, P. (March 1992). Effects of Sodium Naproxen on Differentiated Human Chondrocytes Cultivated in Clusters. Clinical Rheumatology, 11 (1), 60-5. doi:10.1007/BF02207086

Bassleer, C., Henrotin, Y., & Franchimont, P. (1992). In-vitro evaluation of drugs proposed as chondroprotective agents. International Journal of Tissue Reactions, 14 (5), 231-41.

Bassleer, C., Henrotin, Y., Reginster, J.-Y., & Franchimont, P. (1992). Effects of tiaprofenic acid and acethylsalicylic acid on human articular chondrocytes in 3-dimensional culture. Journal of Rheumatology, 19, 1433-1438.

Bassleer, C., Henrotin, Y., & Franchimont, P. (1990). In Vitro Assays of Chondrocyte Functions: The Influence of Drugs and Hormones. Scandinavian Journal of Rheumatology. Supplement, 81, 13-20. doi:10.3109/03009749009096940

Henrotin, Y., Bassleer, C., Collette, J., Nusgens, B., & Franchimont, P. (1990). Radioimmunoassay for Human Type Ii Collagen. Journal of Immunoassay, 11 (4), 555-578. doi:10.1080/01971529008055050

Franchimont, P., Bassleer, C., & Henrotin, Y. (August 1989). Effects of Hormones and Drugs on Cartilage Repair. Journal of Rheumatology. Supplement, 18, 5-9.

Franchimont, P., Bassleer, C., Henrotin, Y., Gysen, P., & Bassleer, R. (August 1989). Effects of Human and Salmon Calcitonin on Human Articular Chondrocytes Cultivated in Clusters. Journal of Clinical Endocrinology and Metabolism, 69 (2), 259-66. doi:10.1210/jcem-69-2-259

Henrotin, Y., Bassleer, C., Reginster, J.-Y., & Franchimont, P. (March 1989). Effects of Etodolac on Human Chondrocytes Cultivated in Three Dimensional Culture. Clinical Rheumatology, 8 (Suppl 1), 36-42. doi:10.1007/BF02214108

Patents

Henrotin, Y., Sanchez, C., De Pauw, E., & Mazzucchelli, G. (30 January 2019). OSTEOMODULIN AND OSTEOMODULIN FRAGMENTS AS BIOMARKERS FOR OSTEOARTHRITIS AND USE THEREOF.

Henrotin, Y., Sanchez, C., De Pauw, E., & Mazzucchelli, G. (27 September 2017). Osteomodulin and osteomodulin fragments as biomarkers for osteoarthritis and use thereof.

Henrotin, Y., Sanchez, C., De Pauw, E., & Mazzucchelli, G. (25 September 2017). Osteomodulin and osteomodulin fragments as biomarkers for osteoarthritis and use thereof.

Henrotin, Y., Lambert, C., Borderie, D., & Rannou, F. (23 June 2016). Coll2-1 peptide and its nitrated form as therapeutic targets for osteoarthritis treatment.

Henrotin, Y., Gharbi, M., DEBERG, M., & De Pauw, E. (20 January 2016). Biomarker for osteoarthritis and use thereof.

Serisier, S., Comblain, F., & Henrotin, Y. (20 November 2014). Joint care composition.

Henrotin, Y., Sanchez, C., Oprenyeszk, F., & Drion, P. (18 November 2014). Intra-articularly supplementation method for treating joint diseases and injuries.

Henrotin, Y., Kesteloot, F., & Sanchez, C. (11 November 2014). Cell cultivation in chitosan alginate hydrogel beads.

Henrotin, Y., Gharbi, M., DEBERG, M., & De Pauw, E. (08 July 2014). Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof.

Henrotin, Y., Sanchez, C., Oprenyeszk, F., & Drion, P. (02 January 2013). An intra-articular supplement for use in treating joint diseases and injuries.

REGINSTER, J.-Y., DEBERG, M., Henrotin, Y., & Christgau, S. (11 December 2012). Detection of specific nitrated markers.

Henrotin, Y., Kesteloot, F., & Sanchez, C. (01 September 2011). CELL CULTIVATION IN CHITOSAN ALGINATE HYDROGEL BEADS.

Henrotin, Y., Sanchez, C., Oprenyeszk, F., & Drion, P. (01 September 2011). An intra-articular supplementation method for treating joint diseases and injuries.

Henrotin, Y., Kesteloot, F., & Sanchez, C. (31 August 2011). Cell cultivation in chitosan alginate hydrogel beads.

Reginster, J.-Y., DEBERG, M., Henrotin, Y., & Christgau, S. (29 March 2011). Detection of specific nitrated markers.

Henrotin, Y., Gharbi, M., Deberg, M., & De Pauw, E. (23 March 2011). BIOMARKER FOR OSTEOARTHRITIS AND/OR OTHER AGEING-RELATED DISEASES, AND USE THEREOF.

Henrotin, Y., Gharbi, M., Deberg, M., & De Pauw, E. (23 February 2011). BIOMARKER FOR OSTEOARTHRITIS AND/OR OTHER AGEING-RELATED DISEASES, AND USE THEREOF.

Reginster, J.-Y., DEBERG, M., Henrotin, Y., & Christgau, S. (01 June 2010). Method for monitoring collagen type II degradation in cartilage.

Henrotin, Y., Gharbi, M., Deberg, M., & De Pauw, E. (09 December 2009). Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof.

REGINSTER, J.-Y., DEBERG, M., Henrotin, Y., & Christgau, S. (12 August 2008). Method for monitoring collagen type II degradation in cartilage.

REGINSTER, J.-Y., DEBERG, M., Henrotin, Y., & Christgau, S. (01 July 2008). Detection of specific nitrated markers.

Reginster, J.-Y., Deberg, M., Henrotin, Y., & Christgau, S. (22 December 2004). DETECTION OF SPECIFIC NITRATED MARKERS.

Reginster, J.-Y., Deberg, M., Henrotin, Y., & Christgau, S. (15 December 2004). METHOD FOR MONITORING COLLAGEN TYPE II DEGRADATION IN CARTILAGE.

Scientific conferences in universities or research centers

Henrotin, Y. (04 December 2015). Les marqueurs biologiques de l'arthrose : de la découverte à l'industrialisation [Paper presentation]. Université de Nantes, Nantes, France.

Henrotin, Y. (10 March 1991). Traitement kinésithérapique de l'arthrose [Paper presentation]. Conférence organisée par le cercle des licenciés en kinesithérapie de l'université de Liège, Liège, Belgium.

Scientific congresses and symposiums

Published communications

Henrotin, Y., Lambert, C., Florin, A., Zappia, J., Centonze, P., & Sanchez, C. (30 May 2023). Urolithin A and B accelerate myocyte fusion into myotubes. Annals of the Rheumatic Diseases, 82 (Suppl 1), 1926-1927. doi:10.1136/annrheumdis-2023-eular.3536

Zappia, J., Tong, Q., Van der Cruyssen, R., Cornelis, F., Lambert, C., Pinto Coelho, T., Grisart, J., Kague, E., Lories, R., Muller, M., Elewaut, D., Hammond, C., Sanchez, C., & Henrotin, Y. (30 May 2023). Osteomodulin down-regulation is associated with osteoarthritis development. Annals of the Rheumatic Diseases, 82 (Suppl 1), 1194-1195. doi:10.1136/annrheumdis-2023-eular.1006

Henrotin, Y., Lambert, C., Florin, A., Zappia, J., Centonze, P., & Sanchez, C. (March 2023). Deciphering Urolithins A And B Activities On Muscle: Transcriptomic Modulation On Human Primary Myotubes. Osteoarthritis and Cartilage, 31, 303. doi:10.1016/j.joca.2023.01.316

Zappia, J., Tong, Q., Van der Cruyssen, R., Cornelis, F., Lambert, C., Pinto Coelho, T., Grisart, J., Muller, M., Elewaut, D., Hammond, C., Sanchez, C., & Henrotin, Y. (March 2023). Osteomodulin Is Involved In Bone And Cartilage Homeostasis And Osteoarthritis Development. Osteoarthritis and Cartilage, 31, 323-S324. doi:10.1016/j.joca.2023.01.350

Demoulin, C., D'Elia, L., Grosdent, S., Roussel, N., Christe, G., Genevay, S., Bailly, F., Hidalgo, B., Vanderthommen, M., Stevens, V., Berquin, A., Henrotin, Y., & Pitance, L. (December 2022). Évaluation de la prise en charge de la lombalgie : développement de vignettes cliniques. Revue du Rhumatisme, 89 (Suppl. 1), 153. doi:10.1016/j.rhum.2022.10.226

Henrotin, Y., Lambert, C., Florin, A., Zappia, J., Centonze, P., & Sanchez, C. (December 2022). Évaluation de l’activité des urolithines A et B sur le muscle : modulation transcriptomique sur les myotubes primaires humains. Revue du Rhumatisme, 89, 49-A50. doi:10.1016/j.rhum.2022.10.061

Zappia, J., Van Der Cruyssen, R., Cornelis, F., Lambert, C., Pinto Coelho, T., Lories, R., Elewaut, D., Sanchez, C., & Henrotin, Y. (December 2022). L’ostéomoduline joue un rôle majeur dans l’homéostasie de l’os et du cartilage. Revue du Rhumatisme, 89, 176. doi:10.1016/j.rhum.2022.10.261

Sanchez, C., Zappia, J., Lambert, C., Dierckxsens, Y., Dubuc, J.-E., Delcour, J.-P., & Henrotin, Y. (April 2022). CURCUMA LONGA AND BOSWELLIA SERRATA EXTRACTS MODULATE DIFFERENT AND COMPLEMENTARY PATHWAYS TO EXERT ANTI-INFLAMMATORY, ANTI-OXIDATIVE AND ANTI-CATABOLIC ACTIVITIES ON CHONDROCYTES: DECIPHERING OF A TRANSCRIPTOMIC STUDY. Osteoarthritis and Cartilage, 30 (Suppl 1), 435. doi:10.1016/j.joca.2022.02.589

Sanchez, C., Lambert, C., Zappia, J., Dubuc, J.-E., Delcour, J.-P., Dierckxsens, Y., & Henrotin, Y. (December 2021). Les extraits de Curcuma longa et de Boswellia serrata agissent par des mécanismes différents et complémentaires pour exercer une action anti-inflammatoire, anti-oxidante et anti-catabolique sur les chondrocytes : déchiffrage d’une étude transcriptomique. Revue du Rhumatisme, 88 (S1), 154. doi:10.1016/j.rhum.2021.10.242

Florin, A., Lambert, C., Sanchez, C., Zappia, J., & Henrotin, Y. (April 2021). Development of a primary skeletal muscle cell culture model from human muscle biopsies. Osteoarthritis and Cartilage, 29 (Suppl), 108.

Zappia, J., Van der Cruyssen, R., Sanchez, C., Lausberg, C., Lambert, C., Florin, A., Elewaut, D., & Henrotin, Y. (April 2021). Osteomodulin impacts positively the bone remodeling process in osteoarthritis. Osteoarthritis and Cartilage, 29 (Suppl 1), 111. doi:10.1016/j.joca.2021.02.155

Zappia, J., Van der Cruyssen, R., Sanchez, C., Lausberg, C., Lambert, C., Florin, A., Elewaut, D., & Henrotin, Y. (April 2021). Osteomodulin Impacts Positively The Bone Remodeling Process In Osteoarthritis. Bone Reports, 14 (Suppl 1), 2352-1872. doi:10.1016/j.bonr.2021.100904

Florin, A., Lambert, C., Sanchez, C., Zappia, J., & Henrotin, Y. (December 2020). Mise au point d’un modèle de culture original de cellules musculaires squelettiques à partir de biopsies musculaires humaines. Revue du Rhumatisme, Volume 87 (Supplément 1). doi:10.1016/j.rhum.2020.10.433

Horcajada, M.-N., Beaumont, M., Sauvageot, N., Poquet, L., Saboudjian, M., Hick, A.-C., Costes, B., Garcia, L., & Henrotin, Y. (June 2020). An oleuropein-based dietary supplement improves joint functionality in older people with hugh knee joint pain. Annals of the Rheumatic Diseases, 79 (Suppl 1), 930.

Sanchez, C., Hemmer, K., Kroemmelbein, N., Seilheimer, B., Dubuc, J.-E., Antoine, C., & Henrotin, Y. (June 2020). A multicomponent medication promotes chondrogenesis and reduces MMP-13 in primary articular chondrocytes from knee osteoarthritis patients in vitro. Annals of the Rheumatic Diseases, 79 (Suppl 1), 1336.

Sanchez, C., Zappia, J., Dierckxsens, Y., Delcour, J.-P., & Henrotin, Y. (June 2020). Boswellia serrata extract and curcumin increase GDF15 production by human primary osteoarthritis chondrocytes: a new mechanism of action. Annals of the Rheumatic Diseases, 79 (Suppl 1), 1336-1337.

Henrotin, Y., Hick, A.-C., Labasse, A., Pelousse, F., Lemaire, J.-M., Helleputte, T., Cobraiville, E., Pirson, S., Garcia, L., & Costes, B. (April 2020). Cartilage biomarkers S-COLL2-1 and S-COLL2-1NO2 are helpful in identifying knee osteoarthritis patients at risk of disease worsening. Osteoarthritis and Cartilage, 28 (Suppl 1), 327-28.

Horcajada, M.-N., Beaumont, M., Sauvageot, N., Poquet, L., Saboundjian, M., Hick, A.-C., Costes, B., Garcia, L., & Henrotin, Y. (April 2020). An oleuropein-based dietary supplement improves joint functionality in older people with high knee joint pain. Osteoarthritis and Cartilage, 28 (Suppl 1), 472-3.

Sanchez, C., Hemmer, K., Krommelbein, N., Seilheimer, B., Dubuc, J.-E., Antoine, C., & Henrotin, Y. (April 2020). A multicomponent medication promotes chondrogenesis and reduces MMP-13 in primary articular chondrocytes from knee osteoarthritis patients in vitro. Osteoarthritis and Cartilage, 28 (Suppl 1), 106-107. doi:10.1016/j.joca.2020.02.171

Sanchez, C., Zappia, J., Dierckxsens, Y., Delcour, J.-P., & Henrotin, Y. (April 2020). Boswellia serrata extract and curcumin increase GDF15 production by human primary osteoarthritis chondrocytes: a new mechanism of action. Osteoarthritis and Cartilage, 28 (Suppl 1), 120.

Sanchez, C., Lambert, C., Dubuc, J.-E., Bertrand, J., Pap, T., & Henrotin, Y. (June 2019). Syndecan-4 is Increased in Osteoarthritic Knee, but not Hip or Shoulder, Articular Hypertrophic Chondrocytes. Annals of the Rheumatic Diseases, 78 (Suppl 2), 1508.

Sanchez, C., Lambert, C., Dubuc, J.-E., Bertrand, J., Pap, T., & Henrotin, Y. (April 2019). Syndecan-4 is increased in osteoarthritic knee, but nor ip or shoulder, articular hypertrophic chondrocytes. Osteoarthritis and Cartilage, 27 (Suppl 1), 159-160.

Montjean, R., Escaich, S., Vêtu, C., Carelli, C., & Henrotin, Y. (November 2018). Le peptide chimérique synthétique P7 réduit la douleur et protège le cartilage chez le rat souffrant d’arthrose après méniscectomie partielle et section du ligament croisé. Revue du Rhumatisme, 85S, 322-A323.

Sanchez, C., Lambert, C., Dubuc, J., Bertrand, J., Pap, T., & Henrotin, Y. (November 2018). Le syndécan-4 est un marqueur de l’hypertrophie des chondrocytes du genou arthrosique. Revue du Rhumatisme, 85S, 327.

Henrotin, Y., Bannuru, R. R., Malaise, M., EA, K., Confavreux, C., Bentin, J., Urbin-Choffray, D., Conrozier, T., Brasseur, Thomas, T., Marrinello, A., Giordan, N., & Richette, P. (June 2018). HYALURONAN DERIVATIVE HYMOVIS® INCREASES CARTILAGE VOLUME AND TYPE II COLLAGEN TURNOVER IN OSTEOARHRITIC KNEE: DATA FROM MOKHA STUDY. Annals of the Rheumatic Diseases, 77 (supplement 2), 1614.

Henrotin, Y., Malaise, M., Wittoek, R., Devlam, K., Brasseur, J.-P., Luyten, F., Jiangang, Q., Van den Berghe, M., Uhoda, R., Bentin, J., De Vroey, T., Erpicum, L., & Dierckxsens, Y. (June 2018). EFFICACY OF BIO-OPTIMISED CURCUMA EXTRACT (FLEXOFYTOL®) FOR PAINFUL KNEE OSTEOARTHRITIS: DATA FROM COPRA, A MULTICENTER RANDOMISED CONTROLLED STUDY. Annals of the Rheumatic Diseases, 77 (supplement 2), 790.

Lambert, C., Borderie, D., Rannou, F., & Henrotin, Y. (June 2018). THE COLL2–1 PEPTIDE OF COLLAGEN TYPE II: A NEW ACTOR OF SYNOVITIS IN OSTEOARTHRITIS. Annals of the Rheumatic Diseases, 77 (supplement 2), 890.

Rabbani, N., Ahmed, U., Lambert, C., Legrand, C., Anwar, A., Rajpoot, K., Pasha, S., Davidson, R., Clark, I., Thornalley, P., & Henrotin, Y. (June 2018). GLUCOSEPANE : A NEW BIOMARKER OF THE SEVERITY OF OSTEOARTHRITIS. Annals of the Rheumatic Diseases, 77 (supplement 2), 181.

Sanchez, C., Mazzucchelli, G., Comblain, F., Lambert, C., De Pauw, E., & Henrotin, Y. (June 2018). Proteomic analysis of osteoblasts secretome provides new insights in mechanisms underlying osteoarthritis subchondral bone sclerosis. Annals of the Rheumatic Diseases, 77 (supplement 2), 894.

Sanchez, C., Mazzucchelli, G., Lambert, C., Comblain, F., De Pauw, E., & Henrotin, Y. (April 2018). Proteomic analysis of osteoblasts secretome provides new insights in mechanisms underlying osteoarthritis subchondral bone sclerosis. Osteoarthritis and Cartilage, 26 (supplement 1), 89. doi:10.1016/j.joca.2018.02.192

Sanchez, C., Mazzucchelli, G., Lambert, C., Comblain, F., De Pauw, E., & Henrotin, Y. (December 2017). L’analyse protéomique du sécrétome des ostéoblastes fournis de nouvelles indications sur les mécanismes de la sclérose sous-chondrale dans l’arthrose. Revue du Rhumatisme, 84 (S1), 295.

Henrotin, Y. (2017). PIASCLEDINE®300 – mode of action in osteoarthritis. In Meeting Report (pp. 8).

Henrotin, Y., Rocasalbas, G., Chausson, M., Comblain, F., Gautier, S., Douette, P., & Dubuc, J.-E. (2017). An innovative non-animal chitosan hydrogel is able to restore the rheology of osteoarthritis synovial fluid ex vivo. Osteoarthritis and Cartilage.

Legrand, C., Centonze, P., Comblain, F., Lambert, C., Sanchez, C., & Henrotin, Y. (April 2017). Study of the evolution of the osteoarthritis pathology and the mechanical properties of cartilage in a spontaneous osteoarthritis model in the Dunkin-Hartley guinea pigs. Osteoarthritis and Cartilage, 25, 314-s315.

Bartels, E., Henrotin, Y., Bliddal, H., Centonze, P., & Henriksen, M. (2017). Relationship bewteen weight loss in obese knee osteoarthritis patients and serum biomarkers of cartilage breakdown: Secondary analyses of a randomised trial. Osteoarthritis and Cartilage, 25, 105.

Henrotin, Y., Patrier, S., Pralus, A., Roche, M., & Nivoliez, A. (2017). Protective actions of microbiota intervention in two animal models of osteoarthritis: Complementary approaches in spontaneous osteoarthritis in Dunkin Hartley guinea pigs and surgically induced in rabbit. Osteoarthritis and Cartilage, 25, 413.

Henrotin, Y., Richette, P., Raman, R., Conrozier, T., Baron, D., Jerosch, J., Migliore, A., Montfort, J., Bard, H., & Chevalier, X. (2017). Decision algorithms for the re-treatment with viscosupplementation in patients suffering from knee osteoarthritis. Osteoarthritis and Cartilage, 25, 357.

Lambert, C., Borderie, D., Rannou, F., & Henrotin, Y. (2017). Le peptide Coll2-1 du collagène de type II : un nouvel acteur de la synovite dans l’arthrose. Revue du Rhumatisme, 84S, 50.

Lambert, C., Legrand, C., Ahmed, U., Anwar, A., Rajpoot, K., Pasha, S., Davidson, R., Clark, I., Thornalley, P., Rabbani, N., & Henrotin, Y. (2017). Le glucosépane : un nouveau marqueur de la sévérité de l’arthrose. Revue du Rhumatisme, 84S, 102.

Legrand, C., Centonze, P., Comblain, F., Lambert, C., Sanchez, C., & Henrotin, Y. (November 2016). Étude de l’évolution de la pathologie arthrosique et des propriétés mécaniques du cartilage sur un modèle d’arthrose spontanée chez le cobaye Dunkin-Hartley. Revue du Rhumatisme, 83S, 209-A210. doi:10.1016/S1169-8330(16)30512-9

Möller, I., Gharbi, M., Martinez, H., Herrero, M., Verges, J., & Henrotin, Y. (June 2016). Effect of chondroitin sulfate on soluble biomarkers of osteoarthritis: how to analyze and interpret the results from an open-label trial in unilateral knee osteoarthritis patients. Annals of the Rheumatic Diseases, 75 (Suppl 2), 1167. doi:10.1136/annrheumdis-2016-eular.3425

Comblain, F., Barthelemy, N., Lefebvre, M., Schwartz, C., Lesponne, I., Serisier, S., Feugier, A., Balligand, M., & Henrotin, Y. (April 2016). Randomized, Double-Blinded, Controlled Clinical Trial Evaluating the Efficacy of a Diet Supplemented with Curcuminoids Extract, Hydrolyzed Collagen and Green Tea extract in Dogs Suffering from Osteoarthritis. Osteoarthritis and Cartilage, 24 (Supp 1), 353.

Comblain, F., Dubuc, J.-E., Lambert, C., Sanchez, C., Lesponne, I., Serisier, S., & Henrotin, Y. (April 2016). Identification of a Spectrum of Therapeutic Targets of a New Treatment for Osteoarthritis Composed by Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract. Osteoarthritis and Cartilage, 24 (Supp 1), 353.

Legrand, C., Lambert, C., Comblain, F., Sanchez, C., & Henrotin, Y. (April 2016). Review of soluble biomarkers of osteoarthritis: lessons from animal model. Osteoarthritis and Cartilage, 24 (suppl 1), 88.

Sanchez, C., Lambert, C., Comblain, F., Legrand, C., & Henrotin, Y. (April 2016). Osteoarthritic sclerotic subchondral osteoblasts secreted elevated concentration of fibulin-3 fragments in vitro. Osteoarthritis and Cartilage, 24 (suppl 1), 83.

Barthélémy, N., Comblain, F., Lesponne, I., Feugier, A., Henrotin, Y., & Balligand, M. (2016). Randomized, Double-Blinded, Controlled Clinical Trial Evaluating the Efficacy of a Diet Supplemented with Curcuminoids Extract, Hydrolysed Collagen and Green Tea Extract in Dogs with Osteoarthritis. Veterinary and Comparative Orthopaedics and Traumatology.

Chevalier, X., Bard, H., Migliore, A., Henrotin, Y., Monfort, J., Conrozier, T., Raman, R., Baron, D., Jerosch, J., & Richette, P. (2016). Recommandations du groupe EUROVISCO pour le retraitement par acide hyaluronique des patients préalablement traités par viscosupplémentation pour une gonarthrose. Revue du Rhumatisme, 83, 124-A125. doi:10.1016/S1169-8330(16)30400-8

Comblain, F., Lambert, C., Lesponne, I., Sanchez, C., Dubuc, J.-E., & Henrotin, Y. (2015). Identification d’un spectre de cibles thérapeutiques d’un nouveau traitement pour l’arthrose composé d’extrait de curcuminoïdes, de collagène hydrolysé et d’extrait de thé vert. Revue du Rhumatisme.

Henrotin, Y., Oprenyeszk, F., Comblain, F., Dubuc, J.-E., Boileau, C., Chausson, M., Lecler, R., Rocasalbas, G., Douette, P., & Gauthier, S. (2015). Étude des propriétés visco-élastiques d’un hydrogel de chitosan de champignon et de ses effets structuro-modulateurs chez le lapin arthrosique. Revue du Rhumatisme.

Henrotin, Y., Oprenyeszk, F., Comblain, F., Dubuc, J.-E., Boileau, C., Chausson, M., Lecler, R., Rocasalbas, G., Douette, P., & Gautier, S. (29 September 2015). Novel Chitosan Hydrogels for the Treatment of Osteoarthritis: Mechanical Support, Lubrication and Prevention of Cartilage Degradation in a Rabbit Model of Osteoarthritis. Arthritis and Rheumatology, 67 (suppl 10).

Runhaar, J., Sanchez, C., Henrotin, Y., & Bierma-Zeinstra, S. M. A. (April 2015). Baseline Fibulin3 concentrations are associated with incidence of clinical knee OA after 30 months in overweight and obese women. Osteoarthritis and Cartilage, 23 (S2), 83. doi:10.1016/j.joca.2015.02.782

Comblain, F., Lambert, C., Lesponne, I., Sanchez, C., Dubuc, J.-E., & Henrotin, Y. (2015). Identification of a Spectrum of Therapeutic Targets of a New Treatment for Osteoarthritis Composed By Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract. Arthritis and Rheumatology, 67 (Suppl10).

Henrotin, Y. (2015). Biomarkers of prognosis and efficacy of treatment in OA. BMC Musculoskeletal Disorders, 16 (suppl 1). doi:10.1186/1471-2474-16-S1-S2

Henrotin, Y., Arden, N., Berenbaum, F., Blanco, F., Castillo, J., Canhagan, P., Hick, A.-C., Hochberg, M., Martel-Pelletier, J., Richette, P., Sawitzke, A., & du Souich, P. (2015). COMBINED CHONDROITIN SULFATE AND GLUCOSAMINE IS MORE EFFICIENT THAN CELEBREX IN REDUCING SERUM LEVELS OF COLL2-1, A CARTILAGE DEGRADATION BIOMARKER, IN PATIENTS WITH SEVERE OA: RESULTS FROM A RANDOMIZED, DOUBLEBLIND, MULTICENTRIC CLINICAL TRIAL. Osteoarthritis and Cartilage, 23 (S2), 86.

Henrotin, Y., & Sahebkar, A. (2015). ANALGESIC EFFICACY AND SAFETY OF CURCUMINOIDS IN CLINICAL PRACTICE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. Osteoarthritis and Cartilage, 23 (S2), 356.

Runhaar, Sanchez, C., Taralla, S., Henrotin, Y., & Bierma-Zeinstra, S. M. A. (2015). Baseline Fibulin3 Concentrations Are Associated with Incidence of Clinical Knee OA after 30 Months in Overweight and Obese Women. Arthritis and Rheumatism, 67 (Suppl10).

Demoulin, C., Marty, M., Genevay, S., Vanderthommen, M., Mahieu, G., & Henrotin, Y. (2013). Are the back educational interventions effective for preventing low back pain. In Abstract book of the 8th Interdisciplinary World Congress on Low Back and Pelvic Pain (pp. 718-719).

Dobson, F., Hinman, R. S., Roos, E. M., Abbott, J. H., Stratford, P., Davis, A., Buchbinder, R., Snyder-Mackler, L., Henrotin, Y., Thumboo, J., & Bennell, K. L. (April 2013). OARSI recommended performance-based tests to assess physical function in people with established hip and knee osteoarthritis. Osteoarthritis and Cartilage, 21 (Supplement April 2013).

Lambert, C., Dubuc, J.-E., Montell, E., Vergés, J., & Henrotin, Y. (April 2013). Effects of chondroitin sulfate on the gene expression profile in the inflamed synovial membrane. Osteoarthritis and Cartilage, 21 (Supplement April 2013).

Lambert, C., Dubuc, J.-E., Montell, E., Vergés, J., & Henrotin, Y. (April 2013). Effects of chondroitin sulfate on the gene expression profile in IL-1β stimulated synovial fibroblast cells cultures. Osteoarthritis and Cartilage, 21 (Supplement April 2013).

Lambert, C., Dubuc, J.-E., Montell, E., Vergés, J., Munaut, C., Noël, A., & Henrotin, Y. (April 2013). Investigation of potential new targets for the diagnosis and/or the treatment of osteoarthritis. Osteoarthritis and Cartilage, 21 (Supplement April 2013).

Oprenyeszk, F., Chausson, M., Maquet, V., Dubuc, J.-E., & Henrotin, Y. (April 2013). The intra-articular injection of a new chitosan biomaterial prevents the progression of osteoarthritis in ACLT rabbit model. Osteoarthritis and Cartilage, 21 (Supplement April 2013), 69.

Comblain, F., Sanchez, C., Lambert, C., Serisier, S., & Henrotin, Y. (2013). Effets bénéfiques et synergiques du curcuma, du thé vert et du collagène hydrolysé sur des chondrocytes bovins cultivés en monocouche. Revue du Rhumatisme, 80S, 130.

Henrotin, Y., Kraus, V., Huebner, J., Helleputte, T., & DEBERG, M. (2013). Baseline measurements of COLL2-1 and COLL2-1 NO2 in urine are highly predictive of joint space narrowing in knee osteoarthritis. Annals of the Rheumatic Diseases.

Sanchez, C., Horcajada, M.-N., Membrez, F., Drion, P., Comblain, F., Offord, E., & Henrotin, Y. (2013). Oleuropein or rutin consumption decreases the spontaneous development of OA in Hartley guinea pig. Arthritis and Rheumatism, 65, 32-33.

Sanchez, C., Horcajada, M.-N., Membrez, F., Drion, P., Comblain, F., Offord, E., & Henrotin, Y. (2013). La consommation d’oleuropéine ou de rutine diminue le développement spontané de l’arthrose chez le cobaye Hartley. Revue du Rhumatisme, 80S, 125-126.

Pesesse, L., Sanchez, C., Delcour, J.-P., Baudouin, C., Msika, P., & Henrotin, Y. (October 2012). Association between chondrocytes hypertrophy and angiogenesis of cartilage in osteoarthritis. Arthritis and Rheumatism, 64 (10 (Suppl)), 760.

Lambert, C., Dubuc, J.-E., Hennuy, B., Montell, E., Vergés, J., & Henrotin, Y. (April 2012). Expression of specific pathways in the inflamed synovial membrane of osteoarthritis patient: Identification of new potential key intermediates. Osteoarthritis and Cartilage, 20 (Supplement 1), 56.

Henrotin, Y., Kraus, V., Brandt, K., Mazzuca, S., Huebner, J., Boulanger, B., & DEBERG, M. (2012). Measurement of urinary Coll2-1NO2 is predictif of joint space narrowing in knee osteoarthritis. Osteoarthritis and Cartilage, 20 (Suppl 1), 80.

Oprenyeszk, F., Chausson, M., Maquet, V., Dubuc, J.-E., & Henrotin, Y. (2012). L'injection intra-articulaire d'un biomatériau à base de chitosane prévient la progression de l'arthrose expérimentale induite par section du ligament croisé chez le lapin. Revue du Rhumatisme, 79 (1), 108-109.

Pesesse, L., Sanchez, C., Baudouin, C., Msika, P., & Henrotin, Y. (2012). Bone sialoprotein: a key mediator of the angiogenic activity of hypertrophic osteoarthritic chondrocytes. Osteoarthritis and Cartilage, 20 (S), 122-S123.

Pesesse, L., Sanchez, C., Delcour, J.-P., Baudouin, C., Msika, P., & Henrotin, Y. (2012). La bone sialoproteine: un facteur clé dans la pathogénie de l'arthrose. Revue du Rhumatisme, 79 (S), 106.

Pesesse, L., Sanchez, C., Delcour, J.-P., Baudouin, C., Msika, P., & Henrotin, Y. (2012). Association entre l'hypertrophie du chondrocyte et l'angiogenèse du cartilage dans l'arthrose. Revue du Rhumatisme, 79 (S), 105-A106.

Gharbi, M., Dubuc, J., Deberg, M., De Pauw, E., & Henrotin, Y. (2011). Fibulin-3 fragments (FIB3-1 and FIB3-2) are potential new biomarkers for the diagnosis of osteoarthritis. Annals of the Rheumatic Diseases, 70 (Suppl 3), 354.

Gharbi, M., Legrand, C., Sanchez, C., & Henrotin, Y. (2011). L’interleukine-1β augmente le catabolisme de la fibuline-3 par les chondrocytes : démonstration in vitro par la mesure des fragments Fib3-1 et Fib3-2. Revue du Rhumatisme, 78 (suppl 5), 131-132.

Henrotin, Y., Conrozier, T., DEBERG, M., Walliser-Lohse, A., Richette, P., Mulleman, D., Maillet, B., Rannou, F., Piroth, C., Hilliquin, P., Vignon, E., & Chevalier, X. (2011). Early decrease of serum biomarkers of type II collagen degradation (Coll2-1) and joint inflammation (Coll2-1NO2) by hyaluronic acid intra-articular injections in patients with knee osteoarthritis. Annals of the Rheumatic Diseases, 70 (Suppl 3), 214.

Henrotin, Y., Kraus, V., Brandt, K. D., Mazzuca, S. A., Huebner, J., Boulanger, B., & DEBERG, M. (2011). Measurements of urinary COLL2-1NO2 is predictif of joint space narrowing in knee osteoarthritis. Osteoarthritis and Cartilage.

Oprenyeszk, F., Mathy, M., Sanchez, C., Dubuc, J. E., Maquet, V., & Henrotin, Y. (2011). New alginate-chitosan hydrogel beads with anti-inflammatory and anabolic effects on human chondrocytes. Osteoarthritis and Cartilage, 19 (Suppl 1), 222.

Oprenyeszk, F., Sanchez, C., Dubuc, J.-E., Maquet, V., & Henrotin, Y. (2011). New alginate-chitosan hydrogel beads with anti-inflammatory and anabolic effects on human chondrocytes. Arthritis and Rheumatism, 63 (10), 697.

Oprenyeszk, F., Sanchez, C., Dubuc, J.-E., Maquet, V., & Henrotin, Y. (2011). Les billes alginate-chitosane : un nouveau biomatériau pour la réparation des lésions du cartilage. Revue du Rhumatisme, 78 (suppl 5), 129-130.

Pesesse, L., Sanchez, C., Walsh, D., Baudouin, C., Msika, P., & Henrotin, Y. (2011). Study of the association between bone sialoprotein, hypertrophic differentiation of chondrocytes and cartilage lesions in osteoarthritic cartilage. Osteoarthritis and Cartilage, 19 (Suppl 1), 106.

Pesesse, L., Sanchez, C., Walsh, D., Baudouin, C., Msika, P., & Henrotin, Y. (2011). La Bone sialoprotéine est associée à la différenciation hypertrophique des chondrocytes et aux lésions du cartilage arthrosique. Revue du Rhumatisme, 78 (suppl 5), 99-100.

Sanchez, C., Pesesse, L., & Henrotin, Y. (2011). Les ostéoblastes des zones sclérosées de l’os sous-chondral arthrosique expriment moins de connexine-43 : une explication possible à la diminution de la sensibilité mécanique de ces cellules. Revue du Rhumatisme, 78 (suppl 5), 75.

Sanchez, C., Pesesse, L., & Henrotin, Y. (2011). Connexin 43 is downregulated in sclerotic human subchondral osteoblasts: a possible explanation for decrease of mechanosensitivity in these cells. Osteoarthritis and Cartilage, 19 (Suppl 1), 200-201.

Mathy, M., Lambert, C., Dubuc, J. E., Montell, E., Vergés, J., & Henrotin, Y. (October 2010). Synovium angiogenesis in osteoarthritis: a new therapy target for chondroitin sulfate. Osteoarthritis and Cartilage, 18, 45-S46. doi:10.1016/S1063-4584(10)60113-6

Henrotin, Y. (2010). Recommandations européennes pour la prise en charge des patients souffrants de lombalgie aigüe et chronique. Kinesitherapie, La Revue, 108, 14-15.

Horcajada, M.-N., Sanchez, C., Scalfo, F., Ameye, L., Henrotin, Y., & Offord, E. (2010). Effect of rosemary extract and related flavonoid carnosol on chondro-protection and on the bone-cartilage crosstalk. Osteoarthritis and Cartilage, 17 (suppl 2), 38-S39. doi:10.1016/S1063-4584(10)60098-2

Lambert, C., Mathy, M., Dubuc, J. E., Montell, E., Vergés, J., & Henrotin, Y. (2010). Etude du phenotype des synoviocytes fibroblast-like isolés à partir de tissu synovial arthrosique. Revue du Rhumatisme, 77, 105.

Mathy, M., Lambert, C., Dubuc, J. E., Montell, E., Vergés, J., & Henrotin, Y. (2010). La chondroitine sulfate stimule la production des facteurs anti angiogéniques TSP-1 et VEGI par les synoviocytes arthrosiques : un nouveau mécanisme d’action pour cette molécule. Revue du Rhumatisme, 77, 251-A252.

Rego-Perez, I., Fernadez-Moreno, M., DEBERG, M., Pertega, S., Fernandez-Lopes, C., Oreiro, N., Acasuso, M., Bonome-Gonzalez, V., Henrotin, Y., & Blanco, F. (2010). The mitochondria-related phenotype in the osteoarthritis disease. Osteoarthritis and Cartilage.

Rego-Perez, I., Fernandez-Moreno, M., DEBERG, M., Pertega, S., Fernandes-Lopez, C., Oreiro, N., Acasuso, M., Henrotin, Y., & Blanco, F. (2010). MtDNA haplogroups define two phenotypes of osteoarthritis. Arthritis and Rheumatism, 62, 348.

Sanchez, C., Pesesse, L., Delcour, J.-P., Msika, P., Baudouin, C., & Henrotin, Y. (2010). Matrix metalloproteinase-3 is a highly mechanosensitive gene in human subchondral osteoblasts. Osteoarthritis and Cartilage, 17 (suppl 2), 217. doi:10.1016/S1063-4584(10)60510-9

Frigato, M., Ramonda, R., Henrotin, Y., Campana, C., Deberg, M., Bosseloir, A., Frallonardo, P., Valvason, C., & Punzi, L. (2009). Biomarkers and HLA typing in erosive and non erosive osteoarthritis of the hands. Annals of the Rheumatic Diseases, 68 (Suppl.3), 473.

Gharbi, M., DEBERG, M., Dubuc, J., De Pauw, E., & Henrotin, Y. (2009). Identification of novel biological markers of osteoarthritis by proteomic approach. Osteoarthritis and Cartilage, 17 (Suppl 1), 74.

Marty, M., & Henrotin, Y. (2009). Information du patient lombalgique : de la recherche à la pratique. Revue du Rhumatisme, 76, 973-975. doi:10.1016/j.rhum.2009.08.003

Marty, M., Moyse, D., Bazin, T., Cedraschi, C., Duplan, B., Duquesnoy, Laroche, F., Valat, J., & Henrotin, Y. (2009). Information delivery to patients with acute low back pain: a longitudinal observational randomized survey. Annals of the Rheumatic Diseases, 68 (Suppl 3), 700.

Rego, I., Fernandez, M., Deberg, M., Pertega, S., Oreiro, N., Galdo, F., Henrotin, Y., & Blanco, F. (2009). The serum levels of biomarkers are related with mitochondrial DNA haplogroups in knee OA patients. Annals of the Rheumatic Diseases, 68 (Suppl 3), 290.

Rego, I., Fernandez, M., DEBERG, M., Pertega, S., Oreiro, N., Galdo, F., Henrotin, Y., & Blanco, F. (2009). Mitochondrial DNA haplogroups modulate the serum levels of biomarkers in patients with osteoarthritis. Osteoarthritis and Cartilage, 17 (Suppl 1), 72.

Richette, P., Eymard, C., Deberg, M., Vidaud, D., Bardin, T., & Henrotin, Y. (2009). Effects of iron depletion on articular biomarkers and joint symptoms in patients with genetic hemochromatosis: a prospective, longitudinal study. Annals of the Rheumatic Diseases, 68 (Suppl 3), 679.

Richette, P., Eymard, C., DEBERG, M., Vidaud, D., Bardin, T., & Henrotin, Y. (2009). Effects of iron depletion on articular biomarkers and joint symptoms in patients with genetic hemochromatosis: a prospective, longitudinal study. Osteoarthritis and Cartilage, 17 (Suppl 1), 75.

Sanchez, C., Gabay, O., Pesesse, L., Msika, P., Baudouin, C., & Henrotin, Y. (2009). Compression induces the expression of a sclerotic phenotype in human subchondral osteoblasts. Osteoarthritis and Cartilage, 17 (suppl 1), 95.

Henrotin, Y., Henot, B., Parmentier, I., & Marty, M. (2008). L'information basée sur un modèle biopsychosocial modifie positivement les croyances des adolescents. Revue du Rhumatisme, 75, 1132.

Henrotin, Y., Marty, M., Appelboom, T., Avouac, B., & Berenbaum, F. (2008). Traduction franc¸aise des recommandations de l’Osteoarthritis Research Society International (OARSI) sur la prise en charge de la gonarthrose et de la coxarthrose. Revue du Rhumatisme.

Henrotin, Y., Pelletier, J., Martel-Pelletier, J., Caron, J., Boileau, Bosseloir, A., Msika, P., Guillou, B., & DEBERG, M. (2008). Follow-up of Coll2-1, Coll2-1 NO2 and myeloperoxidase in dog after transection of the cruciate ligament of the knee. Arthritis and Rheumatism, 58 (Suppl 9), 652.

Henrotin, Y., Pelletier, J., Martel-Pelletier, J., Caron, J., Boileau, C., Bosseloir, A., & DEBERG, M. (2008). Follow-up of Coll2-1, Coll2-1 NO2 and myeloperoxidase in dog after transection of the cruciate ligament of the knee. Annals of the Rheumatic Diseases, 67 (Suppl.2), 593.

Henrotin, Y., Pelletier, J., Martel-Pelletier, J., Caron, J., Boileau, C., Bosseloir, A., Msika, P., Guillou, B., & DEBERG, M. (2008). Follow-up of Coll2-1, Coll2-1 NO2 and myeloperoxidase in dog after transection of the cruciate ligament of the knee. Osteoarthritis and Cartilage, 16 (Suppl 4), 51.

Henrotin, Y., Pelletier, P., Martel-Pelletier, J., Caron, C., Boileau, A., Bosseloir, P., Msika, B., Guillou, B., & DEBERG, M. (2008). Follow-up of Coll2-1, Coll2-1NO2 and myeloperoxydase in dogs after transaction of the cruciate ligament of the knee. Osteoarthritis and Cartilage.

Marty, M., Moyse, D., Bazin, T., Cedraschi, C., Duplan, B., Duquesnoy, B., Laroche, F., Valat, J., & Henrotin, Y. (2008). Information des patients souffrant de lombalgie aigue: enquête sur les pratiques des médecins français. Revue du Rhumatisme, 75, 961-62.

Mathy, M., Barre, S., Sanchez, C., Lambert, C., & Henrotin, Y. (2008). L’application de forces cycliques d’étirement diminue la production de médiateurs de l’inflammation par les chondrocytes arthrosiques. Revue du Rhumatisme, 75 (10-11), 999.

Ramonda, R., DEBERG, M., Campana, C., Frigato, M., Bosseloir, A., Henrotin, Y., & Punzi, L. (2008). Coll2-1, Coll2-1 NO2 and myeloperoxidase serum levels in erosive and non-erosive osteoarthritis of the hands. Osteoarthritis and Cartilage, 16 (Suppl 4), 56.

Sanchez, C., Mathy, M., Gabay, O., Msika, P., Baudouin, C., & Henrotin, Y. (2008). Etude des effets de la compression sur le métabolisme des ostéoblastes sous-chondraux humains. Revue du Rhumatisme, 75 (10-11), 1021.

Deberg, M., Labasse, A., Sanchez, C., Bosseloir, A., & Henrotin, Y. (2007). Follow-up of COLL2-1, COLL2-1NO2 and myeloperoxidase serum levels in marathon runners. Osteoarthritis and Cartilage, 15 (Suppl C), 67.

Deberg, M., Labasse, A., Sanchez, C., Bosseloir, A., & Henrotin, Y. (2007). Etude des variations de marqueurs de la degradation du cartilage et de l’activation des neutrophiles après un marathon. Revue du Rhumatisme, 74 (10-11), 1088-1089.

Huebner, J., DEBERG, M., Henrotin, Y., & Kraus, V. (2007). Coll2-1 and Coll2-1 NO2: markers of early disease in the Hartley guinea pig model of spontaneous OA. Osteoarthritis and Cartilage, 15 (Suppl C), 70.

Mathy, M., Sanchez, C., Priem, F., & Henrotin, Y. (2007). La curcumine inhibe la synthèse d’ interleukine-6, -8, du monoxide d’azote et de la prostaglandine E2 par les chondrocytes bovins. Revue du Rhumatisme, 74 (10-11), 1023.

Mathy, M., Sanchez, C., Priem, F., & Henrotin, Y. (2007). 196. Curcumin inhibits interleukin-6, -8, nitric oxide and prostaglandin E2 synthesis by bovine chondrocytes. Osteoarthritis and Cartilage, 15 (Suppl C), 115.

Sanchez, C., Deberg, M., Msika, P., Baudouin, C., & Henrotin, Y. (2007). Study of the in vitro conditions promoting hypertrophic differentiation of osteoarthritic articular chondrocytes. Osteoarthritis and Cartilage, 15 (Suppl C), 109-S110.

Sanchez, C., Deberg, M., Msika, P., Baudouin, C., & Henrotin, Y. (2007). Etude des conditions in vitro favorables à la differenciation hypertrophique des chondrocytes articulaires arthrosiques. Revue du Rhumatisme, 74 (10-11), 1085-1086.

Sanchez, C., Gabay, O., Salvat, C., Henrotin, Y., & Berenbaum, F. (2007). Mechanical stress strongly induces interleukin-6 production by osteoblasts: a new in vitro 3D compression model. Osteoarthritis and Cartilage, 15 (Suppl C), 84-S85.

Sanchez, C., Gabay, O., Salvat, C., Henrotin, Y., & Berenbaum, F. (2007). Etude des effets de la compression sur le métabolisme des osteoblasts: un nouveau modèle 3D de compression in vitro. Revue du Rhumatisme, 74 (10-11), 1068.

Sanchez, C., Kaut, E., Deberg, M., Delcour, J.-P., & Henrotin, Y. (March 2006). Interleukin-6 mediates subchondral osteoblasts-induced cartilage degradation. Osteoporosis International, 17 (Suppl. 1), 53.

Ameye, L., DEBERG, M., Oliviera, M., Labasse, A., Aeschlimann, J., & Henrotin, Y. (2006). C2C and Coll2-1 biomarkers reveal increased type II collagen catabolism in biglycan/fibromodulin double deficient mice. Osteoarthritis and Cartilage, 14 (Suppl B), 61.

Deberg, M., Labasse, A., Quettier, E., Dubuc, J., Bosseloir, A., & Henrotin, Y. (2006). Coll2-1, Coll2-1 NO2 and myeloperoxydase in OA patients before and after hip or knee replacement. Osteoporosis International.

Deberg, M., Labasse, A., Sanchez, C., Quettier, E., Dubuc, J., Bosseloir, A., & Henrotin, Y. (2006). One year follow-up of COLL 2-1, COLL 2-1 NO2 and myeloperoxydase serum levels in osteoarthritic patients after hip or knee replacement. Osteoarthritis and Cartilage, 14 (Suppl B), 18.

Deberg, M., Labasse, A., Sanchez, C., Quettier, E., Dubuc, J., Bosseloir, A., & Henrotin, Y. (2006). Etude longitudinale de Coll 2-1, Coll 2-1 NO2 et de la myéloperoxydase chez les sujets arthrosiques avant et après la pose d’une prothèse de hanche ou de genou. Revue du Rhumatisme, 73 (10-11), 1032.

Henrotin, Y. (2006). Bone-derived mediators and cartilage degradation. Annals of the Rheumatic Diseases, 65 (Suppl II), 10.

Mathy, M., Hogge, L., Sanchez, C., Deby, G., & Henrotin, Y. (2006). L’interleukine-1beta et l’interleukine-6 dérèglent le système antioxydant enzymatique chez les chondrocytes bovins : une explication possible au stress oxydant. Revue du Rhumatisme, 73 (10-11), 1077.

Mathy, M., Hogge, L., Sanchez, C., Deby, G., & Henrotin, Y. (2006). Interleukin-1beta and interleukin-6 disturb the antioxidant enzyme system in bovine chondrocytes: a possible explanation for oxidative stress generation. Osteoarthritis and Cartilage, 14 (Suppl B), 80.

Rosenberg, S., Marthy, M., Legout, V., Druand-Zaleski, I., Perrot, S., Moyse, D., & Henrotin, Y. (2006). Influence du temps, des activités et de la mémoire sur la mesure de l'intensité de la douleur dans la lombalgie chronique. Revue du Rhumatisme, 73, 1034.

Sanchez, C., Deberg, M., Bellahcene, A., Castronovo, V., Msika, P., & Henrotin, Y. (2006). Phenotypic characterisation of osteoblasts from the sclerotic zone of human osteoarthritic subchondral bone. Osteoarthritis and Cartilage, 14 (Suppl B), 75.

Sanchez, C., Deberg, M., Bellahcene, A., Castronovo, V., Msika, P., & Henrotin, Y. (2006). Caractérisation du phénotype des ostéoblastes issus des zones sclérosées de l’os sous-chondral arthrosique humain. Revue du Rhumatisme, 73 (10-11), 1058.

Henrotin, Y., Deberg, M., Oliviera, M., Labasse, A., Offord, E., Aeschlimann, J., & Ameye, L. (2005). Dietary supplementation with chondroitin sulfate and glucosamine HCL does not slow down articular cartilage erosion in biglycan/fibromodulin deficient mice. Osteoporosis International, 16 (Suppl 3), 105.

Henrotin, Y., Kaut, E., Deberg, M., Delcour, J.-P., & Sanchez, C. (2005). Etude in vitro de l’axe physiopathologique os-cartilage dans l’arthrose : implication de l’interleukin-6. Revue du Rhumatisme, 72 (10-11), 958-986.

Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (2005). P228. Subchondral Bone Osteoblasts Induce Phenotypic Changes in Human Osteoarthritic Chondrocytes. Osteoporosis International, 16 (Suppl.3), 55-56.

Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (2005). Interleukin-1, Interleukin-6 and Oncostatin M Stimulate Normal Subchondral Osteoblasts to Induce Cartilage Degradation. Osteoporosis International, 16 (Suppl 3), 54-S55.

Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (2005). Avocado/soybean unsaponifiables prevent osteoarthritic subchondral osteoblasts-induced cartilage degradation. Osteoporosis International, 16 (Suppl.3), 56.

Sanchez, C., Kaut, E., Deberg, M., & Henrotin, Y. (2005). Interleukin-6 mediates subchondral osteoblasts-induced cartilage degradation. Osteoarthritis and Cartilage, 13 (Suppl A), 157.

Henrotin, Y., Deberg, M., Oliviera, M., Labasse, A., Offord, E., Aeschlimann, J., & Ameye, L. (2004). Dietary supplementation with chondroitin sulfate and glucosamine HCL does not slow down articular cartilage erosion in biglycan/fibromodulin deficient mice. Osteoarthritis and Cartilage, 12 (Suppl B), 33.

Mathy, M., Devel, P., Sanchez, C., Deberg, M., Deby, G., & Henrotin, Y. (2004). Effects of interleukin-1 beta and dexamethasone on the expression by chondrocytes of antioxidant enzymes. Osteoarthritis and Cartilage, 12 (Suppl. B), 51-S52.

Sanchez, C., Deberg, M., Devel, P., Reginster, J.-Y., & Henrotin, Y. (2004). Régulation du Métabolisme des Chondrocytes par l'Oncostatine M et l'Interleukine 6. Revue du Rhumatisme, 71 (10-11), 1008.

Sanchez, C., Deberg, M., Mathy, M., Devel, P., Reginster, J.-Y., & Henrotin, Y. (2004). Etude de l’influence des ostéoblastes sous-chondraux sur l’initiation de la différenciation hypertrophique des chondrocytes humains. Revue du Rhumatisme, 71 (10-11), 917-918.

Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (2004). Subchondral bone osteoblasts induce phenotypic changes in human osteoarthritic chondrocytes. Osteoarthritis and Cartilage, 12 (Suppl. B), 99-S100.

Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (2004). Les ostéoblastes arthrosiques inhibent la synthèse d’agrécane et stimulent la production de métalloprotéases par les chondrocytes humains. Revue du Rhumatisme, 71 (10-11), 917.

Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (2004). Interleukin-1, interleukin-6 and oncostatin M stimulate normal subchondral osteoblasts to induce cartilage degradation. Osteoarthritis and Cartilage, 12 (Suppl. B), 98.

Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (2004). Furanic avocado/soybean unsaponifiables prevent osteoarthritic subchondral osteoblasts-induced cartilage degradation. Osteoarthritis and Cartilage, 12 (Suppl. B), 108-S109.

Henrotin, Y., Deberg, M., Labasse, A., Collette, J., Christgau, S., Henriksen, D. B., Seidel, L., Rovati, L. C., & Reginster, J.-Y. (November 2003). One-year increase of Coll 2-1 level in urine is predictive of OA progression. Osteoporosis International, 14 (Suppl. 7), 12.

Burton, S., Mathy, M., Deby-Dupont, G., CRIELAARD, J.-M., Reginster, J.-Y., & Henrotin, Y. (October 2003). P160. Influence of oxygen tension on nitric oxide and prostaglandin E2 production by bovine chondrocytes. Osteoarthritis and Cartilage, 11 (Suppl.1), 58.

Deberg, M., Labasse, A., Christgau, S., Henriksen, D., Reginster, J.-Y., & Henrotin, Y. (October 2003). Cartilage degradation and oxidative damage in osteoarthritic and rheumatoid arthritic patients. Osteoarthritis and Cartilage, 11 (Suppl.1), 15.

Henrotin, Y., Ralet, B., Croisier, J.-L., & Dubuc, J. E. (2003). Evaluation isocinétique des muscles de la hanche chez le patient coxarthrosique. In Actes des 4èmes Journées Belges d’Isocinétisme (pp. 6).

Mathy, M., Devel, P., Piccardi, N., Reginster, J.-Y., & Henrotin, Y. (October 2003). Avocado/soybean unsaponifiables reverse H2O2 decoupling effect on aggrecan, type II collagen and metalloproteases gene expression in human chondrocytes. Osteoarthritis and Cartilage, 11 (Suppl.1), 99.

Mathy, M., Devel, P., Piccardi, N., Reginster, J.-Y., & Henrotin, Y. (October 2003). Advocado/soybean unsaponifiables decrease the expression of pro-inflammatory genes in human chondrocytes. Osteoarthritis and Cartilage, 11 (Suppl.1), 97-98.

Burton, S., Mathy-Hartet, M., Dupont, G., Crielaard, J.-M., Reginster, J.-Y., & Henrotin, Y. (2003). Effet de la pression partielle en oxygène sur le métabolisme des chondrocytes bovins en culture. Revue du Rhumatisme, 70, 1035.

De Leval, X., Henrotin, Y., Masereel, B., Somers, F., Neven, P., Devel, P., & Delarge, J. (2003). Evaluation of classical NSAIDS on COX-1 and COX-2 purifies enzymes and prognosis of their effects on physiological responses. Fundamental and Clinical Pharmacology, 14, 167.

Deberg, M., Labasse, A., Christgau, S., Henriksen, D., Reginster, J.-Y., & Henrotin, Y. (2003). Dégradation du cartilage et stress oxydatif chez des patients arthrosiques et souffrant d'arthrite rhumatoide. Revue du Rhumatisme, 70, 1034.

Mathy-Hartet, M., Devel, P., Piccardi, N., REGINSTER, J.-Y., & Henrotin, Y. (2003). Les insaponifiables d'avocats/soja s'opposent aux effets délétères d'H2O2 sur le métabolisme du cartilage. Revue du Rhumatisme, 70, 1032.

Bruyère, O., Collette, J., Lejeune, E., Ethgen, O., Richy, F., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (November 2002). Correlation between biochemical markers of bone and cartilage metabolism and structural progression of hand osteoarthritis. A three-year prospective study. Osteoporosis International, 13 (Suppl.3), 51.

Bruyère, O., Collette, J., Lejeune, E., Ethgen, O., Richy, F., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (November 2002). Baseline measurement of urine pyridinoline and deoxypyridinoline is correlated with 3-year hip osteoarthritis progression. Osteoporosis International, 13 (Suppl.3), 51.

Bruyère, O., Ethgen, O., Lejeune, E., Giacovelli, G., Richy, F., Seidel, L., Henrotin, Y., Rovati, L. C., & Reginster, J.-Y. (November 2002). Clinical severity of knee osteoarthritis poorly predicts long-term radiographic outcomes. Osteoporosis International, 13 (Suppl.3), 51.

Bruyère, O., Lambert, V., Dardenne, C., Lejeune, E., Zegels, B., Pahaut, A., Richy, F., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (November 2002). Subchondral tibial bone mineral density predicts joint space narrowing at the medial femoro-tibial compartment in patients with knee osteoarthritis. Osteoporosis International, 13 (Suppl.3), 51-52.

Deberg, M., Christgau, S., Cloos, P., Henriksen, D. B., Sanchez, C., Labasse, A., Reginster, J.-Y., & Henrotin, Y. (November 2002). Development of new immunoassays for the quantification of inflammatory related cartilage degradation. Osteoporosis International, 13 (Suppl. 3), 54.

Deberg, M., Christgau, S., Henriksen, D. B., Seidel, L., Reginster, J.-Y., & Henrotin, Y. (November 2002). The urinary levels of type II collagen peptide COLL 2-1 and its nitrated form (COLL 2-1 NO2) are correlated with the clinical severity of knee osteoarthritis. Osteoporosis International, 13 (Suppl.3), 54.

Henrotin, Y., Deberg, M., Christgau, S., Henriksen, D. B., Seidel, L., & Reginster, J.-Y. (November 2002). Type II collagen derived fragment (COLL2-1) is new marker predictive of osteoarthritis progression. Osteoporosis International, 13 (Suppl.3), 17.

Henrotin, Y., Mathy-Hartert, M., Martin, G., Boumediene, K., Pujol, J. P., & Reginster, J.-Y. (November 2002). Reactive oxygen species downregulate the expression of pro-inflammatry genes by humachondrocytes. Osteoporosis International, 13 (Suppl. 3), 53.

Henrotin, Y., Sanchez, C., Deberg, M., Piccardi, N., Miska, P., & Reginster, J.-Y. (November 2002). Avocado/soybean unsaponifiables increase aggrecan synthesis and reduce catabolic and pro-inflammatory mediators production by human osteoarthritic chondrocytes. Osteoporosis International, 13 (Suppl.3), 53.

Henrotin, Y., Sanchez, C., Mathy-Hartert, M., Deberg, M., & Reginster, J.-Y. (November 2002). Characterization of the metabolism of osteoarthritic chondrocytes cultured in alginate beads. Osteoporosis International, 13 (Suppl. 3), 52.

Mathy-Hartert, M., Devel, P., Hoormaert, S., Burton, S., Reginster, J.-Y., & Henrotin, Y. (November 2002). Hydrogen peroxide increases transforming factor-β3 gene expression in human chondrocytes and reverses interleukin-1β inhibitory effect. Osteoporosis International, 13 (Suppl.3), 52.

Reginster, J.-Y., Rovati, L. C., Deroisy, R., Henrotin, Y., Gatterova, J., Machacek, S., Giacovelli, G., & Pavelka, K. (November 2002). Glucosamine sulfate slows-down osteoarthritis progression in postmenopausal women: pooled analysis of two large, independent, randomised, placebo-controlled, double-blind, prospective 3-year trials. Osteoporosis International, 13 (Suppl.3), 60.

Richy, F., Bruyère, O., Ethgen, O., Cucherat, M., Henrotin, Y., & Reginster, J.-Y. (November 2002). Structural and symptomatic efficacy of glucosamine and chondroitine sulfate in osteoarthrits: a comprehensive meta-analysis. Osteoporosis International, 13 (Suppl.3), 55-56.

Bruyère, O., COLLETTE, J., Lejeune, E., Ethgen, O., Richy, F., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (September 2002). Correlation between biochemical markers of bone and cartilage metabolism and structural progression of hand osteoarthritis. A three year prospective study. Arthritis and Rheumatism, 46 (number 9 (suppl.)), 152-3.

Bruyère, O., COLLETTE, J., Lejeune, E., Richy, F., Ethgen, O., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (September 2002). Baseline measurement of urine pyridinoline and deoxypyridinoline is correlated with 3-year hip osteoarthritis progression. Arthritis and Rheumatism, 46 (number 9 (suppl.)), 149.

Bruyère, O., Ethgen, O., Lejeune, E., Giacovelli, G., Richy, F., Seidel, L., Henrotin, Y., Rovati, L., & Reginster, J.-Y. (September 2002). Clinical severity of knee osteoarthritis poorly predicts long-term radiographic outcomes. Arthritis and Rheumatism, 46 (number 9 (suppl.)), 153.

Bruyère, O., LAMBERT, V., Dardenne, C., Lejeune, E., Zegels, B., Richy, F., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (September 2002). Subchondral tibial bone mineral density predicts joint space narrowing at the medial femoro-tibial compartment in patients with knee osteoarthritis. Arthritis and Rheumatism, 16 (number 9 (suppl.)), 154.

Deberg, M., Christgau, S., Henriksen, D., Cloos, P., COLLETTE, J., Reginster, J.-Y., & Henrotin, Y. (September 2002). Development of new immunoassays for the quantification of inflammatory related cartilage degradation. Arthritis and Rheumatism, 46 (number 9 (suppl.)), 496.

Reginster, J.-Y., Henrotin, Y., Bruyère, O., Gonzalez, C., Giacovelli, G., & Rovati, L. C. (June 2002). Radiographic severity of knee osteoarthritis is highly correlated with future progression of the disease. Annals of the Rheumatic Diseases, 61 (Suppl.1), 124.

Reginster, J.-Y., Henrotin, Y., Bruyère, O., Gonzalez, C., Giacovelli, G., & Rovati, L. C. (June 2002). Joint space narrowing is poorly correlated with symptoms worsening in knee-osteoarthritis: results from the prospective follow-up of 106, placebo-treated patients for three years. Annals of the Rheumatic Diseases, 61 (Suppl.1), 121.

Reginster, J.-Y., Henrotin, Y., Deroisy, R., Giacovelli, G., Gonzalez, C., & Rovati, L. (June 2002). Correlation between mean and minimum joint space measurements in a long-term trial with glucosamine sulfate, an osteoarthritis modifying agent. Annals of the Rheumatic Diseases, 61 (Suppl.1).

Reginster, J.-Y., Rovati, L., Deroisy, R., Henrotin, Y., Gatterova, J., Machacek, S., Gonzalez, C., Giacovelli, G., & Pavelka, K. (June 2002). Glucosamine sulfate slows-down osteoarthritis progression in postmenopausal women: pooled analysis of two large, independent, randomised, placebo-controlled, double-blind, prospective 3-year trials. Annals of the Rheumatic Diseases, 61 (Suppl.1).

Henrotin, Y., Rale, B., Dubuc, J. E., Croisier, J.-L., & Crielaard, J.-M. (March 2002). Isokinetic evaluation of hip muscles in patients with coxarthrosis. Isokinetics and Exercise Science, 10, 31-32.

Henrotin, Y., Mathy, M., Sanchez, C., Martin, G., Boumediene, K., Pujol, J.-P., & Reginster, J.-Y. (2002). Regulation by reactive oxygen species of pro-inflammatory genes in chondrocytes. Osteoarthritis and Cartilage, 10 (Suppl A), 34.

Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (2002). Avocado/soybean unsaponifiables increase aggrecan synthesis and reduce catabolic and pro-inflammatory mediators production by human osteoarthritic chondrocytes. Osteoarthritis and Cartilage, 10 (Suppl A), 34.

Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (2002). Avocado/soybean Unsaponifiables Increase Aggrecan Synthesis and Reduce Catabolic and Pro-inflammatory Mediators Production by Human Osteoarthritic Chondrocytes. Arthritis and Rheumatism, 47, 50-58.

Sanchez, C., Mathy, M., Deberg, M., Reginster, J.-Y., & Henrotin, Y. (2002). Characterization of the Metabolism of Osteoarthritic Chondrocytes Cultured in Alginate Beads. Osteoarthritis and Cartilage, 10 (SA), 34.

Croisier, J.-L., Henrotin, Y., Etienne, L., Debry, O., Halut, P., & Crielaard, J.-M. (2001). Epreuves de repositionnement angulaire. In Actes de la 3ème Journée Belge d’Isocinétisme.

Henrotin, Y., Croisier, J.-L., Etienne, L., Debry, O., Halut, P., & Crielaard, J.-M. (2001). Evaluation isocinétique des patients gonarthrosiques et coxarthrosiques. In Actes de la 3ème Journée Belge d’Isocinétisme (pp. 9).

Andriamanalijaona, R., Ayache, N., Mathy-Hartert, M., Reginster, J.-Y., Henrotin, Y., Pujol, J., & Boumediene, K. (2001). Interleukine-1 β regulation of transforming growth factor-β1 expression in articular chondrocytes : influence of aceclofenac. Osteoarthritis and Cartilage, 9SB, 56.

Ayache, N., Boumediene, K., Mathy-Hartert, M., Reginster, J.-Y., Henrotin, Y., & Pujol, J. (2001). Expression of transforming growth factors and their receptors is differentially modulated by reactive oxygen species and nitric oxide in human articular chondocytes. Osteoarthritis and Cartilage, 9SB, 42-S43.

Bruyère, O., Ethgen, O., Rovati, L. C., Giacovelli, G., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (2001). Radiographic severity of knee osteoarthrits is highly correlated with future progression of the disease. Osteoarthritis and Cartilage, 9 (Suppl.B), 44-45.

Bruyère, O., Ethgen, O., Rovati, L. C., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (2001). Radiographic severity of knee osteoarthrits is highly correlated with future progression of the disease. Clinical Rheumatology, 5 (Suppl.1), 412.

Bruyère, O., Henrotin, Y., Honoré, A., Rovati, L. C., Giacovelli, G., Seidel, L., & Reginster, J.-Y. (2001). Tibial subchondral sclerosis is significantly correlated with long-term (3-year) radiological progression of knee osteoarthritis. Osteoarthritis and Cartilage, 9 (Suppl.B), 23.

Bruyère, O., Henrotin, Y., Honoré, A., Rovati, L. C., Giacovelli, G., Seidel, L., & Reginster, J.-Y. (2001). Tibial subchondral sclerosis and femoral osteophytes are linked to symptomatic and structural severity of knee osteoarthritis. Osteoarthritis and Cartilage, 9 (Suppl.B), 22.

Bruyère, O., Henrotin, Y., Honoré, A., Rovati, L. C., Seidel, L., Dardenne, C.-B., & Reginster, J.-Y. (2001). Impact of joint space width measurement method on sample size calculation in knee osteoarthritis studies. Clinical Rheumatology, 5 (Suppl.1), 413.

Bruyère, O., Henrotin, Y., Honoré, A., Rovati, L. C., Seidel, L., & Reginster, J.-Y. (2001). Tibial subchondral sclerosis is significantly correlated with long-term (3-year) radiological progression of knee osteoarthritis. Arthritis and Rheumatism, 44 (Suppl.1), 139.

Bruyère, O., Henrotin, Y., Honoré, A., Rovati, L. C., Seidel, L., & Reginster, J.-Y. (2001). Tibial subchondral sclerosis is significantly correlated with long-term (3-year) radiological progression of knee osteoarthritis. Clinical Rheumatology, 5 (Suppl.1), 412.

Bruyère, O., Henrotin, Y., Honoré, A., Rovati, L. C., Seidel, L., & Reginster, J.-Y. (2001). Tibial subchondral sclerosis and femoral osteophytes are linked to symptomatic and structural severity of knee osteoarthritis. Clinical Rheumatology, 5 (Suppl.1), 411.

Bruyère, O., Lejeune, E., Dardenne, C.-B., Henrotin, Y., & Reginster, J.-Y. (2001). Relationship between subchondral tibial bone mineral density and joint space width at the medial femoro-tibial compartment in patients with knee osteoarthritis. Osteoarthritis and Cartilage, 9 (Suppl.B), 23.

Bruyère, O., Lejeune, E., Dardenne, C.-B., Henrotin, Y., & Reginster, J.-Y. (2001). Relationship between subchondral tibial bone mineral density and joint space width at the medial femoro-tibial compartment in patients with knee osteoarthritis. Clinical Rheumatology, 5 (Suppl.1), 411.

Bruyère, O., Lejeune, E., Dardenne, C.-B., Henrotin, Y., & Reginster, J.-Y. (2001). Relationship between subchondral tibial bone mineral density and joint space width at the medial femoro-tibial compartment in patients with knee osteoarthritis. Arthritis and Rheumatism, 44 (Suppl.1), 138.

Bruyère, O., Zegels, B., Dardenne, C.-B., Lejeune, E., Henrotin, Y., & Reginster, J.-Y. (2001). Measurement of the tibial subchondral bone mineral density: a potential tool for diagnosis and monitoring of knee osteoarthrits. Clinical Rheumatology, 5 (Suppl.1), 411.

Bruyère, O., Zegels, B., Dardenne, C.-B., Lejeune, E., Henrotin, Y., & Reginster, J.-Y. (2001). Measurement of the tibial subchondral bone mineral density: a potential tool for diagnosis and monitoring of knee osteoarthrits. Osteoarthritis and Cartilage, 9 (Suppl.B), 61.

De Leval, X., Dogne, J., Delange, J., Reginster, J.-Y., & Henrotin, Y. (2001). Evaluation of classical NSAIDS and COX-2 selective inhibitors on purified ovine enzymes and human whole blood. Annals of the Rheumatic Diseases, 60 (S1), 343.

de Leval, X., Dogne, J., Delarge, J., Reginster, J.-Y., & Henrotin, Y. (2001). Evaluation of classical NSAIDS and COX-2 selective inhibitors on purified ovine enzymes and human whole blood. Clinical Rheumatology, 20, 416.

Henrotin, Y., Croisier, J.-L., Dubuc, J., Reginster, J.-Y., & Crielaard, J.-M. (2001). Isokinetic evaluation of knee extensors and flexors in patients with unilateral symptomatic gonarthrotis. Clinical Rheumatology, 20, 414.

Henrotin, Y., Labasse, A., Galais, P., Tsouderos, Y., Crielaard, J.-M., & Reginster, J.-Y. (2001). Strontium ranelate increases cartilage matrix formation. Clinical Rheumatology, 20, 416.

Henrotin, Y., Labasse, A., Galais, P., Tsouderos, Y., CRIELAARD, J.-M., & Reginster, J.-Y. (2001). Strontium ranelate increases cartilage matrix formation. BONE, S28, 104.

Henrotin, Y., Mathy-Hartert, M., Ayache, N., Pujol, J., & Reginster, J.-Y. (2001). Regulation by reactive oxygen species (ROS) of interleukin-1 bêta, nitric oxide and prostaglandin E2 production by human chondrocytes. Clinical Rheumatology, 20, 415.

Henrotin, Y., Mathy-Hartert, M., Dupont, G., Ayache, N., Pujol, J., & Reginster, J.-Y. (2001). The expression of IL-1bêta, iNOS and COX-2 genes by human chondrocytes in differentially regulated by reactive oxygen species. Clinical Rheumatology, 20, 415.

Henrotin, Y., Mathy, M., Ayache, N., Pujol, J., & Reginster, J.-Y. (2001). Regulation by reactive oxygen species (ROS) o finterleukine-1 bêta, nitric oxide and prostaglandine E2 production by human chondrocytes. Tissue Engineering, 7, 647.

Henrotin, Y., Mathy, M., Dupont, G., Ayache, N., Pujol, J., & Reginster, J.-Y. (2001). The expression of IL-1β, iNOS and COX-2 genes by human chondrocytes is differentially regulated by reactive oxygen species. Tissue Engineering, 7, 649.

Henrotin, Y., Sanchez, C., Deberg, M., Piccardi, N., Guillou, B., & Reginster, J.-Y. (2001). Long-term Effects of Avocado/Soybean Unsaponifiable on Human Chondrocytes Metabolism. Tissue Engineering, 7 (5), 648.

Henrotin, Y., Sanchez, C., Deberg, M., Piccardi, N., Guillou, B., & Reginster, J.-Y. (2001). Long-term Effects of Avocado/Soybean Unsaponifiable on Human Chondrocytes Metabolism. Osteoarthritis and Cartilage, 9 (supplB), 25.

Henrotin, Y., Sanchez, C., Deberg, M., & Reginster, J.-Y. (2001). Long-term effects of nonsteroidal antiinflammatory drugs on human chrondrocytes in alginate beads. Tissue Engineering, 7 (5), 648.

Henrotin, Y., Sanchez, C., Deberg, M., & Reginster, J.-Y. (2001). Long-term Effects of Avocado/Soybean Unsaponifiable on Human Chondrocytes Metabolism. Clinical Rheumatology, 20 (5), 45.

Henrotin, Y., Sanchez, C., Deberg, M., & Reginster, J.-Y. (2001). Diacerein by its Metabolite Rhein, Down-Regulates Stromelysins and Nitric Oxide Productions and Up-Regulates Aggrecan Production by Human Chondrocytes in Alginate Beads. Clinical Rheumatology, 20 (5), 414.

Henrotin, Y., Sanchez, C., Deberg, M., & Reginster, J.-Y. (2001). Diacerein by its Metabolite Rhein, Down-Regulates Stromelysins and Nitric Oxide Productions and Up-Regulates Aggrecan Production by Human Chondrocytes in Alginate Beads. Tissue Engineering, 7 (5), 648.

Mathy-Hartert, M., Dupont, G., Ayache, N., Pujol, J., Reginster, J.-Y., & Henrotin, Y. (2001). The expression of IL-1 β, iNOS and COX-2 genes by human chondrocytes is differentially regulated by reactive oxygen species. Osteoarthritis and Cartilage, 9SB, 56-S57.

Reginster, J.-Y., Bruyère, O., Rovati, L. C., Honoré, A., Giacovelli, G., Seidel, L., & Henrotin, Y. (2001). Radiologic features poorly predict clinical outcomes in knee osteoarthritis. Osteoarthritis and Cartilage, 9 (Suppl.B), 49.

Reginster, J.-Y., Bruyère, O., Rovati, L. C., Honoré, A., Seidel, L., & Henrotin, Y. (2001). Radiologic features poorly predict clinical outcomes in knee osteoarthritis. Clinical Rheumatology, 5 (Suppl.1), 412.

Reginster, J.-Y., COLLETTE, J., Bruyère, O., Rovati, L. C., Giacovelli, G., DEROISY, R., Seidel, L., & Henrotin, Y. (2001). Short term (1-year) changes in keratan sulfate levels predict long-term (3-year) radiological evolution of knee osteoarthritis in patients treated with glucosamine sulfate. Arthritis and Rheumatism, 44 (Suppl.1), 139.

Reginster, J.-Y., COLLETTE, J., Bruyère, O., Rovati, L. C., Giacovelli, G., DEROISY, R., Seidel, L., & Henrotin, Y. (2001). Short term (1-year) changes in keratan sulfate levels predict long-term (3-year) radiological evolution of knee osteoarthritis in patients treated with glucosamine sulfate. Osteoarthritis and Cartilage, 9 (Suppl.B), 35.

Reginster, J.-Y., COLLETTE, J., Zegels, B., Henrotin, Y., Bruyère, O., & Durez, P. (2001). Relationship between 1-year change in bone turnover marker PINP and 3-year vertebral fracture risk reduction with raloxifene therapy in postmenopausal women with osteoporosis: result from the MORE trial. Clinical Rheumatology, 5 (Suppl.1), 425.

Reginster, J.-Y., Sakar, S., COLLETTE, J., Zegels, B., Henrotin, Y., Bruyère, O., Wrong, M., Harper, K., & Agnusdei, D. (2001). Relationship between 1-year change in bone turnover marker PINP and 3-year vertebral fracture risk reduction with raloxifene therapy in postmenopausal women with osteoporosis: result from the MORE trial. BONE, 28 (Suppl.1), 239.

Sanchez, C., Deberg, M., Reginster, J.-Y., & Henrotin, Y. (2001). Long-term Effects of Nonsteroidal Antiinflammatory Drugs on Human Chondrocytes in Alginate Beads. Osteoarthritis and Cartilage, 9 (supplB), 32.

Sanchez, C., Deberg, M., Reginster, J.-Y., & Henrotin, Y. (2001). Long-term Effects of Nonsteroidal Antiinflammatory Drugs on Human Chondrocytes in Alginate Beads. Annals of the Rheumatic Diseases, 60 (suppl1), 284.

Sanchez, C., Reginster, J.-Y., & Henrotin, Y. (2001). Long-term Effects of Nonsteroidal Antiinflammatory Drugs on Human Chondrocytes in Alginate Beads. Clinical Rheumatology, 20 (5), 416.

Henrotin, Y., Croisier, J.-L., Dumont, R., Debry, O., Huskin, J.-P., Dubuc, J. E., Leflot, J. P., Reginster, J.-Y., & Crielaard, J.-M. (March 2000). Isokinetic evaluation of knee extensors and flexors in patients with unilateral symptomatic gonarthrosis. Isokinetics and Exercise Science, 8, 41.

Bruyère, O., COLLETTE, J., Zegels, B., Rovati, L. C., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (2000). Baseline values and early (6-month) changes in total and bone specific alkaline phosphatase do not predict long-term (4-year) bone mineral density changes in postmenopausal osteoporotic women treated with fluoride. Arthritis and Rheumatism, 43 (S1), 199.

Christgau, S., Henrotin, Y., Enriksen, D., Rovati, L., Collette, J., DEROISY, R., Christiansen, C., & Reginster, J.-Y. (2000). Cartilage degradation in knee osteoarthritis patients with elevated levels of urinary collagen type II C-telopeptide fragments. Arthritis and Rheumatism, 43 (S1), 1243.

De Leval, X., Dogné, J.-M., Delarge, J., Pirotte, B., Dupont, G., Mathy-Hartert, M., Chahboune, J., Labasse, A., Neven, P., Reginster, J.-Y., & Henrotin, Y. (2000). Comparative effects of nimesulide, nimesulide L-lysine and nimesulide L-lysine L-arginine on human articular chondrocytes in vitro. Mediators of Inflammation, 9, 51.

De Leval, X., Dogne, J.-M., Masereel, B., Pirotte, B., Reginster, J.-Y., Neven, P., Labasse, A., Delarge, J., & Henrotin, Y. (2000). Profile of nimesulide and nimesulide-L-lysine-β-cyclodextrin on chondrocyte metabolism. Fundamental and Clinical Pharmacology, 14, 167.

De Leval, X., Henrotin, Y., Masereel, B., Pirotte, B., Somers, F., Neven, P., Devel, P., Delarge, J., & Dogne, J.-M. (2000). Evaluation of classical NSAIDs on COX-1 and COX-2 purified enzymes and prognosis of their effects on physiological responses. Fundamental and Clinical Pharmacology, 14, 167.

Dogne, J.-M., De Leval, X., Delarge, J., Dupont, G., Mathy-Hartert, M., Chahboune, J., Labasse, A., Neven, P., Somers, F., Pirotte, B., Reginster, J.-Y., & Henrotin, Y. (2000). Synthesis and evaluation of non-carboxylic pyridinic derivatives as cyclooxygenase inhibitors. Mediators of Inflammation, 9, 52.

Henrotin, Y., Croisier, J.-L., Dumont, R., Debry, O., HUSKIN, J.-P., Dubuc, J., Leflot, J., Reginster, J.-Y., & CRIELAARD, J.-M. (2000). Isokinetic evaluation of knee extensors and flexors in patients with unilateral symptomatic gonarthrosis. Annals of the Rheumatic Diseases, 59 (S1), 275.

Henrotin, Y., Mouithys-Mickalad, A., Mathy-Hartert, M., Zheng, S., Dupont, G., & Reginster, J.-Y. (2000). The antioxidant properties of non stroidal anti-inflammatory drugs. Osteoarthritis and Cartilage, 8, 36.

Henrotin, Y., Mouithys-Mickalad, A., Zheng, S., Deby-Dupont, G., Deby, C., LAMY, M., & Reginster, J.-Y. (2000). In vitro study of the antioxydant properties of nonsteroidal anti-inflammatory drugs by chemiluminescence and electron spin resonance (ESR). Annals of the Rheumatic Diseases, 59 (S1), 187.

Henrotin, Y., Zheng, S., Mouithys-Mickalad, A., Deby-Dupont, G., Deby, C., Lamy, M., CRIELAARD, J.-M., & Reginster, J.-Y. (2000). In vitro study of the antioxydant properties of the nimesulide and 4OH nimesulide : effect on HRP- and luminol-dependent chemiluminescence produced by human chondrocytes. Annals of the Rheumatic Diseases, 59 (S1), 265.

Mathy-Hartert, M., Ayache, N., Boumediene, K., Pujol, J., Reginster, J.-Y., & Henrotin, Y. (2000). Effects of antioxidants on interleukin-1β, nitric oxide and prostaglandin E2 production by human chondrocytes. Osteoarthritis and Cartilage, 8, 1.

Reginster, J.-Y., COLLETTE, J., Rovati, L. C., DEROISY, R., Bruyère, O., & Henrotin, Y. (2000). Changes in serum osteocalcin but not other serum and urinary markers of bone and cartilage metabolism, measured after 12 months, are significantly correlated to long-term (36 monts) structural changes in knee osteoarthritis. Arthritis and Rheumatism, 43 (Suppl.1), 398.

Reginster, J.-Y., COLLETTE, J., Rovati, L. C., DEROISY, R., Honore, A., Bruyère, O., Seidel, L., & Henrotin, Y. (2000). Biochemical markers of bone and cartilage remodeling are poorly correlated with clinical and radiological severity of knee osteoarthritis. Arthritis and Rheumatism, 43 (Suppl.1), 339.

Reginster, J.-Y., DEROISY, R., Lee, R., Rovati, L., Lejeune, E., Giacovelli, G., Henrotin, Y., Dacre, J., & Gosset, C. (2000). Long-term disease modifying effect by glucosamine sulfate in knee osteoarthritis : relationship between structure and symptom changes. Annals of the Rheumatic Diseases, 59 (S1), 55.

Henrotin, Y., Croisier, J.-L., Dumont, R., Debry, O., Huskin, J.-P., Dubuc, J. E., Leflot, J. P., & Crielaard, J.-M. (1999). Intérêt de l'évaluation isocinétique du genou gonarthrosique. In Actes de la 2e Journée Belge d'Isocinétisme (pp. 15).

De Leval, X., Dogne, J., Neven, P., Labasse, A., Delarge, J., Reginster, J.-Y., & Henrotin, Y. (1999). Effects of nimesulide and indomethacin on cyclooxygenaxse-1 and 2 : a comparative study. Osteoarthritis and Cartilage, 7 (SA), 32.

Henrotin, Y., Croisier, J.-L., Dumont, R., Debry, O., HUSKIN, J.-P., Dubuc, J., Leflot, J., Reginster, J.-Y., & Crielaard, J.-M. (1999). Isokinetic evaluation of knee extensors and flexors in patients with unilateral symptomatic gonarthrosis. Osteoarthritis and Cartilage, 7 (SA), 94.

Henrotin, Y., Labasse, A., Crielaard, J.-M., & Reginster, J.-Y. (1999). In vitro induced imbalance between stromelysin and TIMP-1 production by human chondrocytes. Osteoarthritis and Cartilage, 7 (SA), 33.

Henrotin, Y., Zheng, S., Labasse, A., Dupont, G., Crielaard, J.-M., & Reginster, J.-Y. (1999). In vitro effects of recombinant human interferon on basal and IL-1bêta stimulated stomelysin, proteoglycans, cytokines (IL-6, IL-8, IL-10), nitric oxide and IL-1ra. Osteoarthritis and Cartilage, 7 (SA), 31.

Henrotin, Y., Zheng, S., Labasse, A., Dupont, G., Crielaard, J.-M., & Reginster, J.-Y. (1999). In vitro effect of recombinant human interferon on basal and IL- stimulated stromelysin, proteoglycans, cytokines (IL-6, IL-8, IL-10), nitric oxide and IL-1ra. Arthritis and Rheumatism, 42 (S1), 254.

Reginster, J.-Y., DEROISY, R., Paul, I., Lee, R., Henrotin, Y., Giacovelli, G., Dacre, J., Rovati, L., & Gosset, C. (1999). Glucosamine sulfate significantly reduces progression of the knee osteoarthritis over 3 years : a large randomised, placebo-controlled, double-blind, prospective trial. Arthritis and Rheumatism, 42 (S1), 400.

Croisier, J.-L., Henrotin, Y., Dumont, R., Huskin, J.-P., Dubuc, J. E., Leflot, J. P., Reginster, J.-Y., & Crielaard, J.-M. (December 1998). Gonarthrose: intérêt de l'évaluation isocinétique. Kiné 2000 : Revue Européenne de la Kinésitherapie, 9 (98/5), 90.

Henrotin, Y., Labasse, A., Deloffre, P., Tsouderos, Y., & Reginster, J.-Y. (1998). Regulation of the chondrocyte metabolism by a new divalent strontium salt (S12911). BONE, 23 (S5), 344.

Henrotin, Y., Labasse, A., Zheng, S., & Reginster, J.-Y. (1998). In vitro models for the study of cartilage damage and repair. Rheumatology in Europe, 27 (S2), 7.

Henrotin, Y., Zheng, S., Dupont, G., Labasse, A., Crielaard, J.-M., & Reginster, J.-Y. (1998). Regulatory role of nitric acid (NO) in chondrocyte responses to cytokines. BONE, 23 (S5), 344.

Henrotin, Y., Zheng, S., Dupont, G., Labasse, A., Simonis, P., Crielaard, J.-M., & Reginster, J.-Y. (1998). Nitric oxid (NO) down-regulates cytokines and PGE2 production by human chondrocytes. Revue du Rhumatisme, 11, 667.

Henrotin, Y., Zheng, S., Dupont, G., Labasse, A., Simonis, P., Crielaard, J.-M., & Reginster, J.-Y. (1998). L’INF gamma est un inhibiteur puissant de la synthèse d’IL-8 par les chondrocytes humains. Revue du Rhumatisme, 11, 744.

Henrotin, Y., Zheng, S., Dupont, G., Labasse, A., Simonis, P., Crielaard, J.-M., & Reginster, J.-Y. (1998). IFN gamma inhibits IL-8 production by IL-1bêta and TNFalpha stimulated human chondrocytes. Revue du Rhumatisme, 11, 668.

Henrotin, Y., Zheng, S., Dupont, G., Labasse, A., Simonis, P., Crielaard, J.-M., & Reginster, J.-Y. (1998). Effets du monoxyde d’azote (NO) sur le métabolisme des chondrocytes. Revue du Rhumatisme, 11, 742.

Henrotin, Y., Croisier, J.-L., Dumont, R., Huskin, J.-P., Dubuc, J. E., Leflot, J. P., Reginster, J.-Y., & Crielaard, J.-M. (November 1997). Isokinetic testing of knee musculature in patient with unilateral gonarthrosis. Revue du Rhumatisme, 11, 740.

Henrotin, Y., Croisier, J.-L., Dumont, R., Huskin, J.-P., Dubuc, J. E., Leflot, J. P., Reginster, J.-Y., & Crielaard, J.-M. (November 1997). Evaluation isocinétique concentrique du genou chez le patient gonarthrosique. Revue du Rhumatisme et des Maladies Osteo-Articulaires, 11, 850.

Henrotin, Y., Famaey, J., Labasse, A., Zheng, X., Simonis, P., Crielaard, J.-M., & Reginster, J.-Y. (1997). Nimesulide, a novel NSAID of the sulfonanilide class, inhibits PGE2 production by human chondrocytes without affecting proteoglycans synthesis. Rheumatology in Europe, 26 (S2), 170.

Henrotin, Y., Labasse, A., Degroote, D., Zheng, X., Simonis, P., Roma, J., Crasborn, L., Crielaard, J.-M., & Reginster, J.-Y. (1997). In vitro study on the effects of aceclofenac on proteoglycan and type II collagen production by human chondrocytes. Osteoarthritis and Cartilage, 5, 61.

Henrotin, Y., Labasse, A., Degroote, D., Zheng, X., Simonis, P., Roma, J., Crasborn, L., Crielaard, J.-M., & Reginster, J.-Y. (1997). In vitro effects of aceclofenac on cytokines (IL-6, IL-8, LIF) and PGE2 production by human chondrocytes. Osteoarthritis and Cartilage, 5, 30.

Henrotin, Y., Labasse, A., Zheng, S., De Groote, D., Jaspar, J., Guillou, B., & Reginster, J.-Y. (1997). The effect of avocado and soybean unsaponifiables on freshly isolated human articular chondrocytes. Rheumatology in Europe, 26 (S2), 280.

Henrotin, Y., Labasse, A., Zheng, S., Guillou, B., & Reginster, J.-Y. (1997). The effect of avocado and soybean unsaponifiables on freshly isolated human articular chondrocytes. Revue du Rhumatisme, 11, 718.

Henrotin, Y., Labasse, A., Zheng, S., Guillou, B., & Reginster, J.-Y. (1997). The effect of avocado and soybean unsaponifiables on freshly isolated human articular chondrocytes. Arthritis and Rheumatism, 40 (S9), 89.

Henrotin, Y., Labasse, A., Zheng, S., Guillou, B., & Reginster, J.-Y. (1997). Etude in vitro des effets des résidus insaponifiables d’avocat et de soja (IAS) sur le métabolisme des chondrocytes humains. Revue du Rhumatisme, 64 (11), 822.

Henrotin, Y., Labasse, A., Zheng, X., Simonis, P., Deloffre, P., Tsouderos, Y., Crielaard, J.-M., & Reginster, J.-Y. (1997). S12911, a new divalent strontium salt increases cartilage matrix formation. Osteoarthritis and Cartilage, 5, 61.

Henrotin, Y., Labasse, A., Zheng, X., Simonis, P., Deloffre, P., Tsouderos, Y., Crielaard, J.-M., & Reginster, J.-Y. (1997). IGF-1 but not IL-1bêta effects on the proteoglycan production by chondrocytes are regulated by strontium salts. Osteoarthritis and Cartilage, 5, 30.

Henrotin, Y., Zheng, X., Dupont, G., Labasse, A., Crielaard, J.-M., & Reginster, J.-Y. (1997). Régulation de la synthèse de cytokines pro-inflammatoires par l’oxyde nitrique (NO). Revue du Rhumatisme, 64 (11), 763.

Henrotin, Y., Zheng, X., Dupont, G., Labasse, A., Crielaard, J.-M., & Reginster, J.-Y. (1997). Modulation of chondrocyte cytokines synthesis by endogeneously produced nitric oxide. Revue du Rhumatisme, 11, 668.

Henrotin, Y., Zheng, X., Dupont, G., Labasse, A., Degroote, D., Jaspar, J., Crielaard, J.-M., & Reginster, J.-Y. (1997). Modulation of chondrocyte cytokines synthesis by endogeneously produced nitric oxide. Rheumatology in Europe, 26 (S2), 83.

Henrotin, Y., Labasse, A., Zheng, S., De Groote, D., Jaspar, J., Guillou, B., & Reginster, J.-Y. (1996). Effects of three avocado/soybean unsaponifiable mixtures on metalloproteinases, prostaglandin E2, proteoglycans and cytokines production by human articular chondrocytes. Revue du Rhumatisme, 63, 751.

Henrotin, Y., Labasse, A., Zheng, S., De Groote, D., Jaspar, J., Guillou, B., & Reginster, J.-Y. (1996). Effects of three avocado/soybean unsaponifiable mixtures on human chondrocytes metabolism. Arthritis and Rheumatism, 39, 226.

Henrotin, Y., Labasse, A., Zheng, S., De Groote, D., Jaspar, J., Guillou, B., & Reginster, J.-Y. (1996). Comparaison des effets de trois mélanges d’insaponifiables d’avocat et de soja sur le métabolisme des chondrocytes articulaires humains in vitro. Revue du Rhumatisme, 63, 879.

Henrotin, Y., Labasse, A., Zheng, S., Deloffre, P., Tsouderos, Y., & Reginster, J.-Y. (1996). S12911, a new divalent strontium salt stimulates cartilage matrix formation. Revue du Rhumatisme, 63, 751.

Henrotin, Y., Labasse, A., Zheng, S., Deloffre, P., Tsouderos, Y., & Reginster, J.-Y. (1996). Effets d’un sel de strontium (S12911) sur le métabolisme des chondrocytes articulaires humains in vitro. Revue du Rhumatisme, 63, 879.

Franchimont, P., Bassleer, C., Henrotin, Y., & Reginster, J.-Y. (1994). Ipriflavone inhibits interleukin-I stimulated neutral metalloprotease synthesis in human chondrocytes cultivated in clusters. Osteoarthritis and Cartilage, 2 (S1), 52.

Franchimont, P., Bassleer, C., Henrotin, Y., & Reginster, J.-Y. (1994). Effet de l'ipriflavone et de ses métabolites sur la synthèse de protéoglycans et de collagène par les chondrocytes humains cultivés en 3 dimensions. Revue du Rhumatisme, 10, 694.

Franchimont, P., Bassleer, C., Henrotin, Y., & Reginster, J.-Y. (1994). Effet de l'ipriflavone et de ses métabolites sur la synthèse de métalloprotéases, induite par l'interleukine I, dans un modèle de chondrocytes humains. Revue du Rhumatisme, 10, 694.

Franchimont, P., Bassleer, C., Henrotin, Y., & Reginster, J.-Y. (1994). Effects of ipriflavone and its metabolites on human articular chondrocytes cultivated in clusters. Osteoarthritis and Cartilage, 2 (S1), 51.

Henrotin, Y., Reginster, J.-Y., & Franchimont, P. (1994). Interactions between IL-Ibêta, IL-6, IL-8, and LIF produced by human articular chondrocytes. Osteoarthritis and Cartilage, 2 (S1), 52.

Henrotin, Y., Labasse, A., Reginster, J.-Y., & Franchimont, P. (1993). Effet du leukemia inhibiting factor (LIF) sur le métabolisme des chondrocytes articulaires humains in vitro. Revue du Rhumatisme, 60, 682.

Henrotin, Y., Labasse, A., Reginster, J.-Y., & Franchimont, P. (1993). Effet de l'IL1béta sur la production de cytokines (LIF, IL6, GMCSF) par les chondrocytes articulaires humains in vitro. Revue du Rhumatisme, 60, 684.

Oral communications or posters

HISSETTE, E., Demoulin, C., VAN CANT, J., Grosdent, S., ROUSSEL, N., CHRISTE, G., GENEVAIS, S., BAILLY, F., Hidalgo, B., Vanderthommen, M., STEVENS, V., BERQUIN, A., Henrotin, Y., & Pitance, L. (15 September 2023). LOW BACK PAIN-RELATED KNOWLEDGE, BELIEFS AND ATTITUDES OF BELGIAN STUDENTS IN MANUAL THERAPY (UNIVERSITY CERTIFICATE) [Paper presentation]. European Congress Manual Therapy / ECMT 2023, Ghent, Belgium.

Raman, R., Zappia, J., Nivelle, R., Bahri, M. A., Lavergne, A., Caetano da Silva Caroline, Degueldre Christian, Ostertag Agnes, Renn, J., Collet Corrine, Plenevaux, A., Solal Cohen Martine, Henrotin, Y., & Muller, M. (07 September 2022). Zebrafish Osteoblast Transcriptome reveals genes that encode bone extra cellular matrix proteins which on mutating affect bone development [Poster presentation]. Deutsche Gesellschaft for Martrixbiologie e.V. 2022 (DGMB 2022), Frankfurt am Main, Germany.

Raman, R., Zappia, J., Nivelle, R., Lavergne, A., Renn, J., Henrotin, Y., & Muller, M. (11 October 2021). Osteoblast populations and bone extracellular matrix proteins during skeletal development in zebrafish [Poster presentation]. 14th Zebrafish Disease Models Conference (ZDMS'14) Virtual Conference, Durham, United States - North Carolina.

Sanchez, C., Lambert, C., Dubuc, J.-E., Bertrand, J., Pap, T., & Henrotin, Y. (07 October 2019). Syndecan-4 is Increased in Osteoarthritic Knee, but not Hip or Shoulder, Articular Hypertrophic Chondrocytes [Paper presentation]. 15th World Congress of ICRS, Vancouver, Canada.

Florin, A., Lambert, C., Sanchez, C., Zappia, J., & Henrotin, Y. (02 October 2019). Development of a muscle cell culture model from human muscle biopsies [Poster presentation]. EORS 2019, Maastricht, Netherlands.

Florin, A., Lambert, C., Sanchez, C., Mobasheri, A., & Henrotin, Y. (03 May 2019). A systematic review of the secretome of skeletal muscle cells [Poster presentation]. Osteoarthritis Research Society International 2019, Toronto, Canada. doi:10.1016/j.joca.2019.02.677

Florin, A., Lambert, C., Sanchez, C., Durieux, N., Mobasheri, A., & Henrotin, Y. (04 April 2019). Sécrétome des cellules musculaires squelettiques: revue systématique de la littérature [Paper presentation]. Congrès Fragilité du sujet âgé, Paris, France.

Henrotin, Y., Cordier, B., Labasse, A., VanderPoelen, S., Boileau, C., Costes, B., & L'hote, C. (April 2019). Identification et caractérisation de nouveaux biomarqueurs de la sarcopénie [Paper presentation]. Fragilité du sujet âgé, Paris, France.

Florin, A., Lambert, C., Sanchez, C., Mobasheri, A., & Henrotin, Y. (20 February 2019). The secretome of skeletal muscle cells: A systematic review [Poster presentation]. International Conference on Frailty & Sarcopenia Research, Miami, United States.

Raman, R., Zappia, J., Dinh Duy Thanh, Henrotin, Y., & Muller, M. (2019). Isolation of Osteoblast RNA from Danio rerio larvae – presenting a novel method or an update to the existing one ! [Poster presentation]. 2nd EDT PhD Student Day, Brussels, Belgium.

Comblain, F., Lambert, C., Sanchez, C., Dubuc, J.-E., Barthélémy, N., Lefebvre, M., Schwartz, C., Lesponne, I., Serisier, S., Feugier, A., Balligand, M., & Henrotin, Y. (May 2017). In vitro and clinical studies of a new nutraceuticals mixture for the management of osteoarthritis [Poster presentation]. Young Researchers in Life Sciences, Paris, France.

Legrand, C., Centonze, P., Comblain, F., Lambert, C., Sanchez, C., & Henrotin, Y. (27 April 2017). Study of the evolution of the osteoarthritis pathology and the mechanical properties of cartilage in a spontaneous osteoarthritis model in the Dunkin-Hartley guinea pigs [Poster presentation]. OARSI World Congress on Osteoarthritis, Caesar's Palace Las Vegas, United States.

Rahnamay Moshtagh, P., Korthagen, N., Plomp, S., Pouran, B., Sanchez, C., Henrotin, Y., Zadpoor, A., & Weinans, H. (2017). Effect of moderate increasing exercice on the mechanical balance of the knee joint in young rats [Paper presentation]. 2017 OARSI World Congress on Osteoarthritis Promoting Clinical and Basic Research in Osteoarthritis, Las Vegas, United States - Nevada.

Henrotin, Y., Rocasalbas, G., Chausson, M., Comblain, F., Gautier, S., Douette, P., & Dubuc, J.-E. (December 2016). Un hydrogel de chitosan d’origine non-animale restaure la fonction rhéologique du fluide synovial arthrosique : étude ex vivo [Poster presentation]. 29ème Congrès de la Société Française de Rhumatologie.

Legrand, C., Centonze, P., Comblain, F., Lambert, C., Sanchez, C., & Henrotin, Y. (16 November 2016). Study of the evolution of the osteoarthritis pathology and the mechanical properties of cartilage in a spontaneous osteoarthritis model in the Dunkin-Hartley guinea pigs [Poster presentation]. Bioforum Proceedings 2016, Liège, Belgium.

Henrotin, Y., Rocasalbas, G., Chausson, M., Comblain, F., Gautier, S., Douette, P., & Dubuc, J.-E. (September 2016). An innovative non-animal chitosan hydrogel is able to restore the rheology of osteoarthritis synovial fluid ex vivo [Poster presentation]. 13th World Congress - International Cartilage Repair Society.

Henrotin, Y. (04 February 2016). Bien soigner l'arthrose: un enjeu de société [Paper presentation]. Grandes Conférences, Mons, Belgium.

Henrotin, Y. (16 January 2016). Biomarqueurs dans l'arthrose et acide hyaluronique [Paper presentation]. 15ème congrès national de la Fédération Française de Rhumatologie, Paris, France.

Henrotin, Y. (07 January 2016). Bien soigner l'arthrose: un enjeu capital pour notre société! [Paper presentation]. Grandes conférences, Gand, Belgium.

Henrotin, Y. (15 December 2015). Arthrose rachidienne lombaire: une réalité? comment la définir? [Paper presentation]. 28ème Congrès de la Société Française de Rhumatologie, Paris, France.

Henrotin, Y. (14 December 2015). L’injection intra-articulaire de KARTILAGE CROSS® réduit le taux sérique de Coll2-1, un marqueur spécifique de la dégradation du cartilage: résultats de l’étude prospective, multicentrique, randomisée, en double aveugle et contrôlée EPIKART [Paper presentation]. 28ème Congrès de la Société Française de Rhumatologie, Paris, France.

Henrotin, Y. (14 December 2015). Des peptides spécifiques de la Fibuline-3 sont prédictifs de l’arthrose du genou chez les femmes en surpoids ou obèses [Paper presentation]. 28ème Congrès de la Société Française de Rhumatologie, Paris, Belgium.

Henrotin, Y. (13 December 2015). Syndrome metabolique: prise en charge par le kinésithérapeute [Paper presentation]. le syndrome métabolique, Marche-en-Famenne, Belgium.

Henrotin, Y. (12 December 2015). Ha INTRAARTICULAR INJECTION: THERAPEUTIC AND ECONOMIC CONSIDERATIONS [Paper presentation]. Seminars in MSK radiology, Bruxelles, Belgium.

Henrotin, Y. (26 November 2015). Les marqueurs biologiques de l'arthrose : de la conception à la qualification [Paper presentation]. Institut Servier, Paris, France.

Henrotin, Y. (17 November 2015). Les biomarqueurs de l'arthrose [Paper presentation]. Programme UE-1 (22U1OA53), Paris, France.

Henrotin, Y. (16 November 2015). Bien soigner l'arthrose: un enjeu capital pour notre société! [Paper presentation]. Grandes conférences, Tournai, Belgium.

Henrotin, Y. (07 November 2015). Prise en charge non pharmacologique de la gonarthrose; actualités et perspectives [Paper presentation]. Congrès International de médecine du sport, Charleroi, Belgium.

Henrotin, Y. (07 November 2015). L'ostéopathie: mythe ou réalité? [Paper presentation]. Collaque l'arthrose dans tous ses états, Paris, France.

Henrotin, Y. (05 November 2015). Biomakers of osteoarthritis [Paper presentation]. State of art in Exercices physiology.

Sanchez, C., Runhaar, J., Taralla, S., Bierma-Zeinstra, S. M. A., & Henrotin, Y. (November 2015). Des peptides spécifiques de la fibuline-3 sont prédictifs de l’incidence de l’arthrose du genou chez les femmes en surpoids ou obèses [Paper presentation]. 28ème Congrès Français de Rhumatologie, Paris, France.

Henrotin, Y. (20 October 2015). Bien soigner l'arthrose: un enjeu capital pour notre société! [Paper presentation]. Grandes conférences, Ottignie, Belgium.

Henrotin, Y. (02 October 2015). Significant reduction of the Serum Levels of a Specific Biomarker of Cartilage Degradation (Coll2-1) following Viscosupplementation Compared to saline solution in patients with Knee Osteoarthritis [Paper presentation]. 3rd International symposium on intra-articular treatment - ISIAT 2015, Budapest, Hungary.

Henrotin, Y. (02 October 2015). Novel chitosan hydrogel for the treatment of osteoarthritis [Paper presentation]. 3rd International symposium on intra-articular treatment - ISIAT 2015, Budapest, Hungary.

Henrotin, Y. (29 September 2015). Bien soigner l'arthrose: un enjeu capital pour notre société! [Paper presentation]. Grandes conférences, Hasselt, Belgium.

Henrotin, Y. (18 September 2015). Soluble biomarkers in OA: can they be used as indicator of HA re-injection? [Paper presentation]. Labhra Europen Board 2 edition, Lyon, France.

Henrotin, Y. (17 September 2015). Bien soigner l'arthrose: un enjeu capital pour notre société! [Paper presentation]. Grandes conférences, Bruge, Belgium.

Henrotin, Y. (01 July 2015). Biomarkers of prognosis and efficacy of reatment [Paper presentation]. Congress of the Institute of Advanced Studies, Surrey, United Kingdom.

Henrotin, Y. (27 June 2015). Légitimité des recommAndations sur la viscosupPlementation [Paper presentation]. Journée nationale du GRIFF, Ste Maxime, France.

Henrotin, Y., Oprenyeszk, F., Dubuc, J.-E., Chausson, M., Lecler, R., Douette, P., & Gauthier, S. (10 May 2015). Prevention of Synovial Membrane Inflammation & Cartilage Degradation by a Novel Chitosan [Paper presentation]. ICRS 2015, Chicago - USA, Chicago, United States.

Henrotin, Y. (02 April 2015). Pourra-t-on prédire la sévérité d’une arthrose dés son début? OUI, grâce aux biomarqueurs [Paper presentation]. 60ème semaine de rhumatologie, Aix-les-Bains, France.

Henrotin, Y. (03 March 2015). HA viscosupplEmentation in OA treatment [Paper presentation]. advisory board in rheumatology - current and future treatment option in osteoarthitis, Paris, France.

Henrotin, Y. (24 January 2015). Quels produits injecterons nous demain dans nos articulations? [Paper presentation]. 3ème journéée de rhumatologie interventionnelle, Paris, France.

Henrotin, Y. (06 December 2014). Innovation dans l'arthrose [Paper presentation]. 27ème congrès français de rhumatologie, Paris, France.

Henrotin, Y. (04 December 2014). L'exercice physique: le traitement de choix de la lombalgie [Paper presentation]. La lombalgie, Marche-en-Famenne, Belgium.

Henrotin, Y. (25 October 2014). Biomarkers of prognosis and efficacy of treatment [Paper presentation]. World Congress on Controversies, Debates & Consensus in Veterinary Medicine, Praha, Czechia.

Henrotin, Y. (24 October 2014). Nutraceuticals for joint healthand biomarkers [Paper presentation]. World Congress on Controversies, Debates & Consensus in Veterinary Medicine, Praha, Czechia.

Henrotin, Y. (20 October 2014). Bien soigner l'arthrose: un enjeu capital pour notre société! [Paper presentation]. Grandes conférences, Louvain-la-neuve, Belgium.

Henrotin, Y. (11 October 2014). Prise en charge de la gonarthrose [Paper presentation]. Société Algérienne de Rhumatologie, Alger, Algeria.

Henrotin, Y. (12 June 2014). biochemical markers to monitor the effects of drugs in knee OA patient [Paper presentation]. Symposium stellite BioIberica, Paris, France.

Henrotin, Y. (26 April 2014). Les vertiges: ça se soigne! [Paper presentation]. Conférence, Marche-en-Famenne, Belgium.

Henrotin, Y. (24 April 2014). Recent advances and innavation in viscosupplementation [Paper presentation]. Orthopaedica Belgica 2014.

Henrotin, Y. (24 April 2014). Disease Modifying drugs for OA: from research to clinical evidences [Paper presentation]. Orthopaedica Belgica 2014, Anvers, Belgium.

Henrotin, Y. (02 December 2013). Physiopathologie du MODIC [Paper presentation]. 26eme congrès français de rhumatologie, Paris, France.

Lambert, C., Dubuc, J.-E., Montell, E., Vergés, J., & Henrotin, Y. (23 November 2013). EFFECTS OF CHONDROITIN SULFATE ON THE GENE EXPRESSION PROFILE IN THE INFLAMED SYNOVIAL MEMBRANE [Paper presentation]. BMJD 2013, Brussels, Belgium.

Lambert, C., Dubuc, J.-E., Montell, E., Vergés, J., & Henrotin, Y. (23 November 2013). EFFECTS OF CHONDROITIN SULFATE ON THE GENE EXPRESSION PROFILE IN INTERLEUKIN-1Β STIMULATED SYNOVIAL FIBROBLAST CELLS CULTURES [Paper presentation]. BMJD 2013, Brussels, Belgium.

Oprenyeszk, F., Chausson, M., Maquet, V., Dubuc, J., & Henrotin, Y. (23 November 2013). Protective effect of a new CHITOSAN BIOMATERIAL against the development of experimental osteoarthritis lesions in rabbit [Paper presentation]. BMJD 2013, Brussels, Belgium.

Oprenyeszk, F., Sanchez, C., Dubuc, J.-E., Maquet, V., & Henrotin, Y. (23 November 2013). A new ALGINATE-CHITOSAN HYDROGEL beads decrease inflammatory and anabolic mediators production by human chondrocytes [Poster presentation]. BMJD 2013, Brussels, Belgium.

Sanchez, C., Horcajada, M.-N., Membrez, F., Drion, P., Comblain, F., Offord, E., & Henrotin, Y. (23 November 2013). Oleuropein or rutin consumption decreases the spontaneous development of OA in Hartley guinea pig [Paper presentation]. Controversies, Debates & Consensus in Bone, Muscle & Joint Diseases, Brussel, Belgium.

Comblain, F., Sanchez, C., Lambert, C., Serisier, S., & Henrotin, Y. (November 2013). SYNERGISTIC BENEFICIAL EFFECTS OF CURCUMA EXTRACT, GREEN TEA EXTRACT AND HYDROLYZED COLLAGEN IN BOVINE CHONDROCYTES IN MONOLAYER CULTURE [Poster presentation]. Bone, Muscle & Joint Diseases 2013, Brussels, Belgium.

Pesesse, L., Sanchez, C., Delcour, J.-P., Bellahcene, A., Baudouin, C., Msika, P., & Henrotin, Y. (November 2013). ASSOCIATION BETWEEN CHONDROCYTE HYPERTROPHY AND ANGIOGENESIS OF CARTILAGE IN OSTEOARTHRITIS [Paper presentation]. Controversies, Debates & Consensus in Bone, Muscle & Joint Diseases.

Pesesse, L., Sanchez, C., Walsh, D., Delcour, J.-P., Baudouin, C., Msika, P., & Henrotin, Y. (November 2013). BONE SIALOPROTEIN AS A KEY FACTOR IN THE PATHOPHYSIOLOGY OF OSTEOARTHRITIS [Paper presentation]. Controversies, Debates & Consensus in Bone, Muscle & Joint Diseases.

Oprenyeszk, F., Chausson, M., Maquet, V., Dubuc, J.-E., & Henrotin, Y. (27 October 2013). Protective effect of intra-articular injection of alginate-chitosan beads in an hydrogel against the development of experimental osteoarthritis lesions in rabbit [Poster presentation]. American College of Rheumatology-ACR13, San Diego, United States.

Comblain, F., Sanchez, C., Lambert, C., Serisier, S., & Henrotin, Y. (02 October 2013). Synergistic beneficial effects of curcuma extract, green tea extract and hydrolysed collagen in bovine chondrocytes in monolayer culture [Paper presentation]. Waltham International Nutritional Sciences Symposium 2013, Portland, United States - Oregon.

Henrotin, Y. (17 September 2013). Soluble biomarkers to evaluate chondroprotection: The Revolution is underway ! [Paper presentation]. International Cartilage Repair Society-ICRS 2013, Izmir, Turkey.

Oprenyeszk, F., Chausson, M., Maquet, V., Dubuc, J.-E., & Henrotin, Y. (16 September 2013). The intra-articular injection of alginate-chitosan beads in an hydrogel prevents the development of osteoarthritis in ACLT model [Paper presentation]. ICRS 2013, Izmir, Turkey.

Pesesse, L., Sanchez, C., Delcour, J.-P., Baudouin, C., Msika, P., & Henrotin, Y. (December 2012). La bone sialoproteine: un facteur clé dans la pathogénie de l'arthrose [Paper presentation]. 25è Congrès Français de Rhumatologie, Paris, France.

Pesesse, L., Sanchez, C., Delcour, J.-P., Baudouin, C., Msika, P., & Henrotin, Y. (December 2012). Association entre l'hypertrophie du chondrocyte et l'angiogenèse du cartilage dans l'arthrose [Paper presentation]. 25è Congrès Français de Rhumatologie, Paris, France.

Pesesse, L., Sanchez, C., Delcour, J.-P., Baudouin, C., Msika, P., & Henrotin, Y. (13 November 2012). Association between chondrocytes hypertrophy and angiogenesis of cartilage in osteoarthritis [Poster presentation]. 2012 Annual Meeting of the American College of Rheumatology, Washington, United States - District of Columbia.

Oprenyeszk, F., Sanchez, C., Dubuc, J.-E., Maquet, V., & Henrotin, Y. (17 September 2012). Alginate-chitosan hydrogel beads decrease inflammatory and anabolic mediators produced by human chondrocytes [Poster presentation]. Belgian Symposium on Tissue Engineering 2012, Leuven, Belgium.

Lambert, C., Dubuc, J.-E., Hennuy, B., Montell, E., Vergés, J., & Henrotin, Y. (17 July 2012). Expression of specific pathways in the inflamed synovial membrane of osteoarthritis patient: Identification of new potential key intermediates [Poster presentation]. 6th European congress of pharmacology, Granada, Spain.

Oprenyeszk, F., Sanchez, C., Dubuc, J.-E., Maquet, V., & Henrotin, Y. (13 May 2012). Anti-inflammatory and anabolic effects of a new alginate-chitosan hydrogel beads on human chondrocytes [Paper presentation]. 10th World Congress of the International Cartilage Repair Society, Montreal, Canada.

Henrotin, Y. (29 April 2012). Les fragments de fibuline-3 (Fib3-1 et Fib3-2)sont des marqueurs de diagnostic de l'arthrose [Paper presentation]. 22ème Congrès national de la Société Marocaine de Rhumatologie, Marrakech, Morocco.

Lambert, C., Dubuc, J.-E., & Henrotin, Y. (19 April 2012). An original methodology to study the synovial tissue in OA patient [Poster presentation]. Biomedica, Liège, Belgium.

Maquet, V., Chausson, M., Gautier, S., Oprenyeszk, F., Sanchez, C., & Henrotin, Y. (19 April 2012). Advances in biomaterials to repair cartilage [Paper presentation]. Biomedica 2012, Liege, Belgium.

Oprenyeszk, F., Sanchez, C., Dubuc, J.-E., Maquet, V., Chausson, M., Drion, P., & Henrotin, Y. (19 April 2012). New alginate-chitosan hydrogel to repair cartilage. A partner ship between www.bcru.be and www.kitozyme.com [Poster presentation]. Biomedica 2012, Liege, Belgium.

Henrotin, Y. (18 April 2012). New alginate-chitosan hydrogel to repair cartilage [Paper presentation]. Congrès Biomedica, Liège, Belgium.

Pesesse, L., Sanchez, C., Baudouin, C., Msika, P., & Henrotin, Y. (April 2012). Bone sialoprotein: a key mediator of the angiogenic activity of hypertrophic osteoarthritic chondrocytes [Poster presentation]. 16th World Congress of the OsteoArthritis Research Society International (OARSI), Barcelona, Spain.

Henrotin, Y. (20 January 2012). The use of biomarkers in the personalized mangement of osteoarthritic patients : myth or reality [Paper presentation]. World Congress on debates and consensus in Bone, Muscles and Joint Diseases, Barcelona, Spain.

Pesesse, L., Sanchez, C., Walsh, D., Baudouin, C., Msika, P., & Henrotin, Y. (2011). La Bone sialoprotéine est associée à la différenciation hypertrophique des chondrocytes et aux lésions du cartilage arthrosique [Paper presentation]. 24ème congrès français de rhumatologie, Paris, France.

Sanchez, C., Pesesse, L., & Henrotin, Y. (2011). Les ostéoblastes des zones sclérosées de l’os sous-chondral arthrosique expriment moins de connexine-43 : une explication possible à la diminution de la sensibilité mécanique de ces cellules [Paper presentation]. 24ème congrès français de rhumatologie, Paris, France.

Mathy, M., Lambert, C., Dubuc, J. E., Montell, E., Vergés, J., & Henrotin, Y. (September 2010). Synovium angiogenesis in osteoarthritis: a new therapy target for chondroitin sulfate [Poster presentation]. 2010 World Congress on Osteoarthritis, Bruxelles, Belgium.

Mathy, M., Lambert, C., Dubuc, J. E., Montell, E., Vergés, J., & Henrotin, Y. (September 2010). La chondroitine sulfate stimule la production des facteurs anti angiogéniques TSP-1 et VEGI par les synoviocytes arthrosiques : un nouveau mécanisme d’action pour cette molécule [Poster presentation]. 23e congrès français de rhumatologie, Paris, France.

Horcajada, M.-N., Sanchez, C., Scalfo, F., Ameye, L., Henrotin, Y., & Offord, E. (2010). Effect of rosemary extract and related flavonoid carnosol on chondro-protection and on the bone-cartilage crosstalk [Paper presentation]. 15th World Congress of the OsteoArthritis Research Society International (OARSI), Brussels, Belgium.

Kesteloot, F., Gabay, O., Msika, P., Baudouin, C., Henrotin, Y., & Sanchez, C. (24 May 2009). Effects of compression on human subchondral osteoblast metabolism [Poster presentation]. ICRS 2009, Miami, United States.

Kesteloot, F., Pelletier, J.-P., Martel-Pelletier, J., Caron, J., Boileau, C., Bosseloir, A., Msika, P., Guillou, B., Henrotin, Y., & Deberg, M. (23 May 2009). Follow-up of COLL2-1, COLL2-1NO2 and myeloperoxydase in dogs after transection of the cruciate ligament of the knee [Poster presentation]. ICRS 2009, Miami, United States.

Sanchez, C., Gabay, O., Pesesse, L., Msika, P., Baudouin, C., & Henrotin, Y. (2009). Compression induces the expression of a sclerotic phenotype in human subchondral osteoblasts [Poster presentation]. 13th World Congress of the OsteoArthritis Research Society International (OARSI), Montréal, Canada.

Sanchez, C., Deberg, M., Msika, P., Baudouin, C., & Henrotin, Y. (2008). Study of the in vitro conditions promoting hypertrophic differentiation of osteoarthritic articular chondrocytes [Poster presentation]. 28th European Workshop for Rheumatology Research, Paris, France.

Sanchez, C., Mathy, M., Gabay, O., Msika, P., Baudouin, C., & Henrotin, Y. (2008). Etude des effets de la compression sur le métabolisme des ostéoblastes sous-chondraux humains [Poster presentation]. 21e Congrès Française de Rhumatologie (SFR), Paris, France.

Deberg, M., Labasse, A., Sanchez, C., Bosseloir, A., & Henrotin, Y. (2007). Follow-up of COLL2-1, COLL2-1NO2 and myeloperoxidase serum levels in marathon runners [Poster presentation]. 12th World Congress of the OsteoArthritis Research Society International (OARSI), Fort Lauderdale, United States - Florida.

Mathy, M., Sanchez, C., Priem, F., & Henrotin, Y. (2007). Curcumin inhibits interleukin-6, -8, nitric oxide and prostaglandin E2 synthesis by bovine chondrocytes [Poster presentation]. 12th World Congress of the OsteoArthritis Research Society International (OARSI), Miami, United States - Florida.

Sanchez, C., Deberg, M., Bellahcene, A., Castronovo, V., Msika, P., & Henrotin, Y. (2007). Phenotypic characterisation of osteoblasts from the sclerotic zone of human osteoarthritic subchondral bone [Poster presentation]. 27th European Workshop for Rheumatology Research, Barcelona, Spain.

Sanchez, C., Gabay, O., Salvat, C., Henrotin, Y., & Berenbaum, F. (2007). Mechanical stress strongly induces interleukin-6 production by osteoblasts: a new in vitro 3D compression model [Poster presentation]. 12th World Congress of the OsteoArthritis Research Society International (OARSI), Fort Lauderdale, United States - Florida.

Deberg, M., Labasse, A., Quettier, E., Dubuc, J., Backelandt, P., & Henrotin, Y. (2006). Coll2-1, Coll2-1 NO2 and myeloperoxidase in OA patients before and after hip or knee replacement [Paper presentation]. ICRS.

Mathy, M., Hogge, L., Sanchez, C., Deby, G., & Henrotin, Y. (2006). Interleukin-1beta and interleukin-6 disturb the antioxidant enzyme system in bovine chondrocytes: a possible explanation for oxidative stress generation [Poster presentation]. 11th World Congress of the OsteoArthritis Research Society International (OARSI), Prague, Czechia.

Sanchez, C., Kaut, E., DEBERG, M., & Henrotin, Y. (2006). Interleukin-6 mediates subchondral osteoblasts-induced cartilage degradation [Paper presentation]. 6th International Cartilage Repair Society (ICRS) Symposium, San Diego, United States - California.

Henrotin, Y., Kaut, E., Deberg, M., Delcour, J.-P., & Sanchez, C. (2005). Interleukin-6 mediates subchondral osteoblasts-induced cartilage degradation [Poster presentation]. 10th World Congress of the OsteoArthritis Research Society International (OARSI), Boston, United States - Massachusetts.

Henrotin, Y., Kaut, E., Deberg, M., Delcour, J.-P., & Sanchez, C. (2005). Etude in vitro de l’axe physiopathologique os-cartilage dans l’arthrose : implication de l’interleukin-6 [Poster presentation]. 18e Congrès Français de Rhumatologie, Paris, France.

Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (2005). Interleukin-1, Interleukin-6 and Oncostatin M Stimulate Normal Subchondral Osteoblasts to Induce Cartilage Degradation [Poster presentation]. 5th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO 5), Roma, Italy.

Mathy, M., Devel, P., Sanchez, C., Deberg, M., Deby, G., & Henrotin, Y. (2004). Effects of Interleukin-1beta and Dexamethasone on the Expression by Chondrocytes of Antioxidant Enzymes [Poster presentation]. 9th World Congress of the OsteoArthritis Research Society International (OARSI), Chicago, United States - Illinois.

Sanchez, C., Deberg, M., Devel, P., Reginster, J.-Y., & Henrotin, Y. (2004). Régulation du Métabolisme des Chondrocytes par l'Oncostatine M et l'Interleukine 6 [Poster presentation]. 17e Congrès Français de Rhumatologie, Paris, France.

Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (2004). Subchondral Bone Osteoblasts Induce Phenotypic Changes in Human Osteoarthritic Chondrocytes [Poster presentation]. 9th World Congress of the OsteoArthritis Research Society International (OARSI), Chicago, United States - Illinois.

Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (2004). Furanic Avocado/Soybean Unsaponifiables Prevent Osteoarthritic Subchondral Osteoblasts- Induced Cartilage Degradation [Poster presentation]. 9th World Congress of the OsteoArthritis Research Society International (OARSI), Chicago, United States - Illinois.

Mouithys-Mickalad, A., Mathy, M., Deby, C., Lamy, M., Henrotin, Y., & Deby-Dupont, G. (22 June 2001). Potential Antioxidant properties of Aceclofenac and its Metabolites: Investigation on an in vitro model [Poster presentation]. The Meeting of the Society for Free Radical Resqearch Europe (SFRR-2001), Roma, Italy.

Henrotin, Y., Sanchez, C., Deberg, M., & Reginster, J.-Y. (2001). Diacerein by its Metabolite Rhein, Down-Regulates Stromelysins and Nitric Oxide Productions and Up-Regulates Aggrecan Production by Human Chondrocytes in Alginate Beads [Poster presentation]. First Biennal Meeting of the European Tissue Engineering Society International (ETES), Freiburg, Germany.

Sanchez, C., Reginster, J.-Y., & Henrotin, Y. (2001). Long-term Effects of Nonsteroidal Antiinflammatory Drugs on Human Chondrocytes in Alginate Beads [Poster presentation]. Annual European Congress of Rheumatology (EULAR), Prague, Czechia.

De Leval, X., Delarge, J., Devel, P., Damas, J., Henrotin, Y., Michaux, C., Pirotte, B., Masereel, B., & Dogne, J. M. (May 2000). Evaluation de la selectivité COX-1/COX-2 de drogues à visée anti-inflammatoire sur sang humain [Poster presentation]. 14èmes Journées Franco-Belges de Pharmacochimie, Lille, France.

De Leval, X., Delarge, J., Devel, P., Damas, J., Henrotin, Y., Neven, P., Masereel, B., Pirotte, B., Somers, F., Wouters, J., Michaux, C., & Dogne, J. M. (04 March 2000). Evaluation of classical NSAIDs in a model of human whole blood assay [Poster presentation]. Réunion de la Société Belge de Physiologie et de Pharmacologie Fondamentales et Cliniques, Bruxelles, Belgium.

De Leval, X., Dogne, J. M., Masereel, B., Pirotte, B., Reginster, J.-Y., Neven, P., Labasse, A., Delarge, J., & Henrotin, Y. (20 November 1999). Profile of nimesulide and nimesulide-L-lysine-β-cyclodextrin on chondrocyte metabolism [Poster presentation]. Réunion de la Société Belge de Physiologie et de Pharmacologie Fondamentales et Cliniques, Bruxelles, Belgium.

De Leval, X., Henrotin, Y., Masereel, B., Pirotte, B., Somers, F., Neven, P., Devel, P., Delarge, J., & Dogne, J. M. (20 November 1999). Evaluation of classical NSAIDs on COX-1 and COX-2 purified enzymes and prognosis of their effects on physiological responses [Poster presentation]. Réunion de la Société Belge de Physiologie et de Pharmacologie Fondamentales et Cliniques, Bruxelles, Belgium.

De Leval, X., Dogne, J. M., Delarge, J., Pirotte, B., Dupont, G., Mathy-Hartert, M., Chahboune, J., Labasse, A., Neven, P., Reginster, J.-Y., & Henrotin, Y. (17 September 1999). Comparative effects of nimesulide, nimesulide L-lysine and nimesulide L-lysine L-arginine on human articular chondrocytes in vitro [Poster presentation]. Groupe de Contact FNRS/FRSM “Mécanismes Cellulaires de l’Inflammation", Bruxelles, Belgium.

Dogne, J. M., De Leval, X., Delarge, J., Dupont, G., Mathy-Hartert, M., Chahboune, J., Labasse, A., Neven, P., Somers, F., Pirotte, B., Reginster, J.-Y., & Henrotin, Y. (17 September 1999). Synthesis and evaluation of non-carboxylic pyridinic derivatives as cyclooxygenase inhibitors [Poster presentation]. Groupe de Contact FNRS/FRSM “Mécanismes Cellulaires de l’Inflammation", Bruxelles, Belgium.

De Leval, X., Dogne, J. M., Neven, P., Labasse, A., Masreel, B., Somers, F., Pirotte, B., De Tullio, P., Delarge, J., Reginster, J.-Y., & Henrotin, Y. (May 1999). Evaluation de la sélectivité COX-1 vs COX-2 de drogues à potentialités anti-inflammatoires [Poster presentation]. Treizièmes Journées Franco-Belges de Pharmacochimie, Liège, Belgium.

Henrotin, Y. (13 September 1991). Excited human chondrocytes can produce oxygen derived free radicals and hydrogen peroxide [Paper presentation]. 1st EULAR Workshopon Cartilage and Bone Diseases, Leuven, Belgium.

Henrotin, Y. (07 September 1991). pPoduction of active oxygen species by human articular chondrocytes [Paper presentation]. Congrès Aging and Free Radicals, Paris, France.

Henrotin, Y. (20 March 1989). RIA for human type II collagen [Paper presentation]. 13th meeting of the Belgian Connective Tissue Society, Leuven, Belgium.

Books

As editor or director

Henrotin, Y. (Ed.). (2012). Nonpharmacological Therapies in the Management of Osteoarthritis. Bentham Science Publishers Ltd. doi:10.2174/97816080531791120101

Book chapters and contributions to collective works

Henrotin, Y. (2019). Glucosamine et chondroitine: un intérêt majeur pour les articulations. In Les cahiers des compléments alimentaires - l'intégral (pp. 69-70). Paris, France: Synadiet.

Henrotin, Y. (2019). Glucosamine et chondroïtine : à titre préventif pour diminuer les coûts liés à l’arthrose. In Les cahiers des compléments alimentaires - l'abrégé (pp. 6-7). Paris, France: Synadiet.

Henrotin, Y. (2016). Les marqueurs biologiques de l'arthrose : de la conception à la qualification. In Institut Servier, De l'arthrose aux arthroses (pp. 58-67). Paris, France: Springer.

Mobasheri, A., Barret-Jolley, R., Staunton, C., Ford, C., & Henrotin, Y. (2015). Nutrigenomics, Inflammaging, and Osteoarthritis: A Review. In D. Bagchi, A. Swaroop, ... M. Bagchi, Genomics, Proteomics and Metabolomics in Nutraceuticals and Functional Foods, 2nd Edition (pp. 71-80). Wiley. doi:10.1002/9781118930458.ch7

Henrotin, Y. (2013). Novel discoveries on the mechanism of action of GAGs in OA. In A modern approach to an old disease: glycosaminoglycans (GAGs) therapy in osteoarthritis (pp. 3-5). Rome, Italy: Health Publishing & Services.

Henrotin, Y., Alvarez-Miezentseva, V., & SIMONI, P. (2013). Arthrose. In A. Cotten, Imagerie musculosquelettique pathologies générales (2ème édition, pp. 1-22). France: Elsevier Masson.

Henrotin, Y., Marty, M., & Mobasheri, A. (2013). NonPharmacological modalities, nutraceuticals and dietary supplements as therapies. In Addressing Unmet Needs in Osteoarthritis (pp. 99-110). Future medicine. doi:10.2217/9781780841656

Bennell, K., Rannou, F., & Henrotin, Y. (2012). Recent advances and perspectives. Non-pharmacological therapies for the management of osteoarthritis in guidelines: discrepancies and translating evidence in practices. In Y. Henrotin, K. Bennell, ... F. Rannou (Eds.), Non-pharmacological therapies in the management of osteoarthritis. Bentham Science.

Henrotin, Y., Nguyen, C., & Genevay, S. (2012). Low back pain. In J. W. Bijlsma (Ed.), EULAR Textbook on Rheumatic Diseases (pp. 853-877). London, United Kingdom: BMJ Group.

Henrotin, Y., Pesesse, L., & Sanchez, C. (2012). Chapiter 10: Identification of mechanosensitive genes in chondrocytes and osteoblasts and their role in OA pathogenesis. In A. Kamklin & I. Kiseleva (Eds.), Mechanical stretch and cytokines (pp. 223-233). Springer. doi:10.1007/978-94-007-2004-6

Henrotin, Y., & Reginster, J.-Y. (2012). New drugs and nutraceuticals in the treatment of osteoarthritis. In S. Cox Gad (Ed.), Development of Therapeutic Agents Handbook (pp. 847-880). Hoboken, United States - New Jersey: Wiley.

Sanchez, C., Mathy, M., & Henrotin, Y. (2011). The mechanosensitivity of cells in joint tissues: Role in the pathogenesis of joint diseases. In A. Kamkin & I. Kiseleva (Eds.), Mechanosensitivity and Mechanotransduction (Volume 4, pp. 297-313). Springer. doi:10.1007/978-90-481-9881-8

Mobasheri, A., Henrotin, Y., Clutterbuck, A., Allaway, D., Lodwig, Harris, P., Mathy-Hartet, M., & Shakibaei, M. (2009). Nutritional biochemistry of curcumin (diferuloymethane) and a review of its biological actions on articular chondrocytes. In S. Haugen & S. Meijer (Eds.), Handbook of Nutritional Biochemistry (pp. 1-24). Nova Science Publishers.

Rannou, F., Poiraudeau, S., & Henrotin, Y. (2009). Low back pain including sciatica and DISH. In J. Bijlsma (Ed.), EULAR Compendium on Rheumatic Diseases (pp. 477-492). BMJ Publishing Group.

Reginster, J.-Y., Kvasz, A., Bruyère, O., & Henrotin, Y. (2002). Glucosamine and chondroitine sulfate. In Anti Aging Medizin 2001 : Konferenz der German Society of Anti-Aging Medicine (pp. 97-104). Berlin, Germany: Congres Compact Publ.

Henrotin, Y., Mathy-Hartet, M., & Reginster, J.-Y. (2001). Influence of nutraceuticals on cartilage health and integrity. In Proceeding of the Large Breed Health Care Symposium (pp. 34-39). Ed.

Croisier, J.-L., Henrotin, Y., Dumont, R., Debry, O., Reginster, J.-Y., & Crielaard, J.-M. (2000). Evaluation isocinétique des muscles du genou au cours de la gonarthrose. In Isocinétisme et personnes âgées (pp. 19-21). ERRF Montpellier Editeur.

Crielaard, J.-M., & Henrotin, Y. (1999). Scientific basis of physical therapy and rehabilitation in the management of patients with osteoarthritis. In J.-Y. Reginster, J.-P. Pelletier, J. Martel-Pelletier, ... Y. Henrotin (Eds.), Osteoarthritis: Clinical and experimental aspects (pp. 453-80). Springer.

Henrotin, Y., & Reginster, J.-Y. (1999). In vitro models for the study of cartilage damage and repair. In J.-Y. Reginster, J.-P. Pelletier, J. Martel-Pelletier, ... Y. Henrotin (Eds.), Osteoarthritis: Clinical and experimental aspects (pp. 53-58). Springer.

Caudron, I., Henrotin, Y., Reginster, J.-Y., & Serteyn, D. (1998). Computerised method to measure asymetrical articular compression on digitised X-rays. In Rivista SIDI Proceedings 5th WEVA Congress (1st part) (pp. 47-52). Ed.

Henrotin, Y., Deby-Dupont, G., Deby, C., & Franchimont, P. (1993). Active oxygen species, articular inflammation and cartilage damage. In I. Emerit & B. Chance (Eds.), Free Radicals and Aging (pp. 308-22). Basel, Switzerland: Birkhauser Verlag.

Franchimont, P., Bassleer, C., & Henrotin, Y. (1992). Régulation autocrine et paracrine de la production de protéoglycanes cartilagineux. In P. Gaucher, P. Netter, D. Régent, D. Mainard, ... P. Gillet (Eds.), Actualités en physiopathologie et pharmacologie articulaires (pp. 433-6). Paris, France: Masson.

Bassleer, R., Henrotin, Y., & Franchimont, P. (1990). Three dimensional culture model for studying human chondrocytes. In A. Maroudas & K. Kuettner (Eds.), Methods in Cartilage Research (pp. 93-95). Academic Press.

Bassleer, C., Henrotin, Y., Baasleer, R., & Franchimont, P. (1989). Effets de l'Etodolac sur le métabolisme des chondrocytes humains cultivés en agrégats. In A. Gaucher, J. Pourel, P. Netter, ... M. Kessler (Eds.), Actualités en physiopathologie et pharmacologie articulaires. Masson.

Theses and dissertations

Post-doctoral thesis

Henrotin, Y. (2003). Approche expérimentale de la pathogénie et du traitement de l'arthrose [Post doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/193172

Doctoral thesis

Henrotin, Y. (1994). Production de protéines matricielles, de cytokines et de formes activées de l'oxygène par les chondrocytes articulaires humains in vitro [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/193173

Expert reports

Henrotin, Y. (2006). Propriétés cryogéniques de la compresse FfleXX. WELLCARE products. https://orbi.uliege.be/handle/2268/130129

Henrotin, Y. (2005). Pharmaceutical/Nutraceutical management of equine and canine osteoarthritis : some new perspectives. https://orbi.uliege.be/handle/2268/130128

Learning materials

Course notes

Henrotin, Y. (2007). Vademecum AESS-CAPAES en sciences de la santé.

Henrotin, Y. (2004). Techniques particulières de la kinésithérapie - 3ème bac - Département des Sciences de la motricité - Section kinésithérapue et réadaptation fonctionnelle.

Henrotin, Y. (2004). Pathologie générale -2ème et 3ème bac - Département des Sciences de la motricité - Section kinésithérapie et réadaptation fonctionnelle.

Other publications and communications

Articles in scientific journals without peer reviewing

Henrotin, Y. (20 November 2024). Influence of the Covid-19 Pandemic on the Algo- Functional Status and the General Health of Osteoarthritis Patients. Archive of Pharmacy and Pharmacology Research, 3 (5), 1-8. doi:10.33552/APPR.2023.03.000573

Bjerre-Bastos, J. J., Hamrouni, N., Henrotin, Y., Thudium, C. S., & Bihlet, A. R. (December 2023). Joint biomarker response to mechanical stimuli in osteoarthritis - A scoping review. Osteoarthritis and Cartilage Open, 5 (4), 100390. doi:10.1016/j.ocarto.2023.100390

Burniat, A., Noël, A., Colige, A., Vanderplasschen, A., de Kerchove d'Exaerde, A., Kupper Cardozo, A., Van Keymeulen, A., Moens, A., Bondue, A., Herpain, A., Marchant, A., Loumaye, A., Beck, B., Van den Heyden, B., Corvilain, B., Lakaye, B., Rogister, B., Malgrange, B., Michiels, C., ... Brunko, E. (2023). Cent scientifiques répliquent à SEA (Suppression des Expériences sur l’Animal vivant) et dénoncent sa désinformation. La Libre Belgique.

Henrotin, Y., & Le Gout, P. (September 2020). Pour une meilleur prise en charge de vos patients arthrosiques: Les enseignements des récentes recommandations internationales de l’OARSI. Rhumatos, 17 (156), 3-11.

Henrotin, Y., & Mathy, C. (April 2020). Les douleurs de la gonarthrose. Comment les prendre en charge? Que dire à vos patients ? Rhumatos, 17 (153), 159-166.

Henrotin, Y. (2020). Le microbiote : une nouvelle cible pour traiter l’arthrose. Rhumatos, 17 (157), 5-8.

Henrotin, Y., Donneau, A.-F., De Vlam, K., Wittoek, R., & Luyten, F. (2020). Responses to "bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: A double-blind multicenter randomized placebo controlled three-arm study": Authors' reply [letter to the editor]. Arthritis Research and Therapy, 22 (1). doi:10.1186/s13075-020-2109-2

Henrotin, Y., Mathy, C., MALAISE, O., Metayer, B., & Albanese, P. (March 2019). La Fondation Arthrose récompense trois chercheurs. Rhumatos, 16, 180-183.

Mobasheri, A., & Henrotin, Y. (2019). Comment on: Efficacy of Curcumin and Boswellia for knee osteoarthritis: Systematic review and meta-analysis [letter to the editor]. Seminars in Arthritis and Rheumatism, 48 (4), 25-e26. doi:10.1016/j.semarthrit.2018.04.002

Henrotin, Y. (February 2017). Les marqueurs biologiques de l’arthrose: De la découverte à l’analyse biologique de routine. Rhumatos, 14 (123), 180-183.

Boulocher, C., & Henrotin, Y. (2017). Vers de nouvelles pistes diagnostiques et thérapeutiques pour l'arthrose chez l'homme. Nouveau Praticien Vétérinaire Canine-Féline, 14 (65), 7-10.

Boulocher, C., & Henrotin, Y. (2017). Diagnostics : les nouveautés sur les biomarqueurs de l'arthrose chez le chien. Nouveau Praticien Vétérinaire Canine-Féline, 14 (65), 58-61.

Marée, M., Guillaume, M., Henrotin, Y., & Sevrin, A. (2017). Intégrer l’éducation pour la santé dans la formation initiale des enseignants du fondamental. Didactiques en Pratique, 3, 49-54.

Henrotin, Y. (January 2016). La physiopathologie du MODIC. Réflexions Rhumatologiques, 20 (179), 5-7.

Henrotin, Y. (November 2015). Légitimité des recommandations sur la viscosupplémentation. Rhumatos, 12 (111), 280.

Henrotin, Y. (March 2015). Quels produits injecterons nous demain dans nos articulations. Rhumatos, 12 (105), 70-71.

Demoulin, C., Marty, M., Genevay, S., Vanderthommen, M., Mahieu, G., & Henrotin, Y. (2013). Analyse de l'efficacité des programmes d'éducation rachidienne pour la prévention des lombalgies. Neurone, 18, 37-39.

Henrotin, Y. (2010). Biomarkers of osteoarthritis:opportunities and challenges for clinicians. SciTopics.

Henrotin, Y. (2009). Long-term cold therapy to treat knee osteoarthritis: proof-of-concept. Hospital Health Care.

Henrotin, Y. (2008). L'arthrose est-elle une maladie génétique ? Réflexions Rhumatologiques, 296 (12), 208-211.

Marty, M., & Henrotin, Y. (2007). L'information du patient lombalgique. Rhumatologie Pratique, 242, 1-3.

Bazin, T., Henrotin, Y., Cedraschi, C., Duquesnoy, B., & Duplan, B. (2006). Pourquoi et comment informer le patient lombalgique ? Réflexions Rhumatologiques, 10 (3), 32-35.

Henrotin, Y. (2006). Nutraceuticals in the management of osteoarthritis - facts and Senses. European Companion Animal Health, 18-20.

Henrotin, Y. (2006). Chondroprotective/structure-modifying drugs: a neverending story. Reumatissimo, 58, 15-16.

Mathy-Hartert, M., Burton, S., Deby-Dupont, G., & Henrotin, Y. (2003). Le Rôle des antioxydants dans la prise en charge des maladies articulaires. Dieta, 33, 22-25.

Henrotin, Y. (2002). NSAIDS : not just COX-2 inhibitors ? Intern Clin Pract Series, 19, 5-17.

Henrotin, Y. (2000). Recommandations Européennes (COST B13) en matière de prévention des lombalgies. Kiné.

Speeches and writings for a general audience

General audience and popularisation articles

Henrotin, Y., & Oprenyeszk, F. (2016). Des champignons contre l'arthrose. Télépro.

Henrotin, Y., & Oprenyeszk, F. (2016). Guérir l'arthrose grâce au champignon de Paris. Soir mag.

Demoulin, C., Roussel, N., Marty, M., Mathy, C., Genevay, S., Henrotin, Y., Tomasella, M., Mahieu, G., & Vanderthommen, M. (2015). Prise en charge des patients lombalgiques : les mots du thérapeute aussi importants que ses mains. Axxon Exclusif.

Henrotin, Y. (2012). Synolyne, nouvelle spin-off pour éradiquer l'arthrose. L'Echo, p. 17.

Henrotin, Y. (March 2012). Un pôle d'excellence wallon en santé articulaire. 15e Jour du Mois, 212.

Henrotin, Y. (2012). Arthrose et la curcumine : protectrice et anti-inflammatoire. Compte-rendu d'une table ronde organisée par les laboratoires Tilman. Ortho-Rhumato, 10 (1).

Henrotin, Y. (May 2011). Vaincre le mal de dos. 60 Millions de Consommateurs, 155.

Henrotin, Y., Demoulin, C., & Zagala, A. (May 2011). Vaincre le mal de dos. Causes, manifestations, diagnostics, traitements : les réponses des spécialistes (Cahier spécial : les gestes et exercices qui soulagent). 60 Millions de Consommateurs, 155, p. 77-87.

Henrotin, Y. (2010). Sus à l'arthrose ! La Libre Belgique.

Henrotin, Y. (2010). L'arthrose en pleine évolution. La Libre Belgique, p. 55.

Henrotin, Y. (2010). L'arthrose n'est pas une fatalité. La Meuse, p. 19.

Henrotin, Y. (2010). Service en mouvement depuis 20 ans. Vers l'Avenir, p. 8.

Henrotin, Y. (April 2010). Les fausses croyances ont bon dos. Le Magazine du Pharmacien, 76, p. 2-5.

Henrotin, Y. (2010). Cinq ans d'enseignement de la kinésithérapie en Communauté Française ? Pour ou contre ? AXXON Magazine, p. 9-10.

Henrotin, Y. (2010). Se faire de vieux os. Le magazine de l'Université de Liège, 5, p. 30.

Henrotin, Y. (2010). Quelle place pour la glucosamine dans l'arthrose ? Impact Médecine, 328, p. 4.

Henrotin, Y. (2010). Mal de dos ? Stop aux idées reçues. La Santé - Femmes d'Aujourd'hui, 14, p. 43-44.

Henrotin, Y. (2010). Chez les gonarthrosiques, perdre du poids diminue la symptomatologie. Impact Médecine, 334, p. 6.

Henrotin, Y. (2010). C'est décidé, je bouge ! Zoom Santé, p. 21-22.

Henrotin, Y. (January 2009). Les idées reçues qui font mal ! La Santé - Femmes d'Aujourd'hui, 1, p. 40-41.

Henrotin, Y. (2008). 7 Belges sur 10 souffrent du dos. La Dernière Heure, p. 5.

Henrotin, Y. (2008). Pas de repos pour le mal de dos. La Libre Belgique, p. 12.

Henrotin, Y. (2008). Maux de dos : la révolution est en marche. Vers l'Avenir, p. 3.

Henrotin, Y. (2008). Mal de dos : mieux vaut prévenir. Le Soir, p. 16.

Henrotin, Y. (October 2008). Dos au mur. De la gymnastique pour dissiper les maux de dos. 15e Jour du Mois, 177, p. 4.

Henrotin, Y. (2008). La mallette de l'écolier. La Dernière Heure.

Henrotin, Y. (2008). Pas de repos pour le mal de dos. Médisphère, 320, p. 26-28.

Henrotin, Y. (2008). Orthèse. IFAC Newsletter, 2, p. 2.

Henrotin, Y. (2008). Mal au dos ? Reprenez rapidement l'exercice ! Kiné-Varia News, 382, p. 12.

Henrotin, Y. (2008). Lombalgies non spécifiques. Eviter le piège de la chronicité - Pour une approche biopsychosociale multidisciplinaire - Recommandations pour les lombalgies aigues. Dossier les Lombalgies - Edition spéciale de La semaine de la douleur, p. 2-4.

Henrotin, Y. (2007). Coup du lapin et cou douloureux. Le Soir.

Henrotin, Y. (2007). Mal de dos : lever les fausses croyances. Périodique de l'Union Nationale des Mutualités Libérales, p. 10-11.

Henrotin, Y. (2006). Retarder la sclérose osseuse. Sciences et Avenir, p. 43.

Henrotin, Y. (2006). Recherche sur le vieillissement : parkinson et arthrose primés. Le Journal du Médecin, p. 1762.

Henrotin, Y. (2006). Comme une trace d'arthrose. Le Vif. L'Express, p. 99.

Henrotin, Y. (2006). L'arthrose diagnostiquée tôt et sans radio ni résonance. Le Soir, p. 24.

Henrotin, Y. (2006). Santé : ça vaut le cou. Le Vif. L'Express, p. 86.

Henrotin, Y. (2006). Mieux mesurer l'arthrose. Folia Urgentia, 49, p. 8.

Henrotin, Y. (2005). Perspectives d'avenir du traitement anti-arthrosique. Medi-Sphere, p. 245.

Henrotin, Y. (2005). Lombalgiques, levez-vous! Le Vif. L'Express, p. 33.

Henrotin, Y. (2004). Un mot d'ordre : bouger ! Le Journal du Médecin, p. 1640.

Henrotin, Y. (2004). Quel enseignement de la kinésithérapie ? Le Soir, p. 15.

Henrotin, Y. (2004). La kiné de qualité en cinq ans à l'unif. L'avenir du Luxembourg, p. 23.

Henrotin, Y. (2004). Rééducation des troubles de l'équilibre chez les patients souffrant de la maladie de Parkinson. Parkinson Magazine, 2, p. 7-9.

Henrotin, Y. (2002). Maux de dos ? Fini, le repos au lit ! La Libre Belgique, p. 5.

Henrotin, Y. (2002). Le dos droit dès les primaires. Le Soir.

Henrotin, Y. (2000). Société Belge des Ecoles du Dos. L'école du dos offre la solution à la chronicité et à la récurrence des problèmes de dos. Actualité magazine, p. 49.

Henrotin, Y. (2000). Pour une école du dos. Le Soir, p. 12.

Henrotin, Y. (23 June 2000). Contre le mal du 21ème siècle ? Le Journal du Médecin, 14, p. 1276.

Henrotin, Y. (24 September 1998). Cartilage, un organe à ne pas négliger ! Semaine Médicale (Médecine Sociale. edition : Couverture Jaune) (La), 45, p. 8.

Henrotin, Y. (24 September 1998). Arthrose, une place de choix pour l'aceclofenac. Semaine Médicale (Médecine Sociale. edition : Couverture Jaune) (La), 45, p. 8.

Conferences given outside the academic context

Henrotin, Y. (2016). Bien soigner l'arthrose, un enjeu capital pour notre société [Paper presentation]. Conférence annuelle, Herstal, Belgium.

Others

Raman, R., Salomao D’Cruz Alison, Dikoum Cyrille, Zappia, J., Anthony Mishal, Caetano da Silva Caroline, Nivelle, R., Lavergne, A., Degueldre Christian, Ostertag Agnes, Bahri, M. A., Renn, J., Collet Corrine, Plenevaux, A., Solal Cohen Martine, Henrotin, Y., & Muller, M. (2022). Osteoblast Transcriptome in 4 days old zebrafish larvae and the role of Fbln1 and Col10a1a bone extracellular matrix proteins during skeletal development [Paper presentation]. German Society for Matrix biology (Deutsche Gesellschaft fuer Matrixbiologie e.V.) DGMB 2022, Frankfurt am Main, Germany.